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IMPROVING THE DESIGN AND OPERATION OF WHO-EPI VACCINE 
DISTRIBUTION NETWORKS 
Jung Lim, Ph.D. 
University of Pittsburgh, 2016 
 
Vaccines have contributed significantly to the prevention of diseases. Yet millions of children, 
especially in low and middle income countries, remain unvaccinated and are exposed to 
preventable diseases such as typhoid, measles and tuberculosis. There are many reasons for this 
including personal belief systems, vaccine safety concerns, problems with vaccine availability, 
failures in the healthcare system, social barriers and economic constraints. International 
organizations are making continual efforts to increase vaccine coverage in these countries using 
various strategies. In this research we focus on the problems associated with poor design and 
operation of vaccine delivery systems and address these issues via four broad contributions. First, 
we present four quantitative models that can be used to optimize the selection of locations for 
vaccine outreach (where teams from clinics go to relatively remote places to administer 
vaccines), in order to maximize the number of residents that can be reached; each model 
addresses a different type of coverage possibility. The models are analyzed and contrasted using 
an example and adapted to address the situation when the coverage assumptions and demands are 
uncertain. Second, we propose modular vaccine packaging as an alternative to current packaging, 
which is not standardized and leads to inefficiencies when packing vaccines into a storage 
 iv 
device; this in turn can result in vaccine shortages. We illustrate the benefits of modular 
packaging over current packaging schemes and storage devices that are commonly used in the 
field. Third, we suggest alternative ordering policies at the clinic level that are based on 
secondary vaccine packaging. The policies draw upon lean concepts that have been used in the 
manufacturing sector to simplify and improve inventory management. Since the ordering units 
are larger, storage space issues may occur at clinics or during vaccine transportation and the new 
ordering polices are analyzed in terms of their effect on storage. Lastly, we propose a 
mathematical model to redesign the vaccine distribution network from a central warehouse to 
individual health clinics and study algorithms to solve this difficult problem.  We propose a 
hybrid algorithm based on mixed integer programming and an evolutionary strategy. We also 
describe how to improve the performance of the evolutionary strategy and how to use the results 
of the evolutionary strategy to reduce the calculation time of the integer programming model.   
 v 
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1.0  INTRODUCTION 
1.1 MOTIVATION AND RESEARCH OBJECTIVE 
In 1974, the World Health Organization (WHO) established the Expanded Programme on 
Immunization (EPI) to ensure that all children have access to vaccines recommended for routine 
use (Bland & Clements, 1997). In many low and middle income countries, EPI and the Global 
Alliance for Vaccines and Immunization (GAVI, which was established in 1999 to extend the 
reach of EPI to the poorest countries) have combined to save millions of lives since the 
establishment of these programs. According to 2013 WHO data (Immunization coverage, Fact 
sheet N°378, 2014), world immunization coverage of diphtheria-tetanus-pertussis (DTP3), Polio, 
Measles, Tetanus and Hepatitis B vaccines is over 80%. Yet, despite improvements in global 
vaccine coverage during the past decade, there are millions of children in these countries who 
still do not get the full regimen of childhood vaccines that are routinely given to children in the 
developed world (GAVI, 2014) and limited resources, competing health priorities, poor 
management of health systems, and inadequate monitoring and supervision remain as key 
challenges. An estimated 22.8 million infants worldwide still miss getting basic vaccines. 
There are a multitude of strategies that can be used to deliver immunization services and 
there are two types of doses that can be given - routine or supplemental. The main distinction is 
that a supplemental dose is “additional” or “extra” to the doses required by the national 
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immunization schedule and may, or may not, be recorded in the child's immunization record. On 
the other hand, a routine dose is one that is prescribed according to the national immunization 
schedule, is administered based on the vaccination history of each individual, counts towards 
“fully immunized” status, and must be recorded on immunization cards and registers 
(WHO/UNICEF Guidance Note, 2011). 
By taking advantage of technology, low-cost mass production of many vaccines has 
become possible. However, keeping vaccines available with low costs remains one of the major 
challenges for vaccine supply chain managers. Most vaccines need to be maintained within a 
narrow temperature range from the point of manufacture to their use in an immunization session, 
within what is called the “cold chain,” which is essential to vaccine delivery. Many of the 
challenges of getting vaccines to children result from the poor management or operation of the 
vaccine supply chain. In particular, poor infrastructure and the constraints of the cold chain cause 
inefficiency in vaccine storage and transportation (Zaffran, 1995, Yadav, Lydon, Oswald, Dicko, 
& Zaffran, 2014).  
In many low and middle income countries supported by EPI, vaccines are distributed via 
their legacy medical supply chain, which is typically a three, four or five tier hierarchical 
network. Vaccines are purchased by international organizations and delivered to a central 
distribution center within each country from multiple suppliers/manufacturers. Through various 
levels of the supply chain, vaccines are then delivered to clinics where the final recipients are 
located. For example, Niger has a four-tier structure: central store, regional stores, district stores 
and clinics. All vaccines come to the central store by air and are transported to children 
successively through regional stores, district stores and finally, clinics. Figure 1 shows the health 
facilities for Niger. Vaccines are periodically replenished at each facility in amounts that can 
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ensure adequate service until the next replenishment. In most countries, for locations that are not 
conveniently located near a clinic, vaccination outreach activities are used, where health workers 
visit such locations. Since each clinic has very limited resources, including health workers, 
storage devices, transportation resources and time, teams from the clinic conduct outreach on 
fixed days in selected locations by foot, or by using locally available means of transportation 
(bicycles, locally arranged transport, etc.) (Ministry of Health, Government of Southern Sudan, 
2009). 
 
 
Figure 1. Health facilities for Niger 
 
This study is motivated by the need to seek improvements in vaccine supply chains and 
ultimately, to have more children be able to have access to vaccines via efficient network flow 
and scientific management. It begins by studying the issue of outreach. Since outreach sessions 
are usually not provided at the same location more than once a month and are planned and 
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organized with the community, they should be arranged such that they cover as many children as 
possible during the limited number of sessions. This study introduces several vaccine outreach 
models with different assumptions based on the maximal coverage location problem and 
investigates the results.  
The second focus of this research is on certain logistics aspects of vaccine delivery.  
Specifically it examines issues associated with storing vaccines efficiently in a storage device 
when transporting them, and on handling the replenishment process at facilities. When an upper 
level distribution center or hospital prepares the vaccines to send to lower level distribution 
centers or clinics, they are often sent in inner packs, which constitute a secondary packaging 
mode for vaccines.  These inner packs are the units in which vials are stored within larger cartons 
and because of their irregular sizes they can lead to inefficient space utilization within a storage 
device. This study is designated to clarify the benefits of the modular vaccine packaging which is 
proposed in Chapter 3. In related work, a vaccine ordering policy is also studied. Currently, at a 
clinic where actual vaccination occurs the vaccines are ordered in vial units. However, counting 
several kinds of vaccine vials and ordering them can lead to errors in the ordering process and 
increases ordering and order fulfillment effort. An ordering policy that is based on using inner 
pack quantities is proposed that can reduce ordering errors and order fulfillment effort.  
In the third part of this research, the problem of redesigning a whole vaccine supply chain 
is studied. Currently, in many countries vaccines are distributed via their legacy medical supply 
chain which is typically not cost-efficient. Because vaccines require a cold supply chain, 
capacity constraints on cold storage and cold transport are critical. Redesigning the vaccine 
supply chain includes: choosing intermediate hubs among the current distribution center 
locations, determining the flow paths from the central distribution facility (where vaccines are 
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received into a country) to health clinics where vaccination actually occurs, the transportation 
vehicles to allocate to each flow path, and storage devices to use at each location. The re-
designed network does not have to follow the current three or four tiered strictly arborescent 
structure commonly found in practice but can use alternative network structures. To re-design 
this network, we develop a mixed-integer optimization model and also suggest heuristic methods 
to get an approximate solution for larger problems. Numerical results are presented using real 
data from different countries. 
1.2 CONTRIBUTIONS 
This dissertation develops models for analyzing the issues raised above. The major contributions 
are: 
• The formulation and solution of mixed integer programming (MIP) models for vaccine 
outreach at the clinic level. 
• Robustness analysis on outreach MIP models with respect to uncertain demand in outreach 
locations and uncertain coverage assumptions. 
• Development of a spreadsheet model that evaluates the impact of different modular packing 
schemes and uses data from the Benin and Niger routine regimen along with commonly 
used vaccine carriers.  
• Applying lean concepts that have been used in the manufacturing sector to vaccine inventory 
management, in order to simplify ordering procedures and evaluate the impact on storage 
and transportation resources. 
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• Creation of a MIP model for redesigning the WHO-EPI vaccine distribution chain in any 
country and developing a hybrid evolutionary strategy /MIP algorithm to solve the model. 
• Development on an algorithm to apply vehicle routing strategies to a vaccine distribution 
network.  
 6 
2.0  COVERAGE MODELS TO DETERMINE OUTREACH VACCINATION 
CENTER LOCATIONS IN LOW AND MIDDLE INCOME COUNTRIES 
2.1 INTRODUCTION 
 
Vaccine delivery in many low and middle income countries is an extremely complex problem.  
The supply chains in such countries are limited in their cold-storage capacity and in their ability 
to transport vaccines quickly to various points throughout the country.  In addition to these 
supply chain limitations, most of these countries have geographically dispersed or nomadic 
populations.  Portions of their populations have limited or no access to vaccination locations due 
to poor infrastructure (poor road conditions or limited transportation) or other geographic 
barriers.  As examples, in the country of Niger, 90% of the roads are unpaved (Blanford, Kumar, 
Luo, & MacEachren, 2012).  In Nigeria, people from some rural areas may have to walk at least 
26 miles to access health care (BBC, 2006).  In Kenya, 40% of the population must travel in 
excess of an hour to the nearest primary healthcare facility (Noor, Amin, Gething, Atkinson, 
Hay, & Snow, 2006). Thus, people from remote locations within resource-deprived countries 
have difficulty reaching immunization locations for their standard regimen of vaccines. This puts 
these individuals at a very high risk of mortality from infectious diseases such as measles, yellow 
fever, polio and tuberculosis.   
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One method to overcome this challenge is to use outreach. Sustained outreach is a 
strategy for reaching remote sections of the population with limited access to immunization 
locations.  With this service, health care workers take vaccines from a fixed immunization 
location and travel to the remote locations, to immunize individuals there.  This service is 
different from a campaign which is a one-time attempt to raise immunization rates. Outreach is 
extremely important to the overall immunization programs in resource-deprived countries.  
Without outreach, many countries would suffer from extremely low coverage rates.  For 
example, a study was carried out in three zones of different population densities within Kenya to 
test the effectiveness of outreach programs as compared to only utilizing fixed immunization 
locations.  The study showed that with outreach, the coverage rate increased from 25% to 57% in 
the zone with lowest population density.  Coverage increased from 54% to 82% in the zone with 
greatest population density (World Health Organization, 1997).  
Outreach is typically provided on a systematic basis, at regular time intervals and regular 
outreach locations.  However, the outreach activities conducted from each immunization location 
can vary greatly depending on financial resources, time constraints, vaccine availability, 
population characteristics, usage rate of the fixed immunization location, health worker training, 
portable cold chain equipment available, and transportation available.  The decisions about when 
and where to conduct outreach and which vaccines to administer, are often made locally, 
depending on each location’s available resources (World Health Organization, 2001). 
Outreach from health centers constitutes the critical final link in the vaccine supply chain, 
which can be quite complex and is typically comprised of four levels in addition to outreach: a 
central location where vaccines are received into the country from manufacturers, regional 
locations (typically five to 10) that serve as distribution hubs, districts (typically 25-100) which 
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serve as the next layer of distribution and where vaccination may occur, and immunization health 
centers (typically 100-2000) which provide vaccinations to patients (Kaufmann, Miller, & 
Cheyne, 2011). Outreach planning has a significant effect on the behavior of the entire vaccine 
distribution chain. As previously noted, in many countries successful outreach greatly increases 
the number of people vaccinated and therefore increases the number of vaccines that must flow 
through the entire vaccine supply chain.  Thus, it is vital that countries consider the design and 
intended operation of their outreach programs as they are designing and equipping their entire 
vaccine supply chain. 
In summary, vaccine delivery is a complicated problem and the effectiveness of delivery 
is critical to reducing mortality rates in many resource-deprived countries.  To increase 
effectiveness outreach is widely utilized.  However, there are no quantitative outreach planning 
models available to help countries and individual facilities plan the optimal outreach strategy.  
The purpose of this chapter is to address this need.   
2.2 PROBLEM DEVELOPMENT AND LITERATURE REVIEW 
The objective in each of the various models formulated in this chapter is to maximize the number 
of people vaccinated through outreach, when resources are limited.  We assume that outreach is 
necessary whenever one or more villages are more than a distance 𝑑𝑑1 (typically, 5 km as per 
WHO guidelines) (Dicko, 2013) from an existing Immunization Health Center (IHC or clinic).  
An outreach team from the IHC visits one or more such villages, and residents from that village 
and all villages that are within a distance 𝑑𝑑1 of it are able to go there to be vaccinated.  We refer 
to a village that serves as an outreach vaccination center as a “center” and the other nearby 
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villages (within distance 𝑑𝑑1) from which residents travel to the center as “satellite” villages.  The 
maximum number of centers that can be selected for outreach during the planning horizon 
depends on the financial and other resources available at the IHC. The objective is to select 
centers so as to maximize the number of residents that can be served at each of the central 
villages and its respective satellite villages.    
As an illustrative example, Figure 2 shows seven villages (represented by the small 
circles) located near an IHC along with their corresponding patient populations (represented by 
the numbers above the circles). Three options are shown for the selection of an outreach center 
from that IHC.  If village A is selected as the center [Case A], then the satellite villages that are 
within 5 km are villages B, C, and D, and thus people in villages A, B, C and D can be 
vaccinated.  People in villages E, F and G will not be vaccinated.  In this case, the number of 
residents that can be covered by outreach is 170.   Similarly, 180 people can be covered in Case 
B and 160 in Case C. Therefore, if we are restricted to a single outreach location, then among 
these three villages, B would be the best option for a center.   
 
 
[Case A] [Case B] [Case C] 
Figure 2. Outreach example: selecting an outreach location 
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While more than one outreach strategy might be possible, there will typically be 
constraints that limit the final choice of outreach options.  For example, outreach to a particular 
location has a cost associated with it (that might depend upon distance or terrain or equipment 
used) and there might be some overall budget for outreach that constrains our choice of outreach 
trips.  Alternatively, costs might be similar for outreach to different sites but we might have a 
direct limit on the number of outreach sessions (e.g., because of personnel, vehicle, or equipment 
limits). In other cases, there might be limits on the length of a trip or preferences for certain trips 
over others.  Different strategies are possible depending on these constraints and the assumptions 
made on the type and amount of patient coverage that can be obtained at a center. 
In this chapter, we introduce three models that have different coverage assumptions and 
an integrated model for multiple IHCs. In addition, we consider the robustness of our solutions 
with respect to coverage assumptions and uncertainty in demand. 
Daskin and Dean (2004) discuss how the location set covering model, maximal covering 
model and P-median model have been used for location planning in health care and review other 
models derived from these three basic facility models. The different model types are applied 
selectively according to a problem's characteristics and objective. The problem addressed here 
may be viewed as a covering problem, which is well-known among facility location models 
(Farahani, Asgari, Heidari, Hosseininia, & Goh, 2012). In particular, it is related to the Maximal 
Covering Location Problem (MCLP), which was developed by Church and ReVelle (Church & 
ReVelle, 1974), with the objective of maximizing the amount of demand covered by a facility. In 
this model, it is assumed that all demand is covered if the demand location is within an 
acceptable service distance, otherwise it is not, i.e., coverage is binary. An extension to this is the 
concept of partial coverage, in which there are two distances: the maximum full coverage 
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distance D1 and the minimum non-coverage distance D2. The demand within distance D1 from a 
facility is fully covered while none of the demand beyond distance D2 is covered.  For demand at 
locations between distances D1 and D2 from the facility, the coverage level is assumed to be a 
decreasing function of the distance to the demand location. Thus, some customers are fully 
covered and the others are partially covered (Berman & Krass, 2002). This variation has been 
called the gradual covering problem by Drezner, Wesolowsky, and Drezner (2004), or MCLP 
with partial coverage by Karasakal and Karasakal (2004). Berman and Krass (2002) collectively 
refer to this class of models as the Generalized Maximal Covering Location Problem (GMCLP). 
In order to apply linear programming, they assume that the function for partial coverage is 
stepwise decreasing, so that the model is similar to MCLP. In these models, all demand at a 
location is assigned to the nearest facility, even though there might be two or more facilities near 
the demand location that are capable of serving the demand. Berman, Drezner, and Krass (2009) 
introduce the cooperative coverage model where the effect of facilities is combined if there are 
more than two facilities near the demand location. However, in this model the coverage is once 
again binary, with a demand location being fully covered if an aggregation of partial coverage 
possible from nearby facilities exceeds a certain threshold; otherwise there is no coverage. That 
is, there is no partial coverage of demand points. 
2.3 COVERAGE MODELS 
In this section, we consider four types of models to optimize coverage from outreach. In all of 
our models we consider multiple outreach locations that can be selected. We start with a basic 
model that is similar to the binary MCLP model. The second model extends this by drawing 
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from the GMCLP approach, with coverage being a stepwise and decreasing function of distance. 
The third model is a new generalization of the cooperative cover model: rather than being binary, 
an accumulation of partial coverage becomes the partial coverage of the location. The final 
model is a larger one that could be viewed as a generalization of any of the first three models.  
Here we formulate it as an extension of the second one, where each facility is constrained to lie 
within a given radial distance from one of several specific points (the IHCs).  
For ease of exposition, we assume that there is sufficient capacity to vaccinate the people 
who are targeted by an outreach trip (although it would be a straightforward extension to add in 
capacity constraints for trips). These models are described in the next four subsections, followed 
by numerical illustrations of each in the section after that. The illustrations use data that is 
generated from partial information on the state of Bihar in northern India that was obtainable, 
and which was the motivating application for this work.  We conclude with a discussion and 
summary of our work in the final section. 
2.3.1 Model 1: Binary coverage model 
In this basic model, it is assumed that residents in villages within a radius of 𝐷𝐷1 km from an 
outreach center are covered, while residents in other villages are not. 
Notation: 
𝑛𝑛: Total number of villages to be served via outreach from the IHC 
𝑝𝑝𝑖𝑖: Number of residents living in village 𝑖𝑖 
𝑐𝑐𝑖𝑖: Cost of outreach at village 𝑖𝑖 if it serves as an outreach center 
𝑑𝑑𝑖𝑖𝑖𝑖: Distance between village 𝑖𝑖 and village 𝑗𝑗 (with 𝑑𝑑𝑖𝑖𝑖𝑖 = 0) 
𝐷𝐷1: Maximal coverage distance  
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𝐶𝐶: Available budget for outreach 
𝑁𝑁: Maximum number of outreach centers that is feasible 
𝑥𝑥𝑖𝑖∈{0, 1}: 1 if village 𝑖𝑖 is selected as an outreach center; 0 otherwise  
𝑦𝑦𝑖𝑖∈{0, 1}: 1 if village 𝑖𝑖 is covered; 0 otherwise 
The mathematical model is as follows: 
 𝑀𝑀𝑀𝑀𝑥𝑥 �𝑝𝑝𝑖𝑖𝑦𝑦𝑖𝑖𝑛𝑛
𝑖𝑖=1
 (1)  
subject to  
 𝑦𝑦𝑖𝑖 ≤ � 𝑥𝑥𝑖𝑖
𝑖𝑖∈𝑆𝑆𝑖𝑖
     for   𝑆𝑆𝑖𝑖 = �𝑗𝑗:𝑑𝑑𝑖𝑖𝑖𝑖 ≤ 𝐷𝐷1, 𝑗𝑗 = 1, … ,𝑛𝑛�,   𝑖𝑖 = 1, … ,𝑛𝑛    (2)  
 �𝑐𝑐𝑖𝑖𝑥𝑥𝑖𝑖
𝑛𝑛
𝑖𝑖=1
≤ 𝐶𝐶      (3)  
 �𝑥𝑥𝑖𝑖
𝑛𝑛
𝑖𝑖=1
≤ 𝑁𝑁 (4)  
 𝑥𝑥𝑖𝑖∈{0,1},    𝑦𝑦𝑖𝑖∈{0,1},    for 𝑖𝑖 = 1, … ,𝑛𝑛     (5)  
 
The objective is to maximize the number of people who are vaccinated by outreach 
(across all villages selected along with their respective satellites).  Constraint (2) ensures that 
village i is covered only if it is D1 km or less from any village j which serves as an outreach 
center (a typical value for D1 might be 5 km). Constraints (3) and (4) respectively ensure that the 
available outreach budget and the limit on the number of outreach centers are not exceeded.  It is 
conceivable that only one of these constraints might exist.  
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2.3.2 Model 2: Variable single coverage model 
In this model, it is assumed that the coverage by outreach is a stepwise decreasing function of 
distance from an outreach center, rather than being binary. Given D1<D2<…<DK and 
1=α1>α2>…>αK>0, coverage is divided into groups:  
• If there are centers within distance D1  of the village, all residents (i.e., a fraction α1=1) go to 
one such center; else 
• If there are centers between distance D1 and D2, then a fraction α2 of the patient population 
will choose to visit one such center; else 
• … 
• If there are centers between distance DK-1 and DK, then a fraction αK of the population will 
choose to visit one such center; else 
• There is no coverage. 
 
A typical example might be K=3 with D1=5 km, D2=8 km, D3=10 km, and α1=1, α2=0.5, 
α3=0.2. 
Additional notation is as follows: 
𝐷𝐷𝑘𝑘: Distance from the outreach center of the 𝑘𝑘𝑡𝑡ℎ coverage boundary,𝑘𝑘 = 1,2, … ,𝐾𝐾 
𝛼𝛼𝑘𝑘: Coverage fraction attained if the nearest center is between 𝐷𝐷𝑘𝑘−1 and 𝐷𝐷𝑘𝑘 𝑘𝑘𝑘𝑘 of 𝑀𝑀 village  
Instead of the yi variables of the prior section we now have 
𝑦𝑦𝑖𝑖𝑘𝑘 ∈ {0, 1}: 1 if village i is covered by a center between 𝐷𝐷𝑘𝑘−1 and 𝐷𝐷𝑘𝑘  𝑘𝑘𝑘𝑘 of it; 0 otherwise 
The model is as follows: 
 
𝑀𝑀𝑀𝑀𝑥𝑥 �𝑝𝑝𝑖𝑖 �𝛼𝛼𝑘𝑘𝑦𝑦𝑖𝑖𝑘𝑘𝐾𝐾
𝑘𝑘=1
𝑛𝑛
𝑖𝑖=1
 (6)  
subject to  
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𝑦𝑦𝑖𝑖𝑘𝑘 ≤ � 𝑥𝑥𝑖𝑖
𝑖𝑖∈𝑆𝑆𝑖𝑖
     𝑓𝑓𝑓𝑓𝑓𝑓   𝑆𝑆𝑖𝑖 = �𝑗𝑗:𝐷𝐷𝑘𝑘−1 ≤ 𝑑𝑑𝑖𝑖𝑖𝑖 ≤ 𝐷𝐷𝑘𝑘, 𝑗𝑗 = 1, … ,𝑛𝑛�,   𝑖𝑖 = 1, … , 𝑛𝑛;                                        𝑘𝑘 = 1, … ,𝐾𝐾 (7)  
 �𝑦𝑦𝑖𝑖𝑘𝑘
𝐾𝐾
𝑘𝑘=1
≤ 1        𝑓𝑓𝑓𝑓𝑓𝑓  𝑖𝑖 = 1, … ,𝑛𝑛 (8)  
 �𝑐𝑐𝑖𝑖𝑥𝑥𝑖𝑖
𝑛𝑛
𝑖𝑖=1
≤ 𝐶𝐶      (9)  
 �𝑥𝑥𝑖𝑖
𝑛𝑛
𝑖𝑖=1
≤ 𝑁𝑁   (10)  
 𝑥𝑥𝑖𝑖∈{0,1},    𝑦𝑦𝑖𝑖𝑘𝑘∈{0,1},    𝑓𝑓𝑓𝑓𝑓𝑓 𝑖𝑖 = 1, … ,𝑛𝑛, 𝑘𝑘 = 1, … ,𝐾𝐾     (11)  
  
In this model the objective is the same as in the previous model but coverage is according 
to the appropriate coverage fraction.  Constraint (7) ensures that yik can be 1 only if village i is 
within the appropriate coverage radius from any outreach center.  Constraint (8) ensures that 
village i is assigned to at most one outreach center. Constraints (9) and (10) are the usual 
budget/resource constraints akin to (3) and (4) in Model 1.  
2.3.3 Model 3: Variable multiple coverage model 
The third model is a generalization of the second one: villages that are not within the 100% 
coverage distance D1 are not restricted to partial coverage by a single center (unless it is the only 
available choice).  Rather, residents who do not visit one such center might choose to visit 
another one. More specifically, given D1<D2<…<DK and 1=α1>α2>…>αK>0, coverage follows 
the following pattern:  
• If there are m1>0 centers within distance D1 of the village, all residents (i.e., a fraction α1=1) 
go to one such center; else 
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• If there are m2>0 centers between distance D1 and D2, then a fraction α2 of the population will 
choose to visit one such center; a further fraction α2 of the remaining population will choose 
to visit another such center; and so on  
… 
• If there are mK>0 centers between distance DK-1 and DK, then a fraction αK of the remaining 
population will choose to visit one such center; a further fraction αK of the remaining 
population will choose to visit another such center; and so on 
• There is no coverage if there is no center within distance DK of the village 
In general, the coverage in a village would be given by  
 𝛽𝛽 = 1 −�(1 − 𝛼𝛼𝑘𝑘)𝑚𝑚𝑘𝑘𝐾𝐾
𝑘𝑘=2
  
As an example, with K=3, D1=5 km, D2=8 km, D3=10 km, α1=1, α2=0.5, α3=0.2, m1=0, 
m2=2, m3=1, the fraction of residents covered would be given by 1-(1-0.5)2(1-0.2)1 = 0.80.  Thus, 
if the village had 100 residents, since there are no centers in the inner circle, 50% (i.e., 50) would 
go to one of the two centers in the next circle while 50% of the remaining 50 (i.e., 25) would go 
to the other, and 20% of the remaining 25 (i.e., 5) would go to the center in the outer circle; 20 
residents would choose not to go to any center for immunization. To further illustrate the 
difference between the model in this section and the previous one, consider the Figure 3 with 
four outreach centers in a region of 20 villages; these centers are located at villages 2, 8, 10 and 
14.  Suppose that as before α1=1, α2=0.5 and α3=0.2 in both models. 
 17 
 Figure 3. Variable outreach coverage example 
 
Consider village 6 and 11, neither of which is within the inner circle of any center and 
thus cannot receive 100% coverage.  Village 6 is within the outer circles of centers located at 
villages 8 and 10: with Model 2, the coverage would be 20%, all at one of centers 8 or 10.  With 
Model 3, the coverage would be 36%: 20% at one of 8 or 10, and 16% (i.e., 20% of the 
remaining 80%) at the other.  Village 11 is within the middle circle of the centers at locations 10 
and 14 and within the outer circle of the center at location 8.  Here the coverage would be 50% 
with the first model (at either center 10 or center 14), but in the second model with three possible 
center options, it would be 1-(1-0.5)2(1-0.2)=80% (50% at one of villages 10 and 14 and 25% at 
the other, 5% at village 8). 
 In our formulation of this problem we restrict ourselves to K=3.  Define the following 
additional notation: 
𝑀𝑀𝑟𝑟: Maximum number of villages within the  𝑓𝑓𝑡𝑡ℎ coverage circle of any village, 𝑓𝑓 = 1,2,3 
𝛽𝛽𝑚𝑚2𝑚𝑚3: Coverage constant with 𝑘𝑘2 centers between (𝐷𝐷1,𝐷𝐷2) and 𝑘𝑘3 centers between (𝐷𝐷2,𝐷𝐷3)        = 1 − (1 − 𝛼𝛼2)𝑚𝑚2(1 − 𝛼𝛼3)𝑚𝑚3   
𝑧𝑧𝑖𝑖𝑘𝑘𝑖𝑖 ∈ {0, 1}: 1 if there are no centers located within distance 𝐷𝐷1of 𝑖𝑖,𝑘𝑘 centers located between 
   distance (𝐷𝐷1,𝐷𝐷2) of 𝑖𝑖, and 𝑙𝑙 centers located between distance (𝐷𝐷2,𝐷𝐷3) of village 𝑖𝑖; 0 otherwise 
 
 1 
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Instead of the yik variables of the prior section we now have 
𝑦𝑦𝑖𝑖 ∈ {0, 1}: 1 if there is at least one center located within distance 𝐷𝐷1of 𝑖𝑖; 0 otherwise  
The values of 𝑀𝑀𝑟𝑟 are determined a priori by preprocessing.  To illustrate the notation, 
consider the outreach assignment shown in Figure 2-2.  For village 11, we have 0 centers within 
distance D1, 2 centers between distance (D1, D2), and 1 center between distance (D2, D3). Thus 
z11,2,1=1 and z11,k,l=0 for all other k, l.  For village 19, the corresponding numbers are 1, 0, and 2, 
but the model will insure z19,k,l=0 for all k, l because there is a center located within distance D1 
of village 19.   
The model is as follows: 
 𝑀𝑀𝑀𝑀𝑥𝑥 �𝑝𝑝𝑖𝑖𝑦𝑦𝑖𝑖𝑛𝑛
𝑖𝑖=1
+ ���𝑝𝑝𝑖𝑖𝛽𝛽𝑘𝑘𝑖𝑖𝑧𝑧𝑖𝑖𝑘𝑘𝑖𝑖𝑀𝑀3
𝑖𝑖=0
𝑀𝑀2
𝑘𝑘=0
𝑛𝑛
𝑖𝑖=1
 (12)  
subject to  
 𝑦𝑦𝑖𝑖 ≤ � 𝑥𝑥𝑖𝑖
𝑖𝑖∈𝑆𝑆𝑖𝑖
     𝑓𝑓𝑓𝑓𝑓𝑓   𝑆𝑆𝑖𝑖 = �𝑗𝑗:𝑑𝑑𝑖𝑖𝑖𝑖 ≤ 𝐷𝐷1, 𝑗𝑗 = 1, … ,𝑛𝑛�,   𝑖𝑖 = 1, … ,𝑛𝑛    (13)  
 ��  𝑧𝑧𝑖𝑖𝑘𝑘𝑖𝑖𝑀𝑀3
𝑖𝑖=0
𝑀𝑀2
𝑘𝑘=0
+ 𝑦𝑦𝑖𝑖 ≤ 1 (14)  
 �𝑘𝑘�𝑧𝑧𝑖𝑖𝑘𝑘𝑖𝑖
𝑀𝑀3
𝑖𝑖=0
𝑀𝑀2
𝑘𝑘=0
≤ � 𝑥𝑥𝑖𝑖
𝑖𝑖∈𝑆𝑆𝑖𝑖
     𝑓𝑓𝑓𝑓𝑓𝑓   𝑆𝑆𝑖𝑖 = �𝑗𝑗:𝐷𝐷1 < 𝑑𝑑𝑖𝑖𝑖𝑖 ≤ 𝐷𝐷2, 𝑗𝑗 = 1, … ,𝑛𝑛�,   𝑖𝑖 = 1, … ,𝑛𝑛 (15)  
 �𝑙𝑙�𝑧𝑧𝑖𝑖𝑘𝑘𝑖𝑖
𝑀𝑀2
𝑘𝑘=0
𝑀𝑀3
𝑖𝑖=0
≤ � 𝑥𝑥𝑖𝑖
𝑖𝑖∈𝑆𝑆𝑖𝑖
     𝑓𝑓𝑓𝑓𝑓𝑓   𝑆𝑆𝑖𝑖 = �𝑗𝑗:𝐷𝐷2 < 𝑑𝑑𝑖𝑖𝑖𝑖 ≤ 𝐷𝐷3, 𝑗𝑗 = 1, … , 𝑛𝑛�,   𝑖𝑖 = 1, … ,𝑛𝑛 (16)  
 �𝑐𝑐𝑖𝑖𝑥𝑥𝑖𝑖
𝑛𝑛
𝑖𝑖=1
≤ 𝐶𝐶      (17)  
 �𝑥𝑥𝑖𝑖
𝑛𝑛
𝑖𝑖=1
≤ 𝑁𝑁    (18)  
 𝑥𝑥𝑖𝑖∈{0,1},    𝑦𝑦𝑖𝑖∈{0,1},    𝑓𝑓𝑓𝑓𝑓𝑓 𝑖𝑖 = 1, … ,𝑛𝑛 (19)  
 𝑧𝑧𝑖𝑖𝑘𝑘𝑖𝑖∈{0,1},   𝑓𝑓𝑓𝑓𝑓𝑓 𝑖𝑖 = 1, … ,𝑛𝑛 ,   𝑘𝑘 = 0, … ,𝑀𝑀2,   𝑙𝑙 = 0, … ,𝑀𝑀3 (20)  
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The objective in this model has two terms: the first one counts the number of residents in 
villages with 100% coverage and the second in villages that obtain partial coverage. Constraints 
(14), (18) and (19) are similar to the ones in the prior models, while (15) ensures that if village i 
gets coverage, it is either 100% coverage or partial coverage from one particular combination of 
villages in the inner and outer secondary coverage circles.  Constraints (16) and (17) along with 
the fact that βkl is monotone increasing in k and l ensure that zikl =1 when there are k centers 
located between distance (D1,D2) and l centers located between distance (D2,D3) of village i.  
2.3.4 Model 4: Model with multiple IHCs 
In the last model we consider an entire district with multiple IHCs located within it.  It is 
possible that a particular village might be a candidate for outreach from more than one IHC. This 
model addresses the problem of developing the best combination of outreach programs across all 
IHCs within a district.  We could embed any of the models of the previous section into a larger 
problem for the entire district as appropriate; here we illustrate the model using the  case where 
there is variable single coverage at each village (as in Model 2). Additional notation is as 
follows: 
𝑘𝑘: Number of different IHCs in the district 
𝑁𝑁𝑞𝑞: Maximum number of outreach activities from IHC 𝑞𝑞 
𝐷𝐷𝑚𝑚𝑚𝑚𝑚𝑚: Maximum travel distance to an outreach location from any IHC 
We define yik similar to what we did in the variable single coverage model but also define 
𝑥𝑥𝑖𝑖𝑖𝑖 = {0, 1}: 1 if village i is selected as a center for outreach from IHC 𝑙𝑙; 0 otherwise  
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The model is as follows: 
 
𝑀𝑀𝑀𝑀𝑥𝑥 �𝑝𝑝𝑖𝑖 �𝛼𝛼𝑘𝑘𝑦𝑦𝑖𝑖𝑘𝑘𝐾𝐾
𝑘𝑘=1
𝑛𝑛
𝑖𝑖=1
 (21)  
subject to 
 
 𝑦𝑦𝑖𝑖𝑘𝑘 ≤ ��𝑥𝑥𝑖𝑖𝑖𝑖
𝑚𝑚
𝑞𝑞=1𝑖𝑖∈𝑆𝑆𝑖𝑖
     𝑓𝑓𝑓𝑓𝑓𝑓   𝑆𝑆𝑖𝑖 = �𝑗𝑗:𝐷𝐷𝑘𝑘−1 ≤ 𝑑𝑑𝑖𝑖𝑖𝑖 ≤ 𝐷𝐷𝑘𝑘, 𝑗𝑗 = 1, … ,𝑛𝑛�,                                                    𝑖𝑖 = 1 𝑡𝑡𝑓𝑓 𝑛𝑛  ,   𝑘𝑘 = 1, … ,𝐾𝐾 (22)  
 �𝑦𝑦𝑖𝑖𝑘𝑘
𝐾𝐾
𝑘𝑘=1
≤ 1        𝑓𝑓𝑓𝑓𝑓𝑓  𝑖𝑖 = 1, … ,𝑛𝑛 (23)  
 �𝑐𝑐𝑖𝑖𝑥𝑥𝑖𝑖
𝑛𝑛
𝑖𝑖=1
≤ 𝐶𝐶 (24)  
 �𝑥𝑥𝑞𝑞𝑖𝑖
𝑛𝑛
𝑖𝑖=1
≤ 𝑁𝑁𝑞𝑞       𝑓𝑓𝑓𝑓𝑓𝑓  𝑞𝑞 = 1, … ,𝑘𝑘 (25)  
 𝑑𝑑𝑞𝑞𝑖𝑖𝑥𝑥𝑞𝑞𝑖𝑖 ≤ 𝐷𝐷𝑚𝑚𝑚𝑚𝑚𝑚        𝑓𝑓𝑓𝑓𝑓𝑓  𝑞𝑞 = 1, … ,𝑘𝑘, 𝑗𝑗 = 1, … ,𝑛𝑛 (26)  
 �𝑥𝑥𝑞𝑞𝑖𝑖
𝑚𝑚
𝑞𝑞=1
≤ 1       𝑓𝑓𝑓𝑓𝑓𝑓  𝑖𝑖 = 1, … ,𝑛𝑛 (27)  
 𝑥𝑥𝑞𝑞𝑖𝑖∈{0,1},    𝑦𝑦𝑖𝑖𝑘𝑘∈{0,1},    𝑓𝑓𝑓𝑓𝑓𝑓 𝑖𝑖 = 1, … ,𝑛𝑛,   𝑘𝑘 = 1, … ,𝐾𝐾;    𝑞𝑞 = 1, … ,𝑘𝑘 (28)  
 
Here C represents the budget for the entire district in (25), a separate limit on the number 
of outreach sessions is defined for each IHC along with a distance constraint for each IHC in 
(26) and (27), and (28) that ensures that if there is an outreach center at a village it must come 
from a unique IHC. 
2.3.5 Numerical example 
We first illustrate the binary, variable single and multiple coverage models with the following 
example based on the Tetia Bambar IHC in the state of Bihar, India. This IHC has a total of 92 
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villages in its catchment area that are candidates for outreach centers. We were provided with the 
distances from the IHC to each outreach village and the patient populations at each village. 
However, the exact locations of these villages in relation to Tetia Bambar were not available, and 
given their small sizes and inconsistencies in how their names were spelled it was impossible to 
accurately locate them on any map. We therefore located the IHC at (0, 0) and randomly 
assigned coordinates to the villages while maintaining the given distances. The resulting 
coordinates of the villages along with their patient populations are listed in Table 1.  
We use coordinate units of 1 km and assume that all distances dij are Euclidean.  For the 
binary coverage model we assume D1 = 5 km.  For the variable coverage models, we also assume 
D2 = 8 km and D3 = 10 km along with coverage fractions α2= 0.5 and α3= 0.2.  In order to 
compare the results across the various models we ignored the budget constraints (i.e., (3), (9), 
and (17)) because it was impossible to obtain even approximate estimates from Bihar.  We only 
used the constraints on the maximum number of outreach activities (centers), N (i.e., (4), (10), 
and (18)). We solved each model for increasing values of N until we obtained 100% coverage. 
For each model, Table 2 lists the coverage obtained for each value of N, along with the 
respective locations of the outreach centers.  The numbers in bold face represent new locations of 
outreach centers that are added to or replace the ones from the previous (lower) value of N.  
The three models often give different locations and levels of coverage when the limit on 
the number of centers does not allow for 100% coverage.  As an example when only 4 centers 
are possible the coverage is 80.9% with Model 1, 88.6% with Model 2 and 90.5% with Model 3, 
and the models do not select the same 4 locations. However, as the number of possible centers 
(and the corresponding coverage) increases the centers start to converge to the same locations.  
In all cases, a total of 9 centers are required before 100% coverage can be obtained; the locations 
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are identical and such that each village is within the inner circle (5 km radius) of at least one 
center. Another interesting observation is that while one new center is always added as we 
increase N, there are many instances with all models where in addition to adding a new center an 
existing location is replaced with a new one. This emphasizes the value of an optimization model 
in selecting the best strategy. As an example, with Models 1 and 2, when N changes from 7 to 8 
four of the existing centers are replaced with five new ones; there are only three in common.  
Similarly, with Models 2 and 3, when N changes from 2 to 3, the two existing locations are 
replaced by three completely new ones. 
 
Table 1. Location information 
Village Location Population  Village Location Population X Y  X Y 
1 -11.84 4.93 228  47 1.38 -9.63 525 
2 -11.03 -7.51 646  48 1.49 5.38 348 
3 -10.07 2.85 366  49 1.53 10.24 401 
4 -10.07 3.61 671  50 1.84 5.19 706 
5 -9.88 0.40 594  51 1.94 4.89 650 
6 -9.78 -3.48 624  52 1.97 -5.86 865 
7 -8.93 3.79 711  53 2.76 -9.79 624 
8 -8.88 2.25 475  54 2.85 3.49 44 
9 -7.95 -3.40 198  55 2.92 2.91 147 
10 -7.75 -6.21 561  56 3.05 -2.49 563 
11 -7.52 0.19 525  57 3.18 5.46 273 
12 -7.13 6.73 1,049  58 3.39 -9.66 618 
13 -6.25 -2.92 554  59 3.43 -4.51 748 
14 -6.07 0.06 496  60 3.96 -7.97 756 
15 -5.37 -1.48 701  61 3.97 0.59 508 
16 -5.19 3.30 293  62 4.59 -7.89 348 
17 -5.14 -5.06 955  63 4.63 1.50 541 
18 -4.67 -8.98 466  64 4.65 4.82 240 
19 -4.65 11.30 246  65 4.69 2.13 463 
20 -4.54 8.41 203  66 5.08 2.93 434 
21 -4.38 2.98 297  67 5.29 -2.83 413 
22 -4.14 -3.25 398  68 5.59 9.87 848 
23 -3.67 0.41 695  69 5.61 -0.88 584 
24 -3.60 9.14 254  70 5.76 -5.74 661 
25 -3.48 -1.44 160  71 6.00 -0.57 636 
26 -3.23 0.92 498  72 6.60 -0.74 682 
27 -2.78 -3.86 442  73 6.71 -8.85 646 
28 -2.62 -9.70 317  74 6.72 5.99 485 
29 -2.38 -6.37 281  75 6.78 -7.45 541 
30 -2.36 -2.23 278  76 7.12 1.47 792 
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Table 1 (continued) 
31 -1.74 -8.48 736  77 7.32 0.80 592 
32 -1.65 -7.33 566  78 7.47 8.17 573 
33 -0.96 3.30 387  79 7.48 6.37 423 
34 -0.89 -10.30 195  80 7.70 5.60 493 
35 -0.78 -3.81 743  81 7.73 1.48 694 
36 -0.71 -3.05 370  82 7.82 -7.71 470 
37 -0.62 11.76 553  83 8.05 -6.30 482 
38 -0.41 -7.66 272  84 8.14 -1.24 355 
39 -0.14 8.26 627  85 8.90 3.83 692 
40 0.08 -10.23 543  86 8.94 3.94 677 
41 0.24 -8.79 473  87 9.03 0.51 540 
42 0.31 -9.84 329  88 9.53 3.62 90 
43 0.41 -7.65 374  89 10.03 5.38 613 
44 0.62 -10.20 491  90 10.27 6.24 313 
45 1.11 6.30 392  91 12.16 -4.61 488 
46 1.19 3.24 619  92 12.88 1.33 456 
 
Table 2. Results for the first three models 
 Model 1: Binary Coverage Model 2: Variable single 
coverage 
Model 3: Variable multiple 
coverage 
N No. 
Covered 
Percent 
Covered 
Center 
Locations 
No. 
Covered 
Percent 
Covered 
Center 
Locations 
No. 
Covered 
Percent 
Covered 
Center 
Locations 
1 10,749 26.9% 51 14,238 35.7% 53 14,238 35.7% 53 
2 20,515 51.4% 48, 51 25,167 63.1% 30, 51 25,463 63.8% 30, 51 
3 27,417 68.7% 11, 48, 51 32,390 81.2% 11, 48, 52 33,093 83.0% 11, 43, 60 
4 32,257 80.9% 8, 17, 48, 51 35,331 88.6% 
7, 17, 48,  
52 36,119 90.5% 
5, 31, 35, 
62 
5 35,812 89.8% 8, 17, 31, 48, 62 37,853 94.9% 
8, 17, 31, 
48, 62 38,347 96.1% 
8, 17, 31, 
48, 62 
6 37,590 94.2% 8, 17, 31, 48, 60, 73 38,742 97.1% 
8, 17, 31, 
48, 60, 73 39,132 98.1% 
8, 17, 31, 
48, 60, 73 
7 39,259 98.4% 6, 8, 30, 31, 60, 69 ,73 39,572 99.2% 
6, 8, 30,  
31, 60,  
69, 73 
39,746 99.6% 
6, 8, 30,  
31, 60,  
69, 73 
8 39,666 99.4% 
10, 11, 23, 
35, 39, 60, 
69, 73 
39,780 99.7% 
10, 11, 23, 
35, 39, 60, 
69, 73 
39,844 99.9% 
6, 8, 23,  
30, 39, 60, 
69, 73 
9 39,894 100.0% 
8, 10, 22, 
23, 35 ,39, 
60, 69, 73 
39,894 100.0% 
8, 10, 22, 
23, 35 ,39, 
60, 69, 73 
39,895 100.0% 
8, 10, 22, 
23, 35 ,39, 
60, 69, 73 
 
 
Finally, it is worth noting that there could be differences in the actual number of people 
covered at a specific outreach center; some centers that cover more locations might cater to a 
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larger number of patients than others.  However, the imbalances are not drastic.  As an 
illustration, consider the case when we have 6 outreach centers, in which case all three coverage 
models choose the same set of six locations for outreach as shown in Table 2 (Villages 8, 17, 31, 
48, 60 and 73).  Table 3 displays the actual population covered at each of these locations under 
the different coverage models. 
 
Table 3. Coverage at each of 6 centers with different coverage models 
Model 
Location No. 
Total 
8 17 31 48 60 73 
Binary 5,704 6,040 3,592 9,766 6,416 6,073 37,590 
Variable Single 5,704 6,490 3,714 9,997 6,416 6,420 38,742 
Variable Multiple 5,971 6,425 3,665 10,214 6,526 6,329 39,132 
 
Figure 3 provides a visual summary of the coverage results. Obviously, the variable 
coverage models always provides higher coverage than the binary coverage model but the 
differences start to get smaller when the number of centers (N) reaches about 7, and the models 
are identical when N =9.  The two variable coverage models behave similarly, and the gains from 
multiple coverage (as well as from variable coverage) over binary coverage are more noticeable 
at intermediate values of N. This is significant because in practice, the values of N are more 
likely to be in this intermediate range: if N is small the options are limited and the benefits of an 
optimization model are not significant, while large N values are unlikely in practice because of 
budgetary considerations and resource constraints. While Figure 4 indicates that we have 
diminishing marginal gains in coverage as we add outreach sessions, it also allows a social 
planner to evaluate these gains in light of the extra resources (monetary, equipment, personnel, 
etc.) that might be required for additional outreach sessions.   
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 Figure 4. Coverage with first three models 
 
Figure 5 further illustrates the differences in results from the three models for an 
intermediate value of N=3.  The three panels in the figure provide a visual depiction of the actual 
locations selected by the models. Notice that location 11 is common to all three models but the 
others differ depending on the model in use.  
 
 
Figure 5. Locations of 6 centers with different types of coverage 
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Finally, to illustrate the multiple IHC model consider a hypothetical district with a total 
of 80 villages served by 4 IHCs.  The locations of the villages and the IHCs are depicted in 
Figure 6. Populations of the individual villages are not shown, but these were randomly 
generated; the total population of the district for this example was equal to 4,645.   
 
 
Figure 6. Locations of 8 outreach centers for maximizing coverage 
 
In defining constraint (26) we assume the same value of Nq for all values of q, i.e., that 
each IHC was restricted to the same maximum number of outreach centers.  The multi-IHC 
problem was solved for values of Nq ranging from 1 through 9; the results on the total coverage 
are shown in Table 4. Once again budget constraints were ignored for the illustration. 
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Table 4. Coverage with 4 IHCs 
Outreach per 
IHC Population 
Coverage 
Percentage 
1 1,387 29.9 
2 2,243 48.3 
3 2,810 60.5 
4 3,169 68.2 
5 3,416 73.5 
6 3,607 77.7 
7 3,743 80.6 
8 3,816 82.2 
9 3,846 82.8 
 
As Table 4 indicates, there is a diminishing marginal benefit from allowing an IHC to 
have an extra outreach center.  In practice the number of outreach centers permissible would be 
limited by the budget and other available resources, but a table such as this one allows planners 
to balance the additional resources expended with more outreach centers against the gains in the 
number of residents vaccinated.  Figure 6 illustrates the case where Nq=2 and shows the locations 
of the two outreach centers for each of the four IHCs; the total coverage here is about 48%. 
2.4 ROBUST MODELS 
In this section, we consider two types of uncertainty. The first is with respect to our coverage 
assumptions. The first three models have different coverage assumptions based on the behavior 
of the underlying population. But it is difficult to know this behavior exactly. If a model that 
does not reflect the actual behavior of the population is applied, the result would not be reliable, 
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and the goal is to examine how the results from one set of assumptions perform when the actual 
behavior is different from the assumed one. The second type of uncertainty is with respect to 
demand. Since there might be a time difference between when the number of people at a location 
is recorded and when an outreach activity occurs, the number of people at a location might not be 
accurate, so that we have to consider possible variation in the number of people that might be 
served by outreach to see how robust a particular outreach strategy might be.  
2.4.1 Robustness for coverage assumptions 
Clearly, a solution to one of the models is feasible for the other models, since any set of outreach 
centers can be a solution. Therefore, we do not need to consider the potential for infeasibility of 
solutions to a model. Rather, a robust solution will be one that provides a good solution for all 
three models without sacrificing very many people that need to be covered. Table 5 shows the 
number of covered people for each model when the optimal solution of each of the other two 
models is applied. The percentage value shown below the number of covered people is the 
percentage difference from the maximum number of people covered by any of the models. 
 
Table 5. The number of covered people in each model with the optimal solution of the other models 
model 1 2 3 
solution 1 2 3 1 2 3 1 2 3 
1 10,749 8,508 8,508 14,060 14,239 14,239 14,060 14,239 14,239 
 
(20.85%) (20.85%) (1.26%) 
  
(1.26%) 
  
2 20,515 19,928 19,928 24,253 25,169 25,169 24,253 25,465 25,465 
 
(2.86%) (2.86%) (3.64%) 
  
(4.76%) 
  
3 27,418 27,163 25,985 32,384 32,394 32,078 32,639 32,840 33,097 
 
(0.93%) (5.23%) (0.03%) 
 
(0.98%) (1.38%) (0.77%) 
 
4 32,260 32,005 29,509 35,249 35,335 34,704 35,442 35,717 36,123 
 
(0.79%) (8.53%) (0.24%) 
 
(1.79%) (1.88%) (1.12%) 
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Table 5 (Continued) 
5 35,816 35,816 35,816 37,857 37,857 37,857 38,351 38,351 38,351 
         
6 37,593 37,593 37,593 38,746 38,746 38,746 39,135 39,135 39,135 
         
7 39,254 39,254 39,254 39,576 39,576 39,576 39,700 39,700 39,720 
      
(0.05%) (0.05%) 
 
8 39,670 39,670 39,652 39,784 39,784 39,775 39,807 39,807 39,837 
  
(0.05%) 
  
(0.02%) (0.07%) (0.07%) 
 
9 39,898 39,898 39,898 39,898 39,898 39,898 39,898 39,898 39,898 
          
These results indicate that choosing the wrong model might result in a significant number 
of people not being served (e.g., 20.85% in this example when the optimal solution from model 2 
is used but the behavior of patients is actually as assumed in model 1.) Note that when we can 
choose more outreach centers the solutions are the same (or very similar) regardless of the model 
used, but when we have a limited budget and the number of outreach centers we can have is 
small wrong assumptions on the population behavior can result in lower coverage.  In order to 
address this issue, a solution that performs well and is robust across all three models is desired 
and can be found using robustness techniques. That is, in order to obtain a robust solution to all 
three models, we have to minimize the maximum difference between the number of people who 
can be covered with each model and the number of people who can be covered with a robust 
solution. The robust model is as follows: 
 Min 𝑡𝑡 (29)  
 
subject to  
 𝐺𝐺1(𝑁𝑁) −�𝑝𝑝𝑖𝑖𝑦𝑦𝑖𝑖𝑛𝑛
𝑖𝑖=1
≤ 𝑡𝑡 (30)  
 𝐺𝐺2(𝑁𝑁) −�𝑝𝑝𝑖𝑖 �𝛼𝛼𝑘𝑘𝑦𝑦𝑖𝑖𝑘𝑘𝐾𝐾
𝑘𝑘=1
𝑛𝑛
𝑖𝑖=1
≤ 𝑡𝑡 (31)  
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 𝐺𝐺3(𝑁𝑁) −�𝑝𝑝𝑖𝑖𝑦𝑦𝑖𝑖𝑛𝑛
𝑖𝑖=1
−���𝑝𝑝𝑖𝑖𝛽𝛽𝑘𝑘𝑖𝑖𝑧𝑧𝑖𝑖𝑘𝑘𝑖𝑖
𝑀𝑀3
𝑖𝑖=0
𝑀𝑀2
𝑘𝑘=0
𝑛𝑛
𝑖𝑖=1
≤ 𝑡𝑡 (32)  
 𝑦𝑦𝑖𝑖 ≤ � 𝑥𝑥𝑖𝑖
𝑖𝑖∈𝑆𝑆𝑖𝑖
     𝑓𝑓𝑓𝑓𝑓𝑓   𝑆𝑆𝑖𝑖 = �𝑗𝑗:𝑑𝑑𝑖𝑖𝑖𝑖 ≤ 𝐷𝐷1, 𝑗𝑗 = 1, … ,𝑛𝑛�,   𝑖𝑖 = 1, … ,𝑛𝑛    (33)  
 �𝑐𝑐𝑖𝑖𝑥𝑥𝑖𝑖
𝑛𝑛
𝑖𝑖=1
≤ 𝐶𝐶      (34)  
 �𝑥𝑥𝑖𝑖
𝑛𝑛
𝑖𝑖=1
≤ 𝑁𝑁 (35)  
 𝑦𝑦𝑖𝑖𝑘𝑘 ≤ � 𝑥𝑥𝑖𝑖
𝑖𝑖∈𝑆𝑆𝑖𝑖
     𝑓𝑓𝑓𝑓𝑓𝑓   𝑆𝑆𝑖𝑖 = �𝑗𝑗:𝐷𝐷𝑘𝑘−1 ≤ 𝑑𝑑𝑖𝑖𝑖𝑖 ≤ 𝐷𝐷𝑘𝑘, 𝑗𝑗 = 1, … ,𝑛𝑛�,   𝑖𝑖 = 1, … , 𝑛𝑛;                                        𝑘𝑘 = 1, … ,𝐾𝐾 (36)  
 �𝑦𝑦𝑖𝑖𝑘𝑘
𝐾𝐾
𝑘𝑘=1
≤ 1        𝑓𝑓𝑓𝑓𝑓𝑓  𝑖𝑖 = 1, … ,𝑛𝑛 (37)  
 𝑦𝑦𝑖𝑖 ≤ � 𝑥𝑥𝑖𝑖
𝑖𝑖∈𝑆𝑆𝑖𝑖
     𝑓𝑓𝑓𝑓𝑓𝑓   𝑆𝑆𝑖𝑖 = �𝑗𝑗:𝑑𝑑𝑖𝑖𝑖𝑖 ≤ 𝐷𝐷1, 𝑗𝑗 = 1, … ,𝑛𝑛�,   𝑖𝑖 = 1, … ,𝑛𝑛    (38)  
 ��  𝑧𝑧𝑖𝑖𝑘𝑘𝑖𝑖𝑀𝑀3
𝑖𝑖=0
𝑀𝑀2
𝑘𝑘=0
+ 𝑦𝑦𝑖𝑖 ≤ 1 (39)  
 �𝑘𝑘�𝑧𝑧𝑖𝑖𝑘𝑘𝑖𝑖
𝑀𝑀3
𝑖𝑖=0
𝑀𝑀2
𝑘𝑘=0
≤ � 𝑥𝑥𝑖𝑖
𝑖𝑖∈𝑆𝑆𝑖𝑖
     𝑓𝑓𝑓𝑓𝑓𝑓   𝑆𝑆𝑖𝑖 = �𝑗𝑗:𝐷𝐷1 < 𝑑𝑑𝑖𝑖𝑖𝑖 ≤ 𝐷𝐷2, 𝑗𝑗 = 1, … ,𝑛𝑛�,   𝑖𝑖 = 1, … ,𝑛𝑛 (40)  
 �𝑙𝑙�𝑧𝑧𝑖𝑖𝑘𝑘𝑖𝑖
𝑀𝑀2
𝑘𝑘=0
𝑀𝑀3
𝑖𝑖=0
≤ � 𝑥𝑥𝑖𝑖
𝑖𝑖∈𝑆𝑆𝑖𝑖
     𝑓𝑓𝑓𝑓𝑓𝑓   𝑆𝑆𝑖𝑖 = �𝑗𝑗:𝐷𝐷2 < 𝑑𝑑𝑖𝑖𝑖𝑖 ≤ 𝐷𝐷3, 𝑗𝑗 = 1, … , 𝑛𝑛�,   𝑖𝑖 = 1, … ,𝑛𝑛 (41)  
 𝑥𝑥𝑖𝑖∈{0,1},    𝑦𝑦𝑖𝑖∈{0,1},    𝑓𝑓𝑓𝑓𝑓𝑓 𝑖𝑖 = 1, … ,𝑛𝑛 (42)  
 𝑦𝑦𝑖𝑖𝑘𝑘∈{0,1},    𝑓𝑓𝑓𝑓𝑓𝑓 𝑖𝑖 = 1, … ,𝑛𝑛, 𝑘𝑘 = 1, … ,𝐾𝐾    (43)  
 𝑧𝑧𝑖𝑖𝑘𝑘𝑖𝑖∈{0,1},   𝑓𝑓𝑓𝑓𝑓𝑓 𝑖𝑖 = 1, … ,𝑛𝑛 ,   𝑘𝑘 = 0, … ,𝑀𝑀2,   𝑙𝑙 = 0, … ,𝑀𝑀3 (44)  
where 𝐺𝐺𝑖𝑖(𝑁𝑁) is the objective value of the model 𝑖𝑖 when the number of outreach location is 𝑁𝑁 
The objective function and constraints (30) – (32) ensure that we minimize the difference 
between the optimal value in each model and the optimal robust value. Since all three models 
optimize the number of people covered for a specific value of N, there is not a significant issue 
with objective function scaling in constraints (30) – (32). However, we could consider scaling t 
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depending on the objective of the robustness analysis. For example, if we want to minimize the 
maximum percentage deviation across the three models from the robust optimum, we can 
multiply t by 𝐺𝐺𝑖𝑖(𝑁𝑁) (e.g., 𝐺𝐺1(𝑁𝑁) − ∑ 𝑝𝑝𝑖𝑖𝑦𝑦𝑖𝑖𝑛𝑛𝑖𝑖=1 ≤ 𝐺𝐺1(𝑁𝑁)𝑡𝑡). Constraints (33) – (44) come from models 
1, 2 and 3. Table 6 shows the result when the robust solution from the above model is evaluated 
using each of the three original models, and the numbers in parentheses display the percentage of 
the population lost as a result of using the robust solution in place of the optimal one. If the 
outreach centers from the robust solution are used, then for any N, the maximum percent 
deviation from the best possible solution is 1.94%. 
 
Table 6. Result of robust solution for uncertain assumption 
𝑁𝑁 
Model 
1 2 3 
1 
10,749 14,060 14,060 
 (1.26%) (1.26%) 
2 
20,117 25,043 25,179 
(1.94%) (0.50%) (1.12%) 
3 
27,163 32,390 32,840 
(0.93%)  (0.77%) 
4 
32,005 35,335 35,717 
(0.79%)  (1.12%) 
5 
35,816 37,857 38,351 
   
6 
37,593 38,746 39,135 
   
7 
39,254 39,576 39,720 
   
8 
39,670 39,784 39,825 
  (0.03%) 
9 
39,898 39,898 39,898 
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2.4.2 Robustness for uncertain demand 
We can also consider uncertainty in the number of people (=demand) at each village. In this 
section, we consider a robust version for Model 1. Those for Model 2 and 3 can be expressed 
similarly. 
Let us define the feasible region A for Model 1 as follows: 
𝛢𝛢 = {(𝒙𝒙,𝒚𝒚)|𝑦𝑦𝑖𝑖 ≤ � 𝑥𝑥𝑖𝑖
𝑖𝑖∈𝑆𝑆𝑖𝑖
  for 𝑆𝑆𝑖𝑖 = �𝑗𝑗:𝑑𝑑𝑖𝑖𝑖𝑖 ≤ 𝐷𝐷1, 𝑗𝑗 = 1, … ,𝑛𝑛�,   𝑖𝑖 = 1, … ,𝑛𝑛,
�𝑐𝑐𝑖𝑖𝑥𝑥𝑖𝑖
𝑛𝑛
𝑖𝑖=1
≤ 𝐶𝐶,�𝑥𝑥𝑖𝑖𝑛𝑛
𝑖𝑖=1
≤ 𝑁𝑁;  𝑥𝑥𝑖𝑖∈{0,1},    𝑦𝑦𝑖𝑖∈{0,1},    𝑓𝑓𝑓𝑓𝑓𝑓 𝑖𝑖 = 1, … ,𝑛𝑛} 
Now suppose that ?̂?𝑝𝑖𝑖 is an estimate of the population in village i and that ?̂?𝑝𝑖𝑖𝛾𝛾𝑖𝑖 is the 
amount by which the true population 𝑝𝑝𝑖𝑖 differs from this estimated value ?̂?𝑝𝑖𝑖, so that 𝑝𝑝𝑖𝑖 − ?̂?𝑝𝑖𝑖 =
?̂?𝑝𝑖𝑖𝛾𝛾𝑖𝑖, i.e., 𝑝𝑝𝑖𝑖 = ?̂?𝑝𝑖𝑖(1 + 𝛾𝛾𝑖𝑖) .  Also assume that  
∑ ?̂?𝑝𝑖𝑖𝛾𝛾𝑖𝑖
𝑛𝑛
𝑖𝑖=1 = 0  so that ∑ 𝑝𝑝𝑖𝑖𝑛𝑛𝑖𝑖=1 = ∑ ?̂?𝑝𝑖𝑖𝑛𝑛𝑖𝑖=1 = 𝐷𝐷 0 < |𝛾𝛾𝑖𝑖| ≤ ?̅?𝛾𝑖𝑖 < 1  
In other words we know the total population (D) across all n villages, but the true 
population 𝑝𝑝𝑖𝑖 at village i could be up to 100?̅?𝛾𝑖𝑖% higher or lower than its estimated population ?̂?𝑝𝑖𝑖. 
Let us define the set 𝐵𝐵 as   
𝛣𝛣 = {𝜸𝜸|�?̂?𝑝𝑖𝑖𝛾𝛾𝑖𝑖𝑛𝑛
𝑖𝑖=1
= 0, |𝛾𝛾𝑖𝑖| ≤ ?̅?𝛾𝑖𝑖 < 1} 
where 𝜸𝜸 is a vector of 𝛾𝛾𝑖𝑖. 
Robust Model: 
max
𝒙𝒙,𝒚𝒚 �inf𝜸𝜸 �?̂?𝑝𝑖𝑖(1 + 𝛾𝛾𝑖𝑖)𝑦𝑦𝑖𝑖𝑛𝑛
𝑖𝑖=1
�(𝒙𝒙,𝒚𝒚) ∈ 𝛢𝛢,𝜸𝜸 ∈ 𝛣𝛣� 
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Note that for a given feasible selection of outreach centers (𝒙𝒙) and corresponding set of 
villages covered (𝒚𝒚), the quantity within the braces represents the smallest value of the true total 
population covered across all different deviations from the estimates that meet conditions 1-3 
above.   The objective of the model is to find the vectors 𝒙𝒙 and 𝒚𝒚 that maximize this value. 
Proposition 
If ?̅?𝛾1 = ?̅?𝛾2 = ⋯ = ?̅?𝛾𝑛𝑛 = ?̅?𝛾, then the optimal solution to the original formulation (Model 1) 
is the optimal solution to the robust formulation. 
Proof: 
Let (𝒙𝒙∗,𝒚𝒚∗) be the optimal solution to Model 1, and consider any feasible (𝒙𝒙,𝒚𝒚) ∈ 𝐴𝐴 and 
define C as the index set of villages that are covered and N as the index set of villages that are 
not covered.  Note that C∪N = {1,2,…,n} and the estimated total coverage is ∑ ?̂?𝑝𝑖𝑖𝑖𝑖∈𝐶𝐶  while the 
estimated population not covered is given by ∑ ?̂?𝑝𝑖𝑖𝑖𝑖∈𝑁𝑁 = 𝐷𝐷 − ∑ ?̂?𝑝𝑖𝑖𝑖𝑖∈𝐶𝐶 .   
Define  
𝜉𝜉(𝒙𝒙,𝒚𝒚) = �𝑝𝑝�𝑖𝑖
𝑖𝑖∈𝐶𝐶
= �𝑝𝑝�𝑖𝑖𝑦𝑦𝑖𝑖𝑛𝑛
𝑖𝑖=1
 
𝜉𝜉̅(𝜸𝜸|𝒙𝒙,𝒚𝒚) = min
𝜸𝜸
� 𝑝𝑝�𝑖𝑖(1 ± 𝛾𝛾𝑖𝑖)𝑦𝑦𝑖𝑖𝑛𝑛
𝑖𝑖=1
�𝜸𝜸 ∈ 𝛣𝛣� 
Note that for the assignment (𝒙𝒙,𝒚𝒚),  𝜉𝜉(𝒙𝒙,𝒚𝒚) is the estimated total coverage, while  
𝜉𝜉̅(𝜸𝜸|𝒙𝒙,𝒚𝒚) is the smallest actual total coverage possible across all differences from the estimates 
that satisfy conditions 1-3 described earlier. 
Case 1:  𝜉𝜉(𝒙𝒙,𝒚𝒚) = ∑ ?̂?𝑝𝑖𝑖𝑖𝑖∈𝐶𝐶 ≤ 𝐷𝐷/2) 
In this case the true total coverage has its minimum value 𝜉𝜉̅(𝜸𝜸|𝒙𝒙,𝒚𝒚) when the true 
population of each village 𝑖𝑖 ∈ 𝐶𝐶 is ?̂?𝑝𝑖𝑖(1 − ?̅?𝛾), as long as this minimum can be attained.   This 
minimum is attained as long as the true total population not covered (in the villages indexed by 
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set N) does not exceed (1 + ?̅?𝛾)∑ ?̂?𝑝𝑖𝑖𝑖𝑖∈𝑁𝑁 , which is the largest possible value that this number can 
take on.   
The true number not covered is given by  𝐷𝐷 − (1 − ?̅?𝛾)(∑ ?̂?𝑝𝑖𝑖𝑖𝑖∈𝐶𝐶 )  and therefore we need to 
show that {𝐷𝐷 − (1 − ?̅?𝛾)(∑ ?̂?𝑝𝑖𝑖𝑖𝑖∈𝐶𝐶 )} ≤ {(1 + ?̅?𝛾)(∑ ?̂?𝑝𝑖𝑖𝑖𝑖∈𝑁𝑁 )}. This is easily done because    {𝐷𝐷 − (1 − ?̅?𝛾)(∑ ?̂?𝑝𝑖𝑖𝑖𝑖∈𝐶𝐶 )} − {(1 + ?̅?𝛾)(∑ ?̂?𝑝𝑖𝑖𝑖𝑖∈𝑁𝑁 )}   
= {𝐷𝐷 − (1 − ?̅?𝛾)(∑ ?̂?𝑝𝑖𝑖𝑖𝑖∈𝐶𝐶 )} − {(1 + ?̅?𝛾)(𝐷𝐷 − ∑ ?̂?𝑝𝑖𝑖𝑖𝑖∈𝐶𝐶 )}  
= ?̅?𝛾{2∑ ?̂?𝑝𝑖𝑖𝑖𝑖∈𝐶𝐶 − 𝐷𝐷} ≤ 0 (because ?̅?𝛾 > 0 and ∑ ?̂?𝑝𝑖𝑖𝑖𝑖∈𝐶𝐶 ≤ 𝐷𝐷/2) 
Therefore 
𝜉𝜉̅(𝜸𝜸|𝒙𝒙,𝒚𝒚) = �(1 − ?̅?𝛾)𝑝𝑝�𝑖𝑖
𝑖𝑖∈𝐶𝐶
= (1 − ?̅?𝛾)𝜉𝜉(𝒙𝒙,𝒚𝒚), 
and in particular, for (𝒙𝒙∗,𝒚𝒚∗) 
𝜉𝜉̅(𝜸𝜸|𝒙𝒙∗,𝒚𝒚∗) = (1 − ?̅?𝛾)𝜉𝜉(𝒙𝒙∗,𝒚𝒚∗) . 
Since (𝒙𝒙∗,𝒚𝒚∗) is optimal for Model 1, it follows that 𝜉𝜉(𝒙𝒙,𝒚𝒚) ≤  𝜉𝜉(𝒙𝒙∗,𝒚𝒚∗), and therefore 
𝜉𝜉̅(𝜸𝜸|𝒙𝒙,𝒚𝒚) ≤  𝜉𝜉̅(𝜸𝜸|𝒙𝒙∗,𝒚𝒚∗). 
Therefore (𝒙𝒙∗,𝒚𝒚∗) is also optimal for Model 2. 
Case 2: 𝜉𝜉(𝒙𝒙,𝒚𝒚) = ∑ ?̂?𝑝𝑖𝑖𝑖𝑖∈𝐶𝐶 > 𝐷𝐷/2) 
Here it is not possible for the true coverage to attain the minimum possible value of (1 − ?̅?𝛾)∑ ?̂?𝑝𝑖𝑖𝑖𝑖∈𝐶𝐶  because the actual total number not covered would then exceed its maximum 
possible value.  Instead we make use of the fact that the minimum actual coverage is attained 
when the actual number not covered is at its maximum of (1 + ?̅?𝛾)∑ ?̂?𝑝𝑖𝑖𝑖𝑖∈𝑁𝑁 .  To show this 
minimum can be attained we need to ensure that the true total number covered is larger than (1 − ?̅?𝛾)∑ ?̂?𝑝𝑖𝑖𝑖𝑖∈𝐶𝐶 , which is the smallest value that it can take on. 
The true number covered is given by  𝐷𝐷 − (1 + ?̅?𝛾)(∑ ?̂?𝑝𝑖𝑖𝑖𝑖∈𝑁𝑁 )  and therefore we need to 
show that {𝐷𝐷 − (1 + ?̅?𝛾)(∑ ?̂?𝑝𝑖𝑖𝑖𝑖∈𝑁𝑁 )} ≥ {(1 − ?̅?𝛾)(∑ ?̂?𝑝𝑖𝑖𝑖𝑖∈𝐶𝐶 )}. This is easily done because 
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   {𝐷𝐷 − (1 + ?̅?𝛾)(∑ ?̂?𝑝𝑖𝑖𝑖𝑖∈𝑁𝑁 )} − {(1 − ?̅?𝛾)∑ ?̂?𝑝𝑖𝑖𝑖𝑖∈𝐶𝐶 }   
= {𝐷𝐷 − (1 + ?̅?𝛾)(𝐷𝐷 − ∑ ?̂?𝑝𝑖𝑖𝑖𝑖∈𝐶𝐶 )} − {(1 − ?̅?𝛾)∑ ?̂?𝑝𝑖𝑖𝑖𝑖∈𝐶𝐶 }  
= ?̅?𝛾{2∑ ?̂?𝑝𝑖𝑖𝑖𝑖∈𝐶𝐶 − 𝐷𝐷} > 0 
Therefore 
𝜉𝜉̅(𝜸𝜸|𝒙𝒙,𝒚𝒚) = 𝐷𝐷 − (1 + ?̅?𝛾)∑ 𝑝𝑝�𝑖𝑖𝑖𝑖∈𝑁𝑁   = 𝐷𝐷 − (1 + ?̅?𝛾)�𝐷𝐷 − ∑ 𝑝𝑝�𝑖𝑖𝑖𝑖∈𝐶𝐶 � = (1 + ?̅?𝛾)(∑ 𝑝𝑝�𝑖𝑖)𝑖𝑖∈𝐶𝐶 − ?̅?𝛾𝐷𝐷  = (1 + ?̅?𝛾)𝜉𝜉(𝒙𝒙,𝒚𝒚) − ?̅?𝛾𝐷𝐷, 
and in particular, for (𝒙𝒙∗,𝒚𝒚∗) 
𝜉𝜉̅(𝜸𝜸|𝒙𝒙∗,𝒚𝒚∗) = (1 + ?̅?𝛾)𝜉𝜉(𝒙𝒙∗,𝒚𝒚∗) − ?̅?𝛾𝐷𝐷. 
Since (𝒙𝒙∗,𝒚𝒚∗) is optimal for Model 1, it follows that 𝜉𝜉(𝒙𝒙,𝒚𝒚) ≤  𝜉𝜉(𝒙𝒙∗,𝒚𝒚∗), and therefore 
𝜉𝜉̅(𝜸𝜸|𝒙𝒙,𝒚𝒚) ≤  𝜉𝜉̅(𝜸𝜸|𝒙𝒙∗,𝒚𝒚∗).∎ 
Example: 
Suppose we have a total of 100 people in our n villages and the true population in any 
individual village i could be higher or lower than the estimated value ?̂?𝑝𝑖𝑖 by no more 10% (so 
?̅?𝛾=0.1). 
Case 1: Suppose ∑ ?̂?𝑝𝑖𝑖𝑖𝑖∈𝐶𝐶 =45 people are estimated to live in villages covered and 
∑ ?̂?𝑝𝑖𝑖𝑖𝑖∈𝑁𝑁 =55 in villages not covered. Then the lowest true coverage possible is 45(0.9) = 40.5 
with 59.5 people not being covered. 
Case 2: Suppose ∑ ?̂?𝑝𝑖𝑖𝑖𝑖∈𝐶𝐶 =55 people are estimated to live in villages covered and 
∑ ?̂?𝑝𝑖𝑖𝑖𝑖∈𝑁𝑁 =45 in villages not covered. Then the lowest true coverage possible is when the actual 
number not covered is at its maximum of 45(1.1) = 49.5, i.e., with 50.5 people being covered. 
According to the previous proposition, the optimal solution to the model without demand 
uncertainty is the robust solution for uncertain demand. If the assumption about the equality of 
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the total population is removed, the result is the same because the objective value for all 
solutions would be decreased by ?̅?𝛾 . In addition, even if the assumption of percentage deviation 
from the estimated population is changed to a fixed amount of deviation from the estimated 
population, the optimal solution is still the robust solution. The fact that the solution to the robust 
model is the same as the solution for the original model is because of the following 
characteristics of the coverage model: 1) it maximizes the number of people who can be covered, 
2) the robust model provides the optimum corresponding to the worst-case scenario for the error 
in the estimated population, and 3) there is no systematic interaction between the populations at 
different locations. Thus, in order to have the best worst-case performance it is optimal to locate 
the outreach points at the locations that maximize coverage with the estimated populations.  This 
follows because if the population at each location can either be reduced by a constant percentage 
or a constant amount then the locations that maximizes coverage in the original problem will still 
provide the highest coverage for the new problem. 
2.5 DISCUSSION AND CONCLUSIONS 
To the best of our knowledge the work reported here is the first to provide a formal modeling 
framework for decision making with respect to outreach. As with any model-based approach, our 
work has some limitations and certain facts are worth keeping in mind.  First, our results apply 
mainly to rural outreach settings with relatively lower population densities; in densely populated 
urban settings coverage models could clearly be much more complex.  However, since most 
urban centers tend to have health posts or clinics with regular hours, outreach generally is 
focused on rural locations.  Second, we assume that the social planner is not biased in favor of 
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outreach plans where the travel is shorter or across easier terrain (which is sometimes the case in 
practice), and that the plans from our model can be implemented in an unbiased fashion. Third, 
in general it could be difficult to predict the exact type of coverage applicable to a particular 
application environment. However, the models could be run under different assumptions of 
coverage, and as the results indicate, in many instances the optimal locations are identical (e.g., 
with N=6 locations), with only the estimates of the populations served being different.  In other 
cases there may be some common locations and some that differ (e.g., with N=3), in which case 
the social planner would make a subjective decision on the locations to select.  
In addition, when it is not possible to specify the coverage assumption, a robust approach 
can be applied by creating a model that combines aspects of the different models into one model 
or by using a minmax regret evaluation of the solutions found by the different models as shown 
previously. Similarly, if there is uncertainty about parameter values then the model can be run 
for different parameter values, either separately or in a combined manner, in order to find a 
robust solution. For example, the first and second radius of model 2 can be assumed to be 4km 
and 6km in one model run and 5km and 8km in a second model run or have both parameter sets 
incorporated into one robust model. Moreover, in the robust formulation for addressing demand 
uncertainty, if the total demand is unchanged and the deviation percentage in each village is the 
same, the optimal solution of the nominal problem is the same as that of the robust problem.   
In summary, outreach is a critical component of EPI vaccination programs in low and 
middle income countries. However, there are no standard guidelines for outreach and these 
activities tend to be conducted in a fairly ad hoc fashion. In particular, the problem modeled in 
this paper is motivated by vaccination activities in India, and our approach is based on adapting 
facility location models to the outreach coverage problem. Based on past and ongoing work 
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related to vaccine logistics that we have done with a number of countries in Asia and sub-
Saharan Africa, we feel that these models can aid decision makers when they are establishing 
outreach policies. The resulting outreach plan affects the performance of the entire vaccine 
supply chain because the demand for vaccines at all levels of the supply chain will vary with the 
outreach plan and the resulting vaccine coverage. 
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3.0  MODULAR VACCINE PACKAGING TO INCREASE PACKING EFFICIENCY  
3.1 INTRODUCTION 
Currently, individual vaccines vials and their component packaging vary significantly in overall 
length, width, and height. This is because the vaccine packaging size is determined by the 
dimensions of both individual cylindrical vials (each containing one or more doses of vaccine) 
and rectangular inner packs that typically contain 10, 20, 50 or 100 vials of a particular vaccine. 
The variability of inner pack and vial dimensions may hinder efficient vaccine distribution 
because it constrains packing of cold boxes and vaccine carriers to quantities that are often 
inappropriate or suboptimal in the context of country-specific vaccination guidelines. In 
particular, estimating storage space requirements is more difficult with non-standard sizes and in 
a resource constrained system it may not be possible to take all the vaccines needed in a carrier 
because of the inefficient packaging.  
Modularized packaging is one way to address this because the consequent increase in 
packing efficiency has the potential to reduce storage space requirements and replenishment 
frequencies.  The standardization of packaging also has the benefit of making operations much 
simpler for personnel since vaccines can be more easily packed and space requirements can be 
more easily estimated. While vaccine vial size has been a recent topic of academic and 
policymaker interest, explorations of alternative packing configurations have not yet addressed 
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inner packs (Assi, et al., 2011; Dhamodharan & Proano, 2012; Parmar, Baruwa, Zuber, & Kone, 
2010; Lee, et al., 2011; Lee & Burke, 2010; Assi, et al., 2013; Brown, et al., 2014; Drain, 
Nelson, & Lloyd, 2003).  The packing analysis in this paper proposes that a solution to 
inefficient packing caused by inner pack and vial size variability is a modular packaging system 
(where vial and inner pack dimensions are more consistent between different vaccines) that 
allows for more effective packing into cold boxes and vaccine carriers. 
3.2 METHODS 
We developed in Microsoft Excel (Microsoft Corp.) a spreadsheet model that evaluated the 
impact of different packing schemes for the Benin routine regimen plus the introduction of the 
Rotarix vaccine. The Benin routine vaccine regimen includes Bacillus Calmette-Guerin (BCG), 
Tetanus, Measles, Oral Polio, Yellow Fever, Diphtheria-Tetanus-Pertussis-Hepatitis B-
Haemophilus influenzae type B (DTC-HepB-Hib), Pneumococcal Conjugate (PCV13), and 
Rotavirus (Rota) vaccines. Specifically, the model is used to compare the current packing 
scheme to that of a proposed modular packaging system.  
The storage device considered is the Dometic RCW25, which is prequalified by the 
WHO, is used in over 100 countries and was noted as a commonly used storage device in a 
recent study of in-country vaccine transport devices (PATH & World Health Organization, 2013; 
World Health Organization, 2010). The RCW 25 has a vaccine storage volume with length 40.5 
cm, width 26.5 cm and height 19 cm after it is packed with conditioned ice. In Benin, workers at 
a “Health Post” (the lowest level of the vaccine distribution chain where vaccines are 
administered) typically travel to a “Commune Store” once per month to pick up vaccines; the 
amount of vaccines picked up depends on the population characteristics of the catchment area 
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served by the Health Post and is determined by workers at the Health Post based on prior 
months’ demand.  The vaccines are transported back to the Health Post in a vaccine carrier using 
a motorcycle. In determining packing efficiency, analyses of both current inner pack/vial sizes 
and the proposed modular system considered the number of fully immunized children (FIC) 
possible and packing efficiency (% space occupied) per fully packed device.  The FIC metric 
ensures that our evaluations are with vaccine carriers that transport the suite of vaccines required 
for an FIC (as opposed to simply filling the carrier with just one or two types of vaccines).  
3.2.1 Conventional packaging configuration 
The dimensions in Table 7 were used for analyses of existing, conventional inner packs and their 
constituent vials; the volume of the inner pack is simply the product of its length, width, and 
height as described by the vaccine manufacturer. These dimensions were used to determine the 
number of conventional inner packs for each vaccine type that could be placed in the RCW25 in 
order to maximize the FIC per device. To pack the device, we used manual modifications. Note 
that each inner pack could be positioned in any orientation and that inner packs of the same type 
could have multiple orientations. For each inner pack combination we placed the inner packs into 
the storage device until its dimensions prohibited the addition of any more.  
 
Table 7. Conventional inner pack dimensions 
Vaccine Type BCG Tetanus Measles Oral Polio Yellow Fever 
DTC-
HepB-Hib 
liquid 
PCV13 Rota 
Length (cm) 18.5 10.6 18.5 15 10.6 18 17.9 14.6 
Width (cm) 9.5 4.7 9.5 12.5 4.7 14.9 9.2 8.5 
Height (cm) 6 5.1 6 7.5 5.1 3.7 4.1 6.9 
volume(L) 1.05 0.25 1.05 1.41 0.25 0.99 0.68 0.86 
Vials/inner pack 50 10 50 100 10 100 50 50 
 
 42 
  
     
BCG 1 pack 1 layer; 18.5 cm height 
1     
     
     
Measles 1 pack 1 layer; 18.5 cm height 2          
     
DTC-HepB-Hib  2 packs 1 layer; 18 cm height 3          
     
PCV13 8 packs 1 layer; 17.9 cm height 4          
     
Rota 5 packs 2 layers; 2×8.5 cm height 
5     
     
     
Oral Polio 1 pack 1 layer; 7.5 cm height 6          
     
Tetanus 3 packs 1 layer; 10.6 cm height 7          
     
Yellow Fever 3 packs 3 layers; 3×4.7 cm height 
8      
     
Figure 7. Packing arrangement in RCW25 for conventional inner packs (Top view) 
 
 
 
     
BCG 1 pack 1 layer; 18.5 cm height 
1     
     
     
Measles 1 pack 1 layer; 18.5 cm height 2          
     
DTC-HepB-Hib  2 packs 1 layer; 18 cm height 3          
     
PCV13 8 packs 1 layer; 17.9 cm height 4          
     
Rota 5 packs 2 layers; 2×8.5 cm height 
5     
     
     
Oral Polio 1 pack 1 layer; 7.5 cm height 6          
     
Tetanus 4 packs 1 layer; 10.6 cm height 7          
     
Yellow Fever 4 packs 4 layers; 3×4.7 cm height 
8     
     
Figure 8. Packing arrangement in RCW25 for conventional inner packs with two additional inner packs 
 
In our simulation of storage device packing, the device is filled with the objective of 
maximizing the number of children that could be fully immunized as per the Benin routine 
vaccination schedule. This involved two steps.  In Step 1 we considered the vaccine schedule 
required for each FIC – for each vaccine we determined the average number of children that can 
be fully vaccinated per inner pack, based on the scheduled number of doses, the wastage rate, the 
number of doses per vial and the number of vials per inner pack, as described in Table 8. For 
example, for BCG the vaccine schedule is one dose per child and the wastage rate is 50%; 
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therefore, on average, 1/(1-.50) = 2 doses are needed per FIC (note that in the remainder of this 
chapter when we reference FIC we mean the expected FIC given the average wastage rates given 
in Table 8) . BCG has 20 doses per vial and an inner pack of BCG contains 50 vials, therefore 
the inner pack contains 50*20 = 1,000 doses total. Because 2 doses on average are needed per 
FIC, on average 1,000/2 = 500 children can be immunized per inner pack of BCG. 
 
Table 8. FIC calculations per inner pack 
 BCG Tetanus Measles Oral Polio 
Yellow 
Fever 
DTC-
HepB-Hib 
liquid 
PCV13 Rota 
Scheduled doses per child 1 2 1 4 1 3 3 2 
Wastage rate 0.5 0.15 0.45 0.17 0.45 0.05 0.01 0.01 
Doses per vial 20 10 10 20 10 2 1 1 
Vials per inner pack 50 10 50 100 10 100 50 50 
FIC per inner pack 500 42.5 275 415 55 63.33 16.5 24.75 
 
In Step 2, beginning with one inner pack of each vaccine type, we incrementally 
increased the number of inner packs in order to increase the expected number of FIC that can be 
served, as illustrated in Table 3-3. Initially we place one inner pack of each vaccine type into the 
carrier, resulting in the FIC values given in the first row (“One of each”). The expected number 
of FIC that the carrier can serve is the minimum FIC value in the row, which is 16.5 for PCV13 
(bold, highlighted); therefore, we next add an inner pack of PCV13 so that there is enough 
PCV13 to vaccinate 2 * 16.5 = 33 children. This results in the FIC values given in row 2 (“+1 
PCV13”), with a new limiting FIC value of 24.75 determined by Rotarix; therefore we next add 
an inner pack of Rotarix. This process is repeated until there is no more room in the storage 
device. This results in the inner pack values shown in the last row (“FINAL”), with a final FIC 
value of 123.75. 
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Table 9. Packing current inner packs into the device 
 
 BCG Tetanus Measles Oral Polio 
Yellow 
Fever 
DTC-HepB-
Hib liquid PCV13 Rotarix 
One of 
Each 
Number of 
inner 
packs 
1 1 1 1 1 1 1 1 
FIC 500 42.5 275 415 55 63.33 16.5 24.75 
+1 
PCV13 
Number of 
inner 
packs 
1 1 1 1 1 1 2 1 
FIC 500 42.5 275 415 55 63.33 33 24.75 
+1 
Rotarix 
Number of 
inner 
packs 
1 1 1 1 1 1 2 2 
FIC 500 42.5 275 415 55 63.33 33 49.5 
FINAL 
Number of 
inner 
packs 
1 3 1 1 3 2 8 5 
FIC 500 127.5 275 415 165 126.67 132 123.75 
 
 
In determining the exact inner pack configuration within the storage device our approach 
was slightly different for conventional and modular inner packs.  The conventional inner packs 
are all of different sizes and their packing was therefore done by trial and error filling from the 
bottom of the storage device. It should be noted that an optimization approach such as 3-
dimensional bin packing would be computationally intensive and unrealistic in the field; rather 
we tried to replicate what a typical field worker might do in an effort to choose among realistic 
solutions. While the packing is easy in the early stages, as the number of inner packs increases 
(at each step in Table 3-3) it becomes more difficult as we need to abandon the current 
configuration and start afresh.  We were able to pack the number of inner packs shown in the last 
row of Table 9 using the configuration shown in Figure 7.   
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3.2.2 Proposed modular packaging configuration 
In designing modular packaging we assumed that all vaccines have vials with the same diameter 
but that the vial heights can change to account for differences in dose volumes. This provided 
uniform vial size in two dimensions and variation in only one dimension. Our data sources 
provided the rectangular dimensions of existing conventional inner packs but not the cylindrical 
dimensions of individual vials. We computed these by dividing the length or width of the inner 
pack by the number of vials in the length or width dimension. When there was inconsistency in 
the unit length and the unit width, we choose the larger value to be conservative. These values 
were then used to determine current vaccine vial volume, in order to design similar modular 
vials. 
Specifically, to determine the ideal modular vaccine vial diameter, we analyzed the 
effects of multiple potential vial diameter sizes on packing efficiency. There are four main 
considerations for deciding the ideal modular vaccine vial diameter:  
1) The number of vials in an inner pack: We required the quantities per inner pack to be values 
that are easy for counting, such as 10, 20, or 50.  
2) Area efficiency: The modular vaccine vial diameter needed to result in an inner pack 
configuration that would fit well into the space available in the storage device. 
3) Vial size as it relates to dose volume: The goal was to create standardized vial sizes but also 
make them similar in size to conventional vials to preserve existing dose per vial calculations 
– thus we found candidate vial diameters by calculating the area occupied by the vials when 
using 10, 20, and 50 vials in an inner pack. 
4) Packing array: We considered diameters that could work with both hexagonal and 
rectangular packing within rectangular inner packs.  
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The above analysis yielded three potential diameters of 1.6 cm, 2.2 cm, and 1.91cm. For 
each diameter and each vaccine type, we calculated the modular vial height based on the volume 
of the original, conventional vial; the calculated modular vial heights are shown in Table 10, and 
also determine the height of the inner pack in which the vials are subsequently stored. The 1.6cm 
diameter vials require relatively large heights while the 2.2 cm diameter vials require relatively 
small heights, in order to maintain current volumes/doses per vial. Therefore, we also evaluated a 
modular system that uses a mixture of 1.6 cm diameter vials for some (small-volume) vaccines 
and 2.2 cm diameter vials for other (large-volume) vaccines. We also considered an intermediate 
vial diameter of 1.91 cm by itself.  
We next examined the three different vial sizes in the context of potential inner pack 
dimensions; optimum inner pack dimensions are shown in Table 10, while the vial configuration 
within each inner pack and the corresponding dimensions are shown in Figure 9. Note that the 
inner packs for 1.6 cm diameter vials and 2.2 cm diameter vials are very similar in length and 
width; this was done purposely in order to maximize the efficiency of the fourth modular system 
that uses a combination of the two vial sizes.  All three inner pack sizes were chosen such that 
they can be packed efficiently into the volume of the RCW25. From Table 10, for the 1.6 cm and 
2.2 cm diameter vials, inner pack dimensions are approximately 8 cm long and 6.5 cm wide. 
Therefore, they can be stored 5-long along the 40 cm length of the storage device and 4-wide 
along the 26.5 cm width of the storage device. The result is that there are 20 stacks of inner 
packs, each occupying the same area, which can each be up to 19 cm tall. For the 1.91 cm 
diameter inner packs, there are 6 stacks of inner packs that can each be up to 19 cm tall. The 
different packing configurations for each vial size within the two dimensions (length × width) of 
the storage device are shown in Figure 10.  
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Table 10. Potential modular inner pack dimensions for different vial diameters 
Diameter 
(cm)  BCG Tetanus Measles Oral Polio 
Yellow 
Fever 
DTC-
HepB-Hib 
liquid 
PCV13 Rota 
1.6 
Length(cm) 8.00 8.00 8.00 8.00 8.00 8.00 8.00 8.00 
Width(cm) 6.40 6.40 6.40 6.40 6.40 6.40 6.40 6.40 
Height(cm) 8.24 9.95 8.24 5.54 9.95 3.91 5.28 6.73 
2.2 
Length(cm) 7.92 7.92 7.92 7.92 7.92 7.92 7.92 7.92 
Width(cm) 6.60 6.60 6.60 6.60 6.60 6.60 6.60 6.60 
Height(cm) 4.36 5.26 4.36 2.93 5.26 2.07 2.79 3.56 
1.91 
Length(cm) 8.53 8.53 8.53 8.53 8.53 8.53 8.53 8.53 
Width(cm) 20.06 20.06 20.06 20.06 20.06 20.06 20.06 20.06 
Height(cm) 5.78 6.98 5.78 3.89 6.98 2.74 3.70 4.72 
1.6 + 2.2 
Length(cm) 7.92 7.92 7.92 8.00 7.92 8.00 8.00 7.92 
Width(cm) 6.60 6.60 6.60 6.40 6.60 6.40 6.40 6.60 
Height(cm) 4.36 5.26 4.36 5.54 5.26 3.91 5.28 3.56 
Diameter(cm) 2.2 2.2 2.2 1.6 2.2 1.6 1.6 2.2 
 
   
1.6cm diameter vials 2.2cm diameter vials 1.91cm diameter vials 
Figure 9. Packing configurations within inner packs for each proposed modular vial size 
 
   
1.6cm diameter 4x5 inner packs 2.2cm diameter 4x5 inner packs 1.91cm diameter 3x2 inner packs 
Figure 10. Packing configurations within storage device 
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As opposed to the trial-and-error approach with the conventional inner packs as described 
in Section 3.2.1, we used a heuristic algorithm for packing the modular inner packs into the 
storage device.  We experimented with two versions of the heuristics based on how field workers 
might fill the storage device.  In version 1 the device was packed by starting on one side of the 
storage device and sequentially stacking inner packs vertically and building up multiple stacks 
(we refer to this as the tower method), while in version 2 we sequentially fill the storage device 
horizontally filling the storage device from the bottom and building up multiple layers (we refer 
to this as the layer method).   
For both methods we started by assigning the storage orientations for inner packs as 
described in the previous paragraph, and then sorted inner packs in decreasing order of height.  
In the tower method we used a first-fit-decreasing heuristic where inner packs were stacked in 
decreasing order of height in a single tower until no more can be placed in that tower, and we 
then search for the largest inner pack that fits in the remaining space (Figure 11).  When no inner 
packs can be fitted into the current tower a new tower is started and this procedure is repeated 
until all inner packs are exhausted. In the layer method, the inner packs are sequentially placed in 
the same layer in decreasing order of height until there is no more space in the layer to form 
several different towers. These towers are then built up layer by layer in a sequential fashion 
until all inner packs are exhausted (Figure 12).   
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Figure 11. Tower packing method 
 
 
 
 
Figure 12.  Layer packing method 
 
In addition to the heuristic tower and layer methods, we also considered a mathematically 
optimized tower method (termed the optimized method) using the following model. 
Notation 
xij: Number of inner packs of vaccine i in the jth tower 
𝐹𝐹: Number of fully immunized child who can be covered 
ci: Number of people who can be covered by one inner pack of vaccine i 
fi: Number of people who must be administrated vaccine i 
hi: Inner pack height of vaccine i  
h: Storage device height 
m: Number of towers in one storage device 
n: Number of the vaccine types 
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  𝑀𝑀𝑀𝑀𝑥𝑥       𝐹𝐹 (45)  
subject to  
 𝑐𝑐𝑖𝑖  �𝑥𝑥𝑖𝑖𝑖𝑖𝑚𝑚
𝑖𝑖=1
≥ 𝐹𝐹       for 𝑖𝑖 = 1 to 𝑛𝑛  (46)  
    �ℎ𝑖𝑖𝑛𝑛
𝑖𝑖=1
𝑥𝑥𝑖𝑖𝑖𝑖 ≤ ℎ         for 𝑗𝑗 = 1 to 𝑘𝑘 (47)  
     𝑥𝑥𝑖𝑖𝑖𝑖 = {0, 1, 2, … } (48)  
 
The objective (45) is to maximize the number of fully immunized children 𝐹𝐹 that can be 
covered by the combination of inner packs of each vaccine in one storage device. Constraint (46) 
insures that the number of FIC cannot exceed the number of people who can be administrated 
each vaccine type. Constraint (47) insures that the sum of height of the inner packs in each tower 
must be less than the height of the storage device. Constraint (48) insures that we only use 
integral numbers of inner packs (no partial inner packs are allowed.)  This model determines the 
optimal way to combine the inner packs into towers to attain the maximum possible FIC value. 
This linear integer programming model is presented mainly as a point of reference for bounding 
the performance of our heuristic approach, since it is unrealistic to expect that this approach will 
be used in the field. 
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3.3 RESULTS 
3.3.1 Conventional packing efficiency 
The number of children who can be fully vaccinated with each vaccine type for the conventional 
inner packs is shown in the bottom row of Table 9 and the maximum expected FIC served by a 
single storage device is 123. The resulting configuration of inner packs within the device is 
illustrated in Figure 7.   
Currently, the FIC-optimizing configuration of conventional inner packs occupies 16.71 
liters, representing 81.93% of the available volume of the RCW25; we refer to this as the volume 
efficiency of the packing. Although there is not enough empty space to add an inner pack of the 
vaccine currently determining the maximum FIC value (Rotarix), we can still use this space for 
other vaccines if we wish to do so. Thus, after filling the device to its FIC capacity, it is possible 
to add in two inner packs of Yellow Fever or two inner packs of Tetanus or one inner pack of 
each (the inner packs of these two vaccines are the same size). The occupied volume and volume 
efficiency now rise to 17.22 liters and 84.4% respectively. Figure 8 illustrates the arrangement 
with one extra inner pack of yellow fever (on top of the previous three) and one extra inner pack 
of tetanus (stored vertically in the empty space shown in Figure 7). 
It is important to note that these packing efficiencies were achieved by evaluating many 
different possibilities and therefore almost certainly reflect a higher packing density than would 
be achieved in practice, since storage devices are generally not packed and repacked multiple 
times.  Thus, it is not likely that this high a degree of space utilization is regularly achieved in 
actual practice 
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3.3.2 Conventional versus modular packing efficiency 
The maximum FIC that can be served by one RCW25 given the current inner pack sizes is 123 as 
calculated above; the same methodology can be applied using the modular inner pack data and 
the results are shown in Table 11 (detailed information about the numbers of doses and inner 
packs achieved with conventional packing and each modular packaging system can be found in 
Table 12). The results also show that the tower method often outperforms the layer method and 
the optimized method always performs as well as or better than the layer and tower methods in 
terms of vaccine storage. In the discussion below we use the term “baseline” or “base” to refer to 
the 123 FIC obtained with conventional packaging.  
 
Table 11. Maximum FIC and occupied volume for different proposed modular vaccine vial diameters 
Diameter 
(cm) 
Layer Method Tower Method Optimization Method 
FIC Vol. % FIC Vol. % FIC Vol. % 
2.2 
(10 vials) 
152 
(96.2%) 92.6% 
155 
(98.1%) 94.1% 
158 
(100%) 94.8% 
1.6 
(20 vials) 
138 
(87.3%) 81.3% 
148 
(93.7%) 86.6% 
158 
(100%) 90.6% 
1.9 
(50 vials) 
148 
(100%) 87.9% 
148 
(100%) 87.9% 
148 
(100%) 87.9% 
Mix 
1.6+2.2 
148 
(93.7%) 87.4% 
145 
(91.8%) 86.1% 
158 
(100%) 91.5% 
    Note that the numbers below the FIC in the parentheses is the percentage  
 
Generally speaking, all modular packing systems exceed baseline packing efficiency, 
both in terms of maximum FIC served and volume efficiency. For example, using modular inner 
packs with vial diameter 2.2 cm, 155 FIC can be served per storage device, with a 94.1% volume 
efficiency, when the tower method is applied. It is also worth noting that (a) this increase in 
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efficiency is mainly because of the new inner pack sizing and is not dependent on the specific 
approach used to store the inner packs within the device, and (b) potential improvements are 
likely to be even higher because any optimization of conventional packing in the field is highly 
unlikely and in reality the actual FIC figure attained is likely to be much lower that our baseline 
value of 123, which was obtained after significant effort.  For catchment areas with higher 
populations where larger volumes of vaccine are required, this has the potential for reductions in 
the number of vaccine carriers required and/or reductions in the replenishment frequency, which 
in turn could yield lower transportation and personnel costs. Estimating such potential savings 
would be the next step in analysis of this novel modular packaging system.  
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 Table 12. Total doses, inner packs, and FIC by antigen for conventional versus proposed modular packaging configurations within the Dometic RCW25 
 
BCG Tetanus Measles Oral Polio Yellow Fever DTP-HepB-Hib  PCV13 Rota 
 
  Total Doses 
Inner 
Packs 
Total 
Doses 
Inner 
Packs 
Total 
Doses 
Inner 
Packs 
Total 
Doses 
Inner 
Packs 
Total 
Doses 
Inner 
Packs 
Total 
Doses 
Inner 
Packs 
Total 
Doses 
Inner 
Packs 
Total 
Doses 
Inner 
Packs FIC 
Conventional Packaging 
Configuration 1000 1 300 3 500 1 2000 1 300 3 400 2 400 8 250 5 123 
Proposed Modular 
Packaging Configuration 
                 2.2 cm Vial Diameter                                   
Layer Method 400 2 400 4 300 3 800 4 300 3 480 24 470 47 310 31 152 
Tower Method 400 2 400 4 300 3 800 4 300 3 500 25 470 47 320 32 155 
Tower Opt. Method 400 2 400 4 300 3 800 4 300 3 500 25 480 48 320 32 158 
1.6 cm Vial Diameter 
                 Layer Method 400 1 400 2 400 2 800 2 400 2 440 11 420 21 280 14 138 
Tower Method 400 1 400 2 400 2 800 2 400 2 480 12 460 23 300 15 148 
Tower Opt. Method 400 1 400 2 400 2 800 2 400 2 520 13 480 24 320 16 158 
1.9 cm Vial Diameter 
                 Layer Method 1000 1 500 1 500 1 1000 1 500 1 500 5 450 9 300 6 148 
Tower Method 1000 1 500 1 500 1 1000 1 500 1 500 5 450 9 300 6 148 
Tower Opt. Method 1000 1 500 1 500 1 1000 1 500 1 500 5 450 9 300 6 148 
1.6 + 2.2 cm Vial Dia. 
                 Layer Method 400 2 400 4 300 3 800 2 300 3 480 12 460 23 300 30 148 
Tower Method 400 2 400 4 300 3 800 2 300 3 480 12 440 22 300 30 145 
Tower Opt. Method 400 2 400 4 300 3 800 2 300 3 520 13 480 24 320 32 158 
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3.4 ANALYSIS WITH MORE STORAGE DEVICES 
Even though the RCW 25 is a widely used cold box, many other devices are used in practice and 
the modular packaging which is designed for the RCW 25 could be used with other storage 
devices. The question of interest is, if this occurs, does this modular packaging still work better 
than conventional packaging? In order to answer this, the space efficiency of the modular 
packaging system is examined using the same analysis method used in the previous research by 
evaluating the modular packaging configurations for the RCW 25 when they are applied to 
another storage device.  
3.4.1 Selection of the new device 
First, we consider the storage devices found in the WHO’s pre-qualified storage device list that 
have similar volumes to that of the RCW 25. These devices are shown in Table 13. 
 
Table 13. WHO pre-qualified storage device list 
PQS code Model Length(cm) Width(cm) Height(cm) Volume(liter) 
E004/025 CB-20-CF 53 23 20 24.4 
E004/031 AICB 503 L 45.5 31 16 22.6 
E004/015 ACB 503L 45.5 30.5 16 22.2 
E004/024 ACB 316 L 44.2 29.3 18.3 23.7 
E004/014 ACB 444 L 45 29.4 16.4 21.7 
E004/013 RCB 444 L 23 45 30 17 23.0 
E004/010 AICB 444 L 44.8 30 16.7 22.4 
E004/036 RCB 444L-A 45 30 15 20.3 
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Seven of the storage devices have dimensions of about 45 cm in length and 30 cm in 
width. Since the volume of the RCW 25 is 20.3 liters, the RCB 444L-A which has 20.3 liters 
volume is chosen to analyze the space efficiency of the modular packaging system. 
3.4.2 Results for the new device with the inner pack configurations for the RCW 25 
When the original inner pack sizes are used, the RCB 444L-A can store vaccines that are able to 
cover 126.6 FICs. Note that this packing configuration was found by evaluating numerous 
configurations and represents a packing density that would be difficult to achieve in practice. 
Table 14 shows the number of FICs when the modular inner packs which were created for the 
RCW 25 are used to fill the RCB 444L-A. When 1.6 cm diameter vials are used, a maximum of 
21 (3 × 7) tower are available in the RCB 444L-A. For 2.2 diameter vials, a maximum of 20 
(4×5) tower are available. When the inner packs are stored vertically in the tower, 112.2 FICs 
can be covered when using 1.6 cm diameter vial inner pack with the tower method, and 118.8 
FICs for 2.2 cm diameters with the layer method. Since the inner pack dimensions are not 
designed for the RCB 444L-A, after filling up the tower in the storage device, there are spare 
spaces where additional inner packs can be stored. If the spare space is used to store vaccines, 
the FICs for the 1.6 and 2.2 diameter vial inner packs increase to 145 with the layer method and 
152 with the tower method each.  
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Table 14. FIC for the heuristic and optimizing methods 
Proposed 
Modular 
Packaging 
Configuration 
No. of 
tower1) 
Tower method Layer method Optimizing method 
In 
towers2) 
+ Spare 
space3) 
In 
towers2) 
+ Spare 
space3) In tower
2) + Spare space3) 
1.6 cm 
diameter 21 
112.2 
(100%)4) 
138.6 
(87.4%) 
110.0 
(98%) 
145.2 
(91.6%) 112.2 158.6 
2.2 cm 
diameter 20 
118.8 
(97.3%) 
152.0 
(98%) 
112.2 
(91.9%) 
145.7 
(93.9%) 122.1 155.1 
1.91 cm 
diameter 6 
99.0 
(100%) 
126.6 
(85.2%) 
99.0 
(100%) 
126.6 
(85.2%) 99.0 148.5 
1.6 cm +2.2 
cm mixed 20 
114.0 
(96%) 
151.8 
(100%) 
110.0 
(92.6%) 
138.6 
(91.3%) 118.8 151.8 
1) The footprint of a tower is the area that one modular inner pack takes in the storage device. 
 
2) When vaccines are filled only in towers 
3) When vaccines are filled in towers and any empty space after filling the towers 
4) Percentage ratio of the FIC of the tower/layer method to the optimizing method 
 
When the inner packs are stored only in towers, the number of FIC is less than 126.6. 
However, when we consider that 126.6 is not the number of FIC that we can expect to attain in 
practice, the value that we obtain with only tower packing is reasonably good. In addition, 
because the spare space can be utilized to store more inner packs, the modular packing systems 
exceed the baseline packing efficiency. Clearly, the optimizing method provides better results 
than the two heuristic methods, but the FIC difference between the heuristic methods and the 
optimizing method is relatively small so the heuristic methods can be used to fill the storage 
devices almost as well as the optimizing method does. 
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3.4.3 New configuration for the RCW 25 and the new device 
Now, we consider new modular configurations that consider the size of the RCW 25 and the new 
device. These configurations allow more modular inner packs to be stored than the modular 
configurations designed for only the RCW 25. Using the same methods as in section 3.2.2, the 
proper inner pack dimensions are chosen and shown in table 15. 
 
Table 15. New modular packaging configuration for RCW 25 and RCB 444L-A 
New Modular 
Packaging 
Configuration 
BCG-20 TT Mea TOPV YF DTP-HepB PCV13 RV 
1.76 
(20 vials per pkg) 
8.8 8.8 8.8 8.8 8.8 8.8 8.8 8.8 
7.04 7.04 7.04 7.04 7.04 7.04 7.04 7.04 
6.81 8.22 6.81 4.58 8.22 3.23 4.36 5.56 
2.45 
(10 vials per pkg) 
8.82 8.82 8.82 8.82 8.82 8.82 8.82 8.82 
7.35 7.35 7.35 7.35 7.35 7.35 7.35 7.35 
3.51 4.24 3.51 2.36 4.24 1.67 2.25 2.87 
1.5 
(20 vials per pkg) 
7.5 7.5 7.5 7.5 7.5 7.5 7.5 7.5 
6 6 6 6 6 6 6 6 
9.38 11.32 9.38 6.30 11.32 4.45 6.00 7.66 
2.08 
(10 vials per pkg) 
7.488 7.488 7.488 7.488 7.488 7.488 7.488 7.488 
6.24 6.24 6.24 6.24 6.24 6.24 6.24 6.24 
4.88 5.89 4.88 3.28 5.89 2.31 3.12 3.98 
2.14 
(50 vials per pkg) 
22.47 22.47 22.47 22.47 22.47 22.47 22.47 22.47 
9.55 9.55 9.55 9.55 9.55 9.55 9.55 9.55 
4.61 5.56 4.61 3.10 5.56 2.19 2.95 3.76 
 
Table 16 shows the number of the towers for each device for different vial diameters. The 
1.76 cm and 2.45 diameter vial inner packs have a similar width and length, so they can be used 
interchangeably. The 1.5 cm and 2.08 diameter vial inner packs also have a similar width and 
length and can be used interchangeably, but only 28 towers in the RCW 444L-A are available 
when they are used interchangeably. 
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Table 16. The number of the towers for RCW 25 and RCB 444L-A 
New Modular Packaging 
Configuration 
RCW 25 RCB 444L-A 
1.76 
(20 vials per pkg) 
15 towers (3 × 5) 20 towers (4 × 5) 
2.45 cm 
(10 vials per pkg) 
15 towers (3 × 5) 20 towers (4 × 5) 
1.5 cm 
(20 vials per pkg) 
20 towers (4 × 5) 30 towers (5 × 6) 
2.45 
(10 vials per pkg) 
20 towers (4 × 5) 28 towers (4 × 7) 
2.14 cm 
(50 vials per pkg) 
4 towers (2 × 2) 6 towers (2 × 3) 
 
However, note that these new configurations might not be realistic because the heights of 
some vials are too short to hold vaccine. Vials less than 3 cm in height may not be tall enough to 
hold vaccine. The short vials occur because the vial size change only considers total vial volume 
and ignores the vial shape. For example, DTP-HepB inner packs with diameter 2.45 cm have a 
height of 1.67 cm, which is definitely too short.    
3.4.4 Results with new configurations 
Table 17 shows the number of FICs for each device when only towers are used for packing. In 
most cases, a modular packaging system can hold more vaccines, as measure by FIC, than the 
conventional packaging configuration (123.6 for the RCW 25 and 126.6 for the RCB 444L-A). 
Note that we do not consider filling any additional spare space so as to simplify the packing 
analysis. Using the spare space permits a storage device to hold more vaccine but makes the 
packing procedure more complicated because a health worker has to consider many different 
ways to utilize the spare space. In addition, even without utilizing the spare space, the modular 
packaging results in better filling of the storage devices than conventional packaging. 
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Table 17. FIC for RCW 25 and RCB 444L-A with new configurations 
New Modular 
Packaging 
Configuration 
RCW 25 RCB 444L-A 
Tower Layer Optimizing Tower Layer Optimizing 
1.76 cm 138.6 (99.5%)1) 
132 
(94.6%) 139.3 
132 
(88.9%) 
138 
(92.9%) 148.5 
2.45 cm 143.6 (98.6%) 
138.6 
(95.1%) 145.7 
143.6 
(92.6%) 
145.2 
(93.6%) 155.1 
1.5 cm 132 (100%) 
118.8 
(90.0%) 132 
151.8 
(92.2%) 
151.8 
(92.2%) 164.7 
2.08 cm 138.6 (100%) 
135.3 
(97.6%) 138.6 
141.9 
(93.5%) 
145.2 
(95.7%) 151.8 
2.14 cm 115.5 (93.3%) 
123.8 
(100%) 123.8 
148.5 
(100%) 
148.5 
(100%) 148.5 
1) Percentage ratio of the FIC of the tower/layer method to the optimizing method  
 
Obviously, the FIC for the RCW 25 decreases and the FIC for the RCB 444L-A 
increases. When the vial configurations for the RCW 25 are used and only the tower space is 
used, the maximum FICs for each device are 158.0 and 122.1, respectively. However, when the 
new configurations for both devices are used and only the tower space is used, the maximum 
FICs for each device are 145.7 and 155.1, respectively. This implies that the new packaging 
configuration results in greater vaccine storage if equal numbers of the two devices are used.  
3.5 DISCUSSION AND CONCLUSIONS 
The results of this study show that modular inner packs permit more vaccines to be stored in the 
storage device. This follows from the fact that we choose to standardize vial diameters and inner 
pack sizes, which in turn leads to easier and more efficient packing in a vaccine carrier.  Under 
the current situation with widely varying inner pack sizes it is not possible to arrive at a 
consistent and space-efficient packing arrangement. Additionally, the modular inner packs would 
actually provide even greater packing efficiency because the height of the inner packs was 
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determined conservatively in our analysis; adjusting for this will likely increase the packing 
efficiency difference by approximately an additional 5%. We also recommend the tower 
approach over the layer approach since the former generally provides slightly better packing 
efficiency. The mathematical model allows more vaccine to be stored in the storage device, but 
the heuristic methods also provide good packing efficiency in all examples. Therefore, if the 
optimizing method is not available, the heuristic ones can provide a good packaging solution. 
Finally, the optimized tower approach would be unrealistic in practice and its results serve 
mainly to provide an upper bound on performance.  Table 11 shows that the heuristic methods do 
well in relation to this bound.  
Since different shapes and sizes of storage devices are used in practice, it is impossible to 
design a modular packaging scheme that fits all storage devices precisely. However, if there is a 
commonly used storage device in a country and it is possible for the vaccine manufacturers to 
manipulate the size of the modular packaging, then selecting the right dimension that give a 
precise fit for the device would be a good strategy to employ. Even if there are different storage 
devices in a country, as long as a modular packaging system is utilized, more vaccines can be 
packed than when conventional packaging is used. We also accrue additional benefits from using 
modular packaging including simple, consistent and fast packing, ease of counting the number of 
vials, and easier handling in general.  
It should be noted that if the demand is not high enough to warrant filling the cold box 
(e.g., at a catchment area with a low population) then packaging is obviously less of an issue.  
Simply filling the carrier with additional vaccines to maximize FIC might not be appropriate if 
there is potential for wastage of excess vaccines at such locations.  The issue of packaging is of 
greater importance when we have sufficient demand and the cold boxes we have cannot take 
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everything needed because of the inconsistent packaging sizes, or when inconsistent sizes make 
it difficult for health care workers to manage limited space in a simple and efficient fashion.   
In summary, there are several advantages to using the modular packaging as listed below; 
the first two are probably the most important. 
1. It achieves higher packing densities for a reasonable packing method such as the tower or 
the layer approach, as indicated by the data in Table 3-5. Also, recall that the heights of 
the modular inner packs were found by using conservative volume estimates and 
therefore the actual packing density differences between conventional and modular 
systems will likely be a few percentage points greater. It is also important to note that the 
conventional packing densities discussed assume that packers optimize space efficiency 
by packing and re-packing to achieve maximum efficiency. Thus, the packing densities 
achieved in practice are probably lower, which further increases the advantage of using 
the modular systems. 
2. The modular packing procedure is much simpler and more consistent. Vaccines are 
simply stacked vertically in the twenty or six vertical stacks (depending on the vial size); 
there is no need to explore numerous complicated orientations and geometrical 
configurations. Thus, high packing efficiencies can be obtained consistently with little 
effort or special expertise required. This is a tremendous advantage from a practical 
standpoint because the personnel packing the storage devices will not require special 
training to ensure that carefully planned packing procedures are followed routinely in the 
field.  
3. The simplified modular packing procedure will be faster since the person packing the 
storage device does not have to spend time exploring different configurations. 
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4. Counting the number of vials is easier because the inner packs have uniform quantities 
(this advantage is somewhat reduced if more than one standard size is adopted). 
5. It is easier to handle the inner packs because they are all the same size, rather than trying 
to handle vaccines with different inner pack sizes. For example, transporting a stack of 
vaccines that has an inner pack that is 12cm × 15cm on top of an inner pack that is 15cm 
× 18cm which is on top of an inner pack that is 20cm × 20cm is more difficult to do 
without toppling it than a stack of three inner packs that all have the same dimensions. 
6. Ideally, the vaccines should be packed with about 1cm of clearance space in between 
each inner pack to promote good air flow and uniform cooling (especially in 
refrigerators). If the inner packs have a consistent modular size, this would facilitate 
inserting spacers in between the stacks of inner packs to insure proper clearance is 
maintained. 
7. If the inner packs are a consistent size, then cold storage devices can be manufactured 
with storage spaces that have dimensions that most efficiently accommodate the inner 
packs.  
These benefits comes from the power of standardization. In this chapter, we have focused 
on standardization of vaccine packaging by changing packaging configurations. The modular 
packaging designed for a storage device can decrease wasted space in the storage device and can 
make it possible to utilize easy stacking methods. If the storage devices are also standardized 
along with the modular packaging size, the space efficiency could be maximized over an entire 
country.  
While our analysis suggests that modular packaging systems offer benefits over 
conventional vaccine packaging in the form of increased potential FICs, higher packing 
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densities, and simplifying the process of a worker packing a storage device, there are several 
limitations to our study. First, we assumed a single conventional packaging type for each existing 
vaccine, while it is likely that existing packaging varies for vaccines from different 
manufacturers or with different dose schedules. Similarly, in designing a potential modular 
packaging system, we assumed that all vaccines could fit in new, optimized vials based on the 
volumes of vials currently in use. This may not be the case for all existing vaccines. Third, our 
packing approach is a heuristic algorithm related to inner pack heights and if these heights are 
widely different it might not provide packings that are as good as the ones in our illustration.  
Finally, in order to quantify the economic benefits of improved packaging, a potential next step 
would be to utilize a vaccine supply chain modeling software, such as HERMES(Assi, et al., 
2011; Lee, et al., 2011; Assi, et al., 2013), to determine the economic impact of changing 
packaging sizes. The impact could vary significantly depending on the country and 
circumstances (e.g., vaccine regimen), and such an analysis would require extensive simulation 
experiments and could be the basis of a future study. 
Our analysis suggests that modular packaging systems could offer significant advantages 
over conventional vaccine packaging systems with respect to space efficiency when combined 
with a reasonable packing method such as the layer or tower method, when they are stored in 
standard vaccine carrying devices. This allows for more vaccines to be stored within the same 
volume while also simplifying the procedures used by field workers for packing storage devices. 
Ultimately, this could be a simple way to help increase vaccine coverage worldwide.  
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4.0  APPLYING LEAN CONCEPTS TO MANAGE VACCINE INVENTORY 
4.1 INTRODUCTION 
Vaccines administered at clinics or health centers are typically supplied from an upper level 
distribution location. The replenishment of vaccines at a clinic usually happens at regularly 
scheduled intervals (e.g., once a month) and requires completing vaccine ordering processes such 
as determining how many vaccine doses remain and requesting the amounts  necessary to cover 
the forecast demand before the next replenishment. This vaccine ordering process is executed by 
health workers at clinics across the country. It is complicated by the fact that there might be five 
to ten different vaccine types (e.g., measles, DTP, polio, etc.) and also that vaccines come in 
multi-dose vials where the number of doses in a vial is different for different vaccine types.  In a 
typical clinic, the health worker counts and records the remaining vaccine vials and translates 
this into a number of doses.  He then determines how many net doses would be required to meet 
the forecast demand until the next replenishment point and translates this into the number of 
vials needed for the next inventory cycle.  This is done for each different vaccine and a combined 
order for vials is then placed with the higher level.  
At the upper level distribution location another health worker counts the number of vials 
ordered by the clinic for each vaccine type and prepares them for delivery to or pickup by the 
clinic. The same distribution location will typically service a number of different clinics in a 
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similar fashion. The vaccines are then transported to the clinic. Currently, an individual vial is 
used as the ordering unit at the clinic, and since this is the smallest physical unit in the 
distribution chain, ordering in vials (as opposed to cases or standard packs of vials) does help to 
minimize clinic vaccine inventory. This is important because cold storage capacity for vaccines 
can often be quite limited at clinics.  However, personnel at clinics who perform logistical 
activities are often poorly trained and lacking in the skills to effectively perform these activities.  
The steps in the replenishment process can be tedious and even trained workers can make 
mistakes in counting and recording the number of remaining vials of several different kinds of 
vaccines, and managing and replenishing inventory at the individual vial level requires 
significant effort. Moreover, Steele (2014) reports that immunization supply chain functions are 
frequently performed in developing countries by pharmacists, clinicians and drivers, as opposed 
to workers who are trained specifically on supply chain functions. She points out that vaccine 
supply chain practices are poor because of poor monitoring systems, resulting in poor data for 
demand forecasting and long procurement processes.  
In this chapter, we conduct an ordering policy analysis with respect to the ordering unit, 
and based on this analysis we recommend the use of inner packs (the next larger packaging unit), 
rather than a vial, when ordering vaccines. In addition to simplifying the ordering process used 
by healthcare workers at the clinics, we show that it reduces the likelihood of vaccine stockouts 
and thus also improves overall vaccination levels at clinics by giving the patient more 
opportunities to get vaccinated. The basic idea behind this simplified ordering process draws 
upon the Kanban concept from Just-In-Time (JIT) inventory systems. JIT is a commonly used 
technique in the manufacturing industry that was popularized by Toyota, and a Kanban is a 
simple visual system that is used for implementing JIT.  JIT/Kanbans have been shown to yield 
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considerable benefits in production settings, including simpler processes, more timely deliveries, 
increased responsiveness, increased firm profitability, and inventory reductions (Monden, 2011; 
Baudin, 2004; Fullerton & McWatters, 2001). In addition to manufacturing, Kanban/bin supply 
systems are being adapted elsewhere and have been shown to provide better inventory control in 
many healthcare settings, e.g., managing critical nursing supplies (Southwest solutions group, 
2015) and other items (Graban, 2011). Rahn (2010) explains why the Kanban method has 
advantages over the commonly used PAR-level system for hospital material management (where 
items are replenished every period to bring inventories back to some base stock level). He 
emphasizes seven main advantages including the fact that no counting is needed, and that it 
promotes better inventory management practices.  The primary disadvantage is that this approach 
might need more physical storage space. 
The remainder of this chapter is structured as follows. First, the problem is described and 
the suggested ordering policies are explained. Next, we perform a storage space analysis at the 
clinic level, with a focus on cold storage requirements. In this section, the methodology and 
equations related to the different ordering policies are presented, and numerical examples are 
illustrated using real data from two countries – Benin and Niger. Third, we perform storage 
space analysis in vaccine transportation between different levels in the supply chain to 
investigate the effect of the proposed ordering polices. We end with a brief discussion of our 
conclusions. 
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4.2 PROBLEM DESCRIPTION 
In this research, we focus solely on the ordering process at the clinic level where vaccinations 
occur. Currently, the vial is the ordering unit and a base-stock policy is applied. Each period the 
health worker counts the remaining vials of each vaccine, records these numbers and then orders 
the number of vials needed to return to an inventory level equal to the average demand during 
the replenishment cycle.  Note that for some vaccines the shelf life is limited once the vaccine 
vial has been opened and any vaccine remaining after this period has to be discarded.  Such 
wastage is referred to as open vial waste (OVW) and this has been studied by Lee et al. (2010), 
Dhamodharan & Proano (2012) and Mofrad et al. (2014). The demand forecast is first inflated by 
a factor to account for the percentage of OVW (where applicable) to compute the number of 
vials needed and a buffer factor is added to account for demand variability. Using a base stock 
level (in vials) equal to the average adjusted demand plus a 25% buffer is a standard 
recommendation of the WHO (World Health Organization, 2014).  
The upper level health worker receives order requests from the clinics and then picks the 
corresponding vials for each clinic and prepares them for shipment. All of the vial counting for 
all of the vaccines at both the clinic and the upper level is done manually and there are ample 
opportunities for ordering and order fulfillment errors. Since manufactures distributed vaccine 
vials in inner packs that typically range in size from 10 to 200 vials in one inner pack depending 
on the vaccine type and manufacturer, we propose two ordering policies based on inner packs 
and compare them with the current policy, which uses a vial as the unit. 
The first proposed policy is referred to as the inner pack unit ordering policy, where a 
clinic orders vaccines only in inner pack units. For a given vaccine, the clinic worker counts the 
number of unopened inner packs and individual vials in any open pack to determine the number 
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of vials remaining and then calculates the required number of vials based on the forecast 
demand. This policy still requires some counting of vials to obtain the number remaining, but 
since there is at most one open inner pack at any time for a given vaccine, the worker only has to 
count the number of remaining vials in this one inner pack. For example, if an inner pack 
contains 20 vials and we have one unopened inner pack and one open one with 11 vials in it, 
only the latter would be counted to determine the current inventory of 31 units. If we require 55 
vials for the next cycle (typically, one month), this means we need to order 24 more vials. Since 
ordering is based on rounding up to the next full inner pack, two inner packs are ordered. At the 
upper level the order fulfillment process is even simpler because only full inner packs are 
handled and no individual vial counting is required.  
The second policy is referred to as a kanban ordering policy, where each empty inner 
pack is set aside in a specified location.  The worker only counts the number of empty inner 
packs at the location for each vaccine and orders enough material to replenish these. 
Alternatively, one might follow a process like the one common in many manufacturing 
environments where each container - or inner pack in our case - is placed in its own slot 
(possibly, a location that is marked with a prominently marked symbol or color).  When the inner 
pack is completely emptied it is discarded and the slot is empty (or the symbol is exposed), and 
this represents the fact that a replacement is required for it, so that we order as many inner packs 
as there are empty slots. In this context, each inner pack corresponds to a Kanban bin and the 
number of bins replenished is equal to the number fully consumed. This Kanban ordering idea is 
borrowed from the traditional Kanban materials management system for lean and just-in-time 
production. It most closely resembles a signal Kanban (Monden, 2011). An example signal 
Kanban is shown in Figure 13 where there are three measles inner packs that are stored. At the 
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time of reorder the healthcare worker simply orders the number of inner packs equal to the 
number of empty storage locations. Thus, only one inner pack is ordered in case (a) and two are 
ordered in case (b).  
 
 
Figure 13. Signal Kanban example 
 
The primary advantage of simplifying the ordering method is that it is easier to 
implement when the personnel involved might not be well trained, and it reduces potential errors 
that could occur during ordering. However, one drawback of the Kanban based idea is that it 
does require more storage space at the clinic. This is because the maximum number of vials 
stored under the current vial unit ordering method is equal to the order up to level, but if the 
inner pack unit or Kanban ordering policy is applied, the maximum amount stored will generally 
increase. In addition, a cold storage device used in transportation between points in the 
distribution chain may not be able to hold all of the vaccines, because filling the storage device 
with only inner packs both potentially increases the number of vials that must be transported and 
also decreases packing efficiency due to having to pack the physical dimensions of the inner 
pack rather than individual vials. In order to address these space issues, we evaluate the effect on 
storage space at the clinic level and in transportation in the following sections. 
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4.3 CLINIC STORAGE DEVICE ANALYSIS 
Introducing the simplified ordering policies of the previous section generally leads to needing 
more storage space at the clinic because vaccines are now ordered in inner pack units. In order to 
evaluate the effect of the two proposed policies on incremental space requirements, we perform a 
clinic storage device analysis. To understand the true impact at a high level, we use real data to 
calculate the total number of storage devices needed across the entire set of clinics in a country 
in order to store vaccines for each policy, and we repeat these calculations for different inner 
pack sizes. Since a public health decision maker would not want the number of storage devices 
to increase significantly due to the resulting increase in system-wide costs, our goal is to also 
determine an inner pack size that results in only a modest increase in the required number of 
storage devices country-wide. 
4.3.1 Methodology 
The total number of storage device needed is estimated conservatively by summing the minimum 
number of storage devices required at each location for each ordering policy.  This can be 
computed using several pieces of available information: the monthly demand, the average 
number of vaccination days per week, device storage volumes, and vaccine information such as 
dose(s) per patient, number of doses per vial and packed volume per vial. The first step is to 
estimate the average total number of doses needed per vaccination day for vaccine 𝑖𝑖 at location 𝑗𝑗 (= 𝑠𝑠𝑖𝑖𝑖𝑖 ) as follows: 
𝑠𝑠𝑖𝑖𝑖𝑖 = �𝑑𝑑𝑖𝑖𝑀𝑀𝑖𝑖� × 𝑝𝑝𝑖𝑖 (49)  
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 where 𝑑𝑑𝑖𝑖 denotes the patients per month expected at location/local clinic 𝑗𝑗, 𝑀𝑀𝑖𝑖 denotes the 
number of vaccination days per month at location 𝑗𝑗, and  𝑝𝑝𝑖𝑖 denotes the doses per patient of 
vaccine 𝑖𝑖. 
Next, we calculate the number of vials 𝑘𝑘𝑖𝑖𝑖𝑖 required per month for vaccine 𝑖𝑖 at 
location 𝑗𝑗,  as follows: 
𝑘𝑘𝑖𝑖𝑖𝑖 = ��� 𝑠𝑠𝑖𝑖𝑖𝑖1 − 𝑓𝑓𝑜𝑜𝑜𝑜(𝑠𝑠𝑖𝑖𝑖𝑖, 𝑜𝑜𝑖𝑖)� × 𝑀𝑀𝑖𝑖𝑜𝑜𝑖𝑖� × (1 + 𝑏𝑏)� (50)  
where  𝑜𝑜𝑖𝑖 denotes the number of doses per vial of vaccine 𝑖𝑖, 𝑓𝑓𝑜𝑜𝑜𝑜 is the open vial waste which is 
a function of 𝑠𝑠𝑖𝑖𝑖𝑖 and 𝑜𝑜𝑖𝑖,  and 𝑏𝑏 denotes the buffer value; the (1 + 𝑏𝑏) term is used to add a buffer 
to account for variability in the patient arrival process.  
Because 𝑘𝑘𝑖𝑖𝑖𝑖 is the number of vials required per month, anytime the inventory level is 
below 𝑘𝑘𝑖𝑖𝑖𝑖 at the beginning of the month, ordering needs to occur. Thus, 𝑘𝑘𝑖𝑖𝑖𝑖 − 1 is the largest 
number of vials that can be on hand when ordering occurs. Assume we use inner packs 
containing k vials. With our first (inner pack) ordering policy, we simply count the number of 
vials in any currently open inner pack (say, x) and the number of unopened inner packs (say, y) 
and if 𝑘𝑘𝑦𝑦 + 𝑥𝑥 < 𝑘𝑘𝑖𝑖𝑖𝑖 we place an order for ⌈(𝑘𝑘𝑖𝑖𝑖𝑖 − 𝑘𝑘𝑦𝑦 − 𝑥𝑥)/𝑘𝑘⌉ inner packs.    
With the second (Kanban) ordering policy, we have to be more careful. Recall that we 
order as many inner packs as the number fully consumed, and assume that the policy is 
implemented by assigning each inner pack a slot and ordering enough to fill each empty slot. 
Then the minimum number of slots to set aside (say n) is given by 
𝑛𝑛 − 1 ≥  𝑘𝑘𝑖𝑖𝑖𝑖 − 1
𝑘𝑘
 (51)  
 73 
𝑛𝑛 =  �𝑘𝑘𝑖𝑖𝑖𝑖 − 1
𝑘𝑘
� + 1 (52)  
It might seem that we could simply let 𝑛𝑛 = ⌈𝑘𝑘𝑖𝑖𝑖𝑖/𝑘𝑘⌉ but this is not sufficient because we 
want to ensure that when there is a partially empty inner pack (as would often occur) at an 
ordering time, we order sufficient inventory. For example, suppose the inner pack size is 20, 𝑘𝑘𝑖𝑖𝑖𝑖 
is 50, and we have two full inner packs plus one inner pack with 6 vials in it when we review the 
inventory prior to deciding on whether to place an order. If we only set n = ⌈50/20⌉ =3 slots 
then we will not order any vaccines since all three slots are currently occupied (two by full inner 
packs and one by the inner pack with 6 vials). However, we will only have 46 vials on hand, 
which is below our desired inventory level. Thus, the + 1 term is needed to insure that the clinic 
always starts with the minimum required number of vials. Otherwise, a partially filled inner pack 
(in the extreme case, with as little as one vial in it) would result in us not placing an order to 
replenish that inner pack, which might cause the starting level of stock to be below the desired 
amount and increases the likelihood of a vaccine shortage during that cycle.  Furthermore, we 
use 𝑘𝑘𝑖𝑖𝑖𝑖 − 1 rather than 𝑘𝑘𝑖𝑖𝑖𝑖 because in the case that 𝑘𝑘𝑖𝑖𝑖𝑖 − 1 is an integer multiple of the inner 
pack size, using 𝑘𝑘𝑖𝑖𝑖𝑖 could result in holding one more inner pack than is strictly necessary, 
because in this special case even if the last inner pack only has one vial remaining that is 
sufficient.  For example, if the inner pack size is 20 and 𝑘𝑘𝑖𝑖𝑖𝑖 is 61, then using n = ⌈𝑘𝑘𝑖𝑖𝑖𝑖/𝑘𝑘⌉ + 1 =
⌈61/20⌉ + 1 will result in using 5 slots. However, only 4 slots are actually required because 
even if the inner pack in the last slot contains only one vial we will have sufficient vial inventory 
for the month.  
We made the assumption that vaccine vials are stored in inner packs in the storage device 
when the inner pack unit ordering policy or Kanban ordering policy is used. Therefore, even if 
only one vial is left in the inner pack the volume of one entire inner pack is still occupied. The 
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Kanban ordering policy needs sufficient space to store the number of inner packs required to 
provide 𝑘𝑘𝑖𝑖𝑖𝑖 vials and then one more inner pack because inner packs are only replaced once they 
are fully empty. The inner pack unit ordering policy also needs enough space to hold the number 
of inner packs required to provide 𝑘𝑘𝑖𝑖𝑖𝑖 vials, plus one, because at times one inner pack may have 
as few as one vial remaining but still occupies an entire inner pack’s volume. For example, let 
𝑘𝑘 = 10 and 𝑘𝑘𝑖𝑖𝑖𝑖 = 14, then �𝑚𝑚𝑖𝑖𝑖𝑖−1𝑘𝑘 � + 1 = �14−110 � + 1 = 3, so space to hold three inner packs is 
needed. If there are 18 vials left at the time of reordering, no vaccine is ordered under the inner 
pack ordering policy (because 18 > 14), but one inner pack is ordered in the Kanban ordering 
policy (because one inner pack location is empty). If there are 13 vials left at the time of 
reordering, both policies order one inner pack. Thus, the Kanban and inner pack ordering 
policies both require sufficient space to store the same maximum number of inner packs although 
the average inventory level of the inner pack ordering policy will be lower. 
To estimate the required vaccine storage volume for a vaccine we start with the packed 
volume per vial (which we define as 𝑔𝑔𝑖𝑖𝑜𝑜). For vaccines that require a diluent (a liquid that is used 
to reconstitute freeze dried vaccines), the diluent must also be stored in the storage device before 
it is used. We assume that 10% of a vaccine’s diluent is stored in the storage device at any point 
in time. Thus, the net storage volume per vial of a vaccine, 𝑔𝑔𝑖𝑖, is given by 
𝑔𝑔𝑖𝑖 = 𝑔𝑔𝑖𝑖𝑜𝑜 + 0.1𝑙𝑙𝑖𝑖       (53)  
where 𝑙𝑙𝑖𝑖 denotes the packed diluent volume of vaccine 𝑖𝑖.  Using an inner pack of 𝑘𝑘 vials, we 
need a packed volume of (𝑔𝑔𝑖𝑖 × 𝑘𝑘) units of space per inner pack, and multiplying this by the 
number of inner packs required, we may estimate the minimum required volume of vaccine 𝑖𝑖 at 
location 𝑗𝑗 with inner packs of size k, denoted as 𝑓𝑓𝑖𝑖𝑖𝑖𝑘𝑘, via: 
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𝑓𝑓𝑖𝑖𝑖𝑖𝑘𝑘 = (𝑔𝑔𝑖𝑖 × 𝑘𝑘) × ��𝑘𝑘𝑖𝑖𝑖𝑖 − 1𝑘𝑘 � + 1� (54)  
So, the corresponding estimate of the number of storage devices 𝑛𝑛𝑖𝑖  needed at location 𝑗𝑗  
is given by  
𝑛𝑛𝑖𝑖 = �∑ 𝑓𝑓𝑖𝑖𝑖𝑖𝑘𝑘𝑖𝑖∈𝐼𝐼𝑐𝑐𝑖𝑖 � (55)  
 
where 𝑐𝑐𝑖𝑖 is the capacity of a storage device at location 𝑗𝑗 and 𝐼𝐼 is the index set of all vaccines.  
Summing these over 𝑗𝑗 ∈ 𝐽𝐽, where 𝐽𝐽 is the set of  clinics, finds the total number of storage devices 
needed within an entire country. In particular, if 𝑘𝑘=1 for all vaccines ∑ 𝑛𝑛𝑖𝑖𝑖𝑖∈𝐽𝐽  is the total number 
of storage devices needed in the country using the vial unit ordering policy.  In general, let 
𝑠𝑠 = (𝑖𝑖,𝑘𝑘) ∈ 𝑆𝑆, where S is the set of pairs of vaccine types and corresponding inner pack sizes. 
For example, if BCG uses an inner pack of size 20, measles one of size 10 and PCV one of size 
50, then  𝑆𝑆 = {(𝐵𝐵𝐶𝐶𝐺𝐺, 20), (𝑀𝑀𝑀𝑀𝑀𝑀𝑠𝑠𝑙𝑙𝑀𝑀𝑠𝑠, 10), (𝑃𝑃𝐶𝐶𝑉𝑉, 50)}, and the total number of storage devices 
needed in the country, 𝑁𝑁(𝑆𝑆), may be estimated as: 
𝑁𝑁(𝑆𝑆) = � ∑ 𝑓𝑓𝑖𝑖𝑖𝑖𝑘𝑘(𝑖𝑖,𝑘𝑘)∈𝑆𝑆
𝑐𝑐𝑖𝑖𝑖𝑖∈𝐽𝐽
� (56)  
Note that in this particular capacity analysis we only consider clinic cold storage space 
and do not consider any transportation capacity issues. 
4.3.2 Numerical example 
We illustrate our approach by applying it to data from two countries: Benin and Niger. Table 18 
provides summary data for these two countries. (Haidari et al., 2015; Lee et al., 2012) 
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Table 18. Summary data for Benin and Niger 
 Benin Niger 
Number of local clinics 658 695 
Number of vaccines 8 8 
Vaccination days per month 5 – 28 16 
Mean clinic demand 
(Range of clinic demands) 
564 
(100 - 3300) 
1,083 
(300 - 3,400) 
 
Vaccine information for Benin and Niger is shown in Tables 19 and 20. Note that the 
same vaccine can have a different packed volume per vial in different countries because the 
vaccine might be supplied by a different manufacturer. The data also shows that different 
countries can require different numbers of doses of a particular vaccine. 
 
Table 19. Vaccine information for Benin 
Name Vaccine presentation 
Doses/ 
vial 
Packed vol./ 
vial(cc) 
Doses 
/person 
Diluent vol./ 
vial(cc) 
Current inner 
pack size 
Tuberculosis Lyophilized 20 21.09 1 12 50 
Tetanus 
Toxoid Liquid 10 25.41 2  10 
Measles Lyophilized 10 21.09 1 25 50 
Oral Polio Liquid 20 14.06 4  100 
Yellow Fever Lyophilized 10 25.41 1 25.4 10 
DTC-HepB-
Hib liquid Liquid 2 9.92 3  100 
PCV13 Liquid 1 17.13 3  50 
Rotavirus Liquid 1 13.5 2  50 
*Note that the current inner pack size is inferred from the WHO vaccine database and vaccine information for Benin 
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Table 20. Vaccine Information for Niger 
Name Vaccine presentation 
Doses/ 
vial 
Packed vol./ 
vial(cc) 
Doses 
/person 
Diluent vol./ 
vial(cc) 
Current inner 
pack size* 
Tuberculosis Lyophilized 20 24 1 14 50 
Tetanus 
Toxoid Liquid 10 30 3  10 
Measles Lyophilized 10 21.3 1 5 10 
Oral Polio Liquid 20 20 4  100 
Yellow Fever Lyophilized 10 25 1 6 10 
DTC-HepB-
Hib liquid Liquid 1 16.8 3  50 
PCV13 Liquid 1 12 3  50 
Rotavirus Liquid 1 45.9 3  10 
*Note that the current inner pack size is inferred from the WHO vaccine database and vaccine information for Niger 
 
The following analysis considers inner pack sizes of 10, 20, 50, and 100, which represent 
round numbers that are commonly seen in practice. The first analysis is done for Benin. If we set 
the inner pack sizes of all vaccines to be the same, the total number of storage devices needed 
and the annual operation costs are as follows: 
 
Table 21. Total number of storage devices by inner pack size for Benin 
 Vial unit ordering Inner pack unit ordering/Kanban ordering 
Inner pack size (k) 1 10 20 50 100 
Total number of storage 
devices  664 664 670 706 1117 
Annual operation costs($) 521,535 521,535 526,545 555,593 898,018 
 
As seen in Table 21, with k=10 there is no need to purchase any additional cold storage 
devices.  With inner packs of k=20 vials for all vaccine, only six more storage devices are 
 78 
needed and even when the inner pack has 50 vials there is only a modest increase in the number 
of additional storage devices needed. 
Given that each vaccine has its own characteristics, it follows that the inner pack sizes of 
all vaccines need not be the same. To find a reasonable inner pack size for each vaccine, a 
marginal volume analysis was done for each vaccine, where the inner pack size of the selected 
vaccine increases but all of the others are set to 1. The results are shown in Table 22; e.g., for the 
measles vaccine, using k=10, 20, 50 and 100 result in marginal increases in volume of 4%, 9%, 
25% and 55%, respectively, and we could pick a size depending on the percentage increase that 
we are willing to tolerate.  We consider two such values, corresponding to marginal increase in 
volume of up to 10% and up to 20%.  The orange colored cells indicate the inner pack size 
breakpoint for up to a 10% volume increase, while the blue colored cells represent the breakpoint 
for up to a 20% increase. If the breakpoints are the same for 10% and 20%, then only an orange 
colored cell is shown. For Tuberculosis, Tetanus Toxoid, Measles and Yellow Fever, the 10% 
and 20% breakpoint volume inner pack sizes are the same (=20).  
 
Table 22. Marginal volume increase for each vaccine Benin 
Vaccines  1 10 20 50 100 
Tuberculosis Volume 5,325 5,506 5,710 6,572 8,040 Increase % 0% 3% 7% 23% 51% 
Tetanus Toxoid Volume 5,325 5,532 5,764 6,727 8,382 Increase % 0% 4% 8% 26% 57% 
Measles Volume 5,325 5,545 5,783 6,669 8,259 Increase % 0% 4% 9% 25% 55% 
Oral Polio Volume 5,325 5,439 5,568 6,101 7,017 Increase % 0% 2% 5% 15% 32% 
Yellow Fever Volume 5,325 5,579 5,855 6,877 8,714 Increase % 0% 5% 10% 29% 64% 
DTC-HepB-Hib liquid Volume 5,325 5,405 5,498 5,845 6,323 Increase % 0% 1% 3% 10% 19% 
PCV13 Volume 5,325 5,434 5,570 6,007 6,705 
Increase % 0% 2% 5% 13% 26% 
Rotavirus Volume 5,325 5,443 5,595 6,135 6,955 Increase % 0% 2% 5% 15% 31% 
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Using the inner pack sizes corresponding to the 10% and 20% marginal increases in 
volume for each vaccine, the total number of storage devices needed is shown in Table 23, along 
with the results for the current inner pack size combination. 
 
Table 23. The total number of storage devices by inner pack size Benin 
 Vial unit ordering Inner pack unit ordering/Kanban ordering 
Inner pack size 1 10 20 Up to 10% 
Up to 
20% Current 50 100 
Total number of 
storage devices 664 664 670 670 678 699 706 1,117 
Annual operation 
costs($) 521,535 521,535 526,545 526,545 533,427 550,557 555,593 898,018 
 
As seen in Table 23, with inner packs of k=50 for DTC-HepB-Hib and k=20 for all other 
vaccines (up to a 10% marginal volume increase) we still require the same number of additional 
storage devices (6) as the case where all inner packs are of size 20.  On the other hand, using 
inner packs of  k=100 for DTC-HepB-Hib, k=50 for Polio, PCV13 and Rotavirus, and k=20 for 
all other vaccines (up to a 20% marginal increase in volume) we require 14 additional storage 
devices.  Finally, if we switched to an inner pack ordering or Kanban ordering policy while 
staying with the inner packs that are currently in use (as shown in Table 19), we would still need 
only 35 additional devices country-wide. 
Conducting a similar analysis in Niger, we picked inner pack sizes for each vaccine with 
up to a 5% and up to a 10% marginal volume increase. Note that we did not consider a value of 
20% because even with inner pack sizes of 100 there was only a 7% increase and vaccines do not 
typically come in inner packs larger than 100 vials (Table 24).  
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Table 24. Marginal volume increase for each vaccine Niger 
Vaccines  1 10 20 50 100 
Tuberculosis Volume 19,788 19,813 19,841 20,275 21,093 Increase% 0% 0% 0% 2% 7% 
Tetanus Toxoid Volume 19,788 19,788 19,788 20,194 20,863 Increase% 0% 0% 0% 2% 5.4% 
Measles Volume 19,788 19,860 19,959 20,168 20,870 Increase% 0% 0% 1% 2% 5.5% 
Oral Polio Volume 19,788 19,788 19,788 20,044 20,655 Increase% 0% 0% 0% 1% 4% 
Yellow Fever 
Volume 19,788 19,873 19,988 20,235 21,059 
Increase% 00% 0% 1% 12% 6% 
DTC-HepB-Hib 
liquid 
Volume 19,788 19,788 19,788 20,017 20,180 
Increase% 0% 0% 0% 1% 2% 
Rotavirus Volume 19,788 19,788 19,788 20,412 20,858 Increase% 0% 0% 0% 3% 5.4% 
PCV13 Volume 19,788 19,813 19,841 19,951 20,068 Increase% 0% 0% 0% 1% 1% 
 
If up to a 5% and up to a 10% volume increase inner pack size for each vaccine are 
applied, the total number of storage devices needed is shown in Table 25. Table 25 also shows 
results for the current combination of inner pack sizes. 
 
Table 25. Total number of storage devices by inner pack size for Niger 
 Vial unit ordering Inner pack unit ordering/kanban ordering 
Inner pack size (k) 1 10 20 Current 50 Up to 5% 100/  Up to 10% 
Total number of 
storage devices 1,057 1,068 1,068 1,122 1,177 1,188 1,499 
Annual operation 
costs($) 679,975 686,468 686,468 716,030 747,712 755,159 850,136 
 
The Niger results indicate that using inner packs of up to 20 for all vaccines requires only 
eleven more storage devices over the entire country than with the current vial unit ordering 
policy; this is a very small increase. Note that this is less than the number of storage devices 
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needed if used the new ordering policies with the current set of inner pack sizes. Choosing inner 
packs of size 50 for all vaccines results in needing 120 more storage devices which represents 
only about a 10% increase in the total number of devices. If we increase the inner pack sizes up 
to 100 then there is a significant increase in the number of storage devices needed. We could also 
use a combination of inner packs of size 20 for all vaccines except PCV13 and DTC-HepB-Hib 
liquid where a size of 50 would be used (a larger inner pack is used for PCV13 and DTC-HepB-
Hib liquid because both are relatively small volume and have high demand) This results in a 
need for 1,069 storage devices across the country, which is an increase of only twelve over the 
single vial ordering policy. Thus, ordering logistics in Niger can be greatly simplified from both 
the ordering and fulfillment viewpoints with very little impact on the number of storage devices 
needed countrywide at the clinic level. 
4.4 TRANSPORTATION STORAGE SPACE ANALYSIS 
So far, we have only considered clinic cold storage space and not transportation capacity. 
Typically, vaccines are transported to clinics in vaccine carriers, using small 4×4 vehicles, 
motorcycles, bicycles or even on foot. These vaccine carriers have limited storage space and 
given that inner packs take up more space in a carrier than individual vials, ordering policies that 
use an inner pack unit may require more storage devices in transportation, and specific devices 
might not be suitable in the first place. According to the WHO’s specifications, the capacity of 
vaccine carriers which are used for vaccine vial transportation is between 0.5 and 5 liters (World 
Health Organization, 2010).  
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The BK-VC 1.7-CF which is used from the District distribution centers to clinics in 
Benin has a capacity of 1.7 liters. In Niger on the other hand, a 5 liter vaccine carrier is used 
(Assi et al., 2013). In addition, although the average volume of vaccines transported to a clinic 
might be similar, there is a higher degree of variation in the total volume required with the inner 
pack policies and the packing efficiency is worse since their replenishment unit is an inner pack. 
Therefore, we need to consider how using inner packs affects storage space requirements when 
transporting vials to clinics.  
4.4.1 Simulation model 
In order to examine the effect of using inner packs on transport capacity requirements, a model is 
developed using Microsoft Excel VBA to simulate a clinic’s ordering policy. We assume that the 
daily demand follows a Poisson distribution, and values of these demands at each clinic j for 
each vaccine i are randomly generated using a mean value of sij (as given by (49)). Monthly 
orders are placed according to each of the ordering policies that we study. The simulation model 
has the following parameters: inner pack size, doses per vial, whether or not the vaccine 
experiences open vial waste, buffer percentage, annual number of patients served at the location, 
vaccination days per month, doses per patient, and ordering policy.  
The model assumes that 1) the lead time is zero, 2) back orders are not allowed, 3) the 
vaccine shelf lives are long enough that expiration is not a problem, and 4) vaccines are ordered 
each month.  We run the simulation using the inner pack sizes found from the previous section 
that analyzed storage device requirements at the clinic level.  The output of the model is the 
number of vials or inner packs ordered each month for each vaccine type under each ordering 
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policy; this determines the total amount of vaccine that must be transported to the clinic from the 
next higher level, and hence, the required transportation storage capacity. 
4.4.2 Methodology 
The simulation model is run for 2000 months and for each month, and for each vaccine, it yields 
either the number of inner packs (for the two simplified policies that use an inner pack unit), or 
the number of vials ordered (for the current ordering policy). From this data, the volumes of the 
shipments are then calculated. Since the transportation storage devices should be able to 
transport the required vaccine amount of vaccine every month with a high probability, we 
specify the required total volume to be such that at least 95% of all orders (as estimated from the 
simulation output) can be successfully transported. This is estimated from the output of the 
simulation. Using this vaccine replenishment data and the capacity of each transportation storage 
device we then estimate the number of transportation storage devices required.  
For the current ordering policy with vial ordering/storage, we decrease the available 
space in the device to account for its packing efficiency. For example, if the capacity of a storage 
device is 3 liters and the packing efficiency is 80%, the storage device can hold 2.4 liters of 
vaccine vials; thus, if our requirement was for 6 liters of vaccines, we would need 3 devices. 
With the two simplified ordering polices, we use a trial-and-error method for packing the 
required vaccine inner packs into the physical dimensions of the transport storage device, given 
their dimensions and the dimensions of the storage space in the device. While a more 
sophisticated approach such as a 3D bin packing algorithm could be used, we chose to use the 
simpler methods that might be used in practice by a healthcare worker in the field. 
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4.4.3 Numerical example and Result 
The results from the simulation and the analysis are shown below for Benin. The transportation 
storage device commonly used at clinics in Benin (BK-VC 1.7-CF) has a vaccine storage volume 
of length 10 cm, width 10 cm and height 17 cm after it is packed with conditioned ice. The 
average annual patient demand, which is 550, is used to determine daily demand for doses of 
each vaccine. Since some of the current inner packs (Tuberculosis, Measles, DTC-HepB-Hib and 
PCV13) are too large to be held in the BK-VC 1.7-CF, assessing the simplified ordering policies 
with these inner packs is impossible, and the only option is to order in vial units. However, as we 
saw in the storage device space analysis, 10- or 20-vial inner packs could be considered with 
very little increase in clinic storage requirements. Table 26 shows the actual inner pack 
dimensions for the 10-vial inner packs. Note that the new dimensions are calculated based on the 
current vial diameter and height. 
 
Table 26. 10 vial inner pack dimensions 
Vaccines Tuberculosis Tetanus Measles Oral Polio 
Yellow 
Fever 
DTC-
HepB-
Hib 
PCV13 Rota 
Length(cm) 9.25 10.6 9.25 7.5 10.6 9 8.95 7.3 
Width(cm) 3.8 4.7 3.8 2.5 4.7 2.98 3.68 3.4 
Height(cm) 6 5.1 6 7.5 5.1 3.7 4.1 6.9 
 
Using the current vial unit ordering policy, we need 6.39 liters to cover all orders with a 
probability of 0.95, and 6.55 liters with 0.99 probability. Using the Kanban ordering policy or 
inner pack unit ordering policy with 10-vial inner packs for all vaccines, 6.49 liters are needed to 
cover all orders with the 0.95 probability, and 6.67 liters with 0.99 probability. Table 27 shows 
the corresponding number of inner packs of each vaccine for the simplified ordering policies. 
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Table 27. Number of inner packs for the simplified ordering polices 
Vaccines Tuberculosis Tetanus Measles Oral Polio 
Yellow 
Fever 
DTC-
HepB-
Hib 
PCV13 Rota 
Kanban 
ordering 2 1 2 1 2 8 14 12 
Inner pack 
unit ordering 2 1 2 1 2 7 16 11 
 
Table 28 shows the number of storage devices required to hold 6.39 liters of vaccine vials 
for different packing efficiencies. For example, if an effective 80% of device storage space is 
available, five storage devices are needed. In fact, if the packing efficiency is between 80% and 
90%, five storage devices will suffice. 
 
Table 28. Number of storage devices required to hold 6.39 liters of  vaccine vials 
Packing efficiency 70% 80% 90% 100% 
The number of the storage 
devices 6 5 5 4 
 
When 10-vial inner pack vaccines are used, we estimated that six storage devices are 
required for both the Kanban ordering policy and the inner pack unit ordering policy to cover 
95% of vaccine delivery. With 20-vial inner packs, seven storage devices are required for both 
policies.  
Clearly, if the inner pack size cannot be changed, the simplified ordering policies are not 
practical. However, if 10 or 20 vial inner pack can be used, one or two more additional 
transportation storage devices (vaccine carriers) would be required at each clinic.  
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4.5 DISCUSSION AND CONCLUSIONS 
Ordering vaccines in inner pack quantities has many advantages over single vial ordering 
including convenience in managing inventories, fewer errors in counting and ordering, and 
reduced order fulfillment effort. If vaccines are stored within an inner pack, a health worker can 
easily distinguish vaccines from each other and more readily find the particular vaccine that the 
worker is looking for because there is vaccine information on the outside face of the inner pack. 
In addition, at the upper level distribution center, the complicated vial counting process to supply 
clinics will be replaced by a much simpler process of picking one, or counting just a few inner 
packs. Counting errors at the upper levels will decrease and order preparation and distribution 
time will be saved. EPI vaccines are not particularly expensive, so there is no real disadvantage 
to holding more vaccines at the clinic level, as long as there is sufficient storage space.  
The results from Benin and Niger indicate that while there is no common inner pack size 
that is best for all vaccines, if we use inner packs of size 10 or 20 for all vaccines only a few 
more storage devices are needed. Thus, even though these simplified ordering policies increase 
the storage volume needed, if we choose the proper inner pack size these negative consequences 
can be minimized such that the additional number of storage devices needed is very small (on the 
order of 1%).  In terms of transportation storage space, the proposed ordering policies are not 
practical without changing the inner pack size. However, if 10- or 20-vial inner packs are used 
across all vaccines, one or two more storage devices in transportation will be required to service 
orders with a high probability. Note that in general, a vaccine carrier is inexpensive (e.g., the 
2009 price of a BK-VC 1.7-CF is US$ 12.00), so purchasing one or two devices would be very 
affordable for a clinic. But if transportation resources are constrained it might become necessary 
for an additional trip to a clinic in order to carry additional vaccine carriers.  In this case the 
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transportation cost will increase and it might be difficult to implement due to time and resource 
limitations.    
In conclusion, we recommend adapting simplified ordering polices based on well-known 
lean concepts (that are widely used in manufacturing) to a major public health sector. There are 
several key managerial insights relating to this recommendation. First, only replenishing using 
inner pack quantities reduces logistical effort and potential ordering errors at multiple levels of 
the supply chain. This is particularly valuable in the context of lower and middle income 
countries as many of the workers involved in the vaccine supply chains in these countries are not 
well trained in logistics systems operations. Second, while the average inventory levels do 
increase slightly with the simplified policies, the increase is minor and only causes minor 
increases (less than a few percent) in the number of cold storage devices needed at facilities if 
the inner pack sizes are carefully chosen. Third, transport logistics are also not impacted 
significantly. Thus, we can achieve significant benefits from simplified ordering policies with 
modest increases in operational costs by selecting proper vaccine inner pack sizes.  
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5.0  REDESIGN OF VACCINE DISTRIBUTION NETWORKS IN LOW AND 
MIDDLE-INCOME COUNTRIES 
5.1 INTRODUCTION 
In many low and middle income countries supported by the Expanded Program on 
Immunization, vaccines are distributed through a legacy medical supply chain. The legacy 
medical supply chain consists of traditional medical facilities including a central distribution 
center for the country, regional hospitals, district hospitals, and clinics. Their locations and 
connections within the supply chain network (SCN) have typically been determined based on 
political boundaries or the existing administrative hierarchy. Since the distribution network is not 
optimized, the legacy medical supply chain is not necessarily a cost-efficient one.   
In this chapter, we separate the cold chain for vaccine distribution from the legacy 
medical supply chain and address it independently.  The primary characteristic of this chain is 
that it requires cold storage and transportation of a narrowly defined set of vaccines at controlled 
temperatures of between 2 and 8°C. When the vaccine supply chain is separated from the 
medical supply chain, redesigning it can be approached via mathematical models. In this chapter, 
a mixed integer programming (MIP) model for designing the vaccine supply chain network is 
introduced.  As our analysis with real data shows, the solution of this problem can be quite 
difficult, and an evolutionary strategy (ES) is therefore proposed to solve the network design 
problem.  
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The remainder of this chapter is structured as follows. Section 2 describes the problem. 
Section 3 presents the mixed integer mathematical model and Section 4 proposes the 
evolutionary strategy to solve the problem. In Section 5, sensitivity analysis is performed. 
Section 6 introduces a looping factor that is applied to the transport vehicle routing and 
illustrates how to apply it. We talk about how to improve the ES in section 7. In section 8, we 
describe how to use the results from the ES to enhance the MIP performance. Each section 
presents its own numerical examples based on real data to illustrate the problem and solution 
characteristics. 
5.2 PROBLEM DESCRIPTION 
EPI vaccines from foreign manufacturers typically enter a country via air or sea and are initially 
stored in a central distribution center. Then via intermediate distribution centers, they are 
transported to local clinics, where actual vaccinations take place. The legacy medical supply 
chains in most countries have a 3, 4 or 5 tier arborescent structure. For instance, in a typical 4-
tier vaccine supply chain, vaccines move from the central distribution center to regional 
distribution centers, and from a regional distribution center to district distribution centers, and 
finally, from a district distribution center to clinics. However, since the distance from the main 
source node, (the central distribution center), to a final sink node (a local clinic) varies widely 
and the supply chain network design was not optimized, this hierarchical and arborescent 
structure does not guarantee an optimal distribution scheme.  
Our goal is to send vaccines from one fixed source node to a set of fixed sink nodes 
efficiently. If intermediate distribution centers (hub distribution centers) through which vaccines 
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are transported from a source node to sink nodes are selected properly, the distribution network 
will be more efficient. While the current network has a fixed number of tiers, this does not have 
to be the case in general and we do not assume any such restriction. That is, vaccines can be 
supplied to local clinics from the central distribution center through any number of hub 
distribution centers, or even directly. A hub distribution center is a facility that stores vaccines 
and supplies vaccines to local clinics as well as other hubs. Only the local clinic is assumed not 
to have any distribution role. Hub distribution centers are selected from the current regional and 
district distribution centers, which serve as a set of candidates.  
This research considers several different storages devices at each facility and different 
transportation modes/vehicles for transporting vaccines between facilities. Each facility is 
allowed to choose its own storage devices for vaccines as well as its own transportation vehicles.  
These storage devices have different capacities and a facility can have different storage devices 
to hold its required volume of vaccines.  Note that the storage capacity can be changed only in 
discrete increments corresponding to additional devices. As with storage devices, there are 
several types of capacitated transportation vehicles from which a facility can choose one. In 
addition, we consider a replenishment/trip frequency along with vehicle capacity. For example, if 
the total required volume at a facility in a year is 120 units and the replenishment frequency is 
once a month, the required storage volume at the facility is 10 units, but if the replenishment 
frequency is once every three months, 30 units of storage capacity is needed. The trip frequency 
also works in the same way, e.g., if each replenishment must move 10 units and the capacity of 
the vehicle is 5 units, then two trips will be required per replenishment.  With respect to cost, we 
consider transportation cost, storage cost, and facility operation cost. Transportation cost is 
calculated using a travel distance between two nodes and increases discretely according to the 
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number of vehicle trips needed to deliver the required volume. Storage cost is also related to the 
volume of required vaccines and increases discretely according to the number of storage devices 
required to store the vaccines. Even though there are several vaccines handled, only the total 
volume of vaccines affects the capacity of transportation and storage so that we only consider the 
total volume of vaccines along arcs and at nodes. Facility operation costs are incurred when a 
facility is open. 
In this research, we decide the locations of hub distribution centers, the flows from the 
central distribution center to local clinics through hub distribution centers, the storage devices 
and their numbers at each facility, the transportation vehicles used and the number of trips 
required for each vaccine flow between facilities, taking into account the assumed trip frequency 
for each connection between supply chain levels.  
We make the following assumptions to reflect a real vaccine supply chain:  
(1) Only local clinics have demand and demands at each clinic are fixed based on the 
population served by the clinic.  
(2) The location of the central distribution center does not change. 
(3) A hub distribution center can only be located at the current regional and district 
distribution center locations. 
(4) Every local clinic is supplied via a hub distribution center (or directly from the central 
distribution center). 
(5) Each operational facility has exactly one inbound flow except the central distribution 
center, which has none. 
(6) Enough vaccine should be supplied to clinics to satisfy all demand. 
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(7) If a hub is supplying another hub and is supplied by the central distribution center, it is 
replenished quarterly. 
(8) If a hub is supplied by another hub, it is replenished monthly. 
(9) The replenishment frequency of local clinics is once a month. 
(10) The storage device type at a local clinic is given. 
(11) There is a required 25% buffer at each location so that the total required storage volume is 
inflated by a factor of 1.25. 
(12) If more than one trip to a lower level facility is required, it does not change the 
replenishment frequency to the lower level facility, i.e., we assume that the multiple trips 
are done on the same day. 
The supply chain network design problem is well-known to the operations research 
community and there are many papers as well as reviews on this topic. The p-median problem, 
the uncapacitated facility location problem (UFLP), and the capacitated facility location problem 
(CFLP) are introduced as the basic network location problems in many papers [e.g., (Klose & 
Drexl, 2005), (Melo, Nickel, & Saldanha-Da-Gama, 2009) and (Mirchandani, 1990)]. These 
location problems have been mostly studied for single level systems (Şahin & Süral, 2007). 
Various extensions to these basic models have been derived, such as the capacitated facility 
location problem with single sourcing (CFLPSS), the two-stage capacitated facility location 
problem (TSCFLP), and the multi-commodity or multi-activity uncapacitated facility location 
problem (MUFLP) (KloseA. & DrexlA., 2005). Mirchandani et al. discuss a stochastic variant of 
the p-median problem (Mirchandani, Oudjit, & Wong, 1985). The uncapacitated facility 
location/network design problem (UFLNDP) is introduced by Daskin et al. (Daskin, Hurter, & 
VanBuer, 1993) and the capacitated facility location/network design problem (CFLNDP) is 
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introduced by Melkote et al. (Melkote & Daskin, 2001). With UFLNDP and CFLNDP, where the 
facility location and network design problems are combined, similar to the problem in this 
chapter, it is often more economical to change the configuration of the underlying network rather 
than adding and locating new facilities (Melkote & Daskin, 2001). If a network has hierarchical 
features, there are two basic distinct MIP models: flow-based and assignment-based formulations 
(Şahin & Süral, 2007). Narula and Ogbu examine flow-based formulations for multi-flow 
systems (Narula & Ogbu, 1979) and Şahin et al. construct a two-level multi-flow assignment-
based model (Şahin, Süral, & Meral, 2007).  
More recently, hub location models have received considerable attention (Klose & Drexl, 
2005). Algorithms for solving the uncapacitated hub location problem (UHLP) have been 
developed by several researchers [e.g., (Klincewicz, 1996), (Ernst & Krishnamoorthy, 1998), and 
(Hamacher, 2000)]. The capacitated case has been studied by several researchers, e.g., (Aykin, 
1994) and (Ebery, Krishnamoorthy, Ernst, & Boland, 2000). Unlike the general models or papers 
mentioned above, recent work has considered more complexities to cope with a more realistic 
variety of situations. For example, Rahmaniani and Ghaderi have worked on a combined facility 
location and network design problem with multiple types of capacitated links and suggested a 
fix-and-optimize heuristic based on the firefly algorithm (Rahmaniani & Ghaderi, 2013). 
Kalaitzidou et al. optimize multiechelon supply chain networks with generalized production and 
warehousing nodes using a mathematical programming model (Kalaitzidou, Longinidis, Tsiakis, 
& Georgiadis, 2014). In this model, the optimization procedure decides which mid echelon 
locations produce items and which ones only distribute items.  
Regarding applying genetic algorithms to supply chain problems, the first was an 
application to a transportation problem used a nonstandard genetic algorithm for solving linear 
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and nonlinear transportation problems (Michalewicz, Vignaux, & Hobbs, 1991). The authors 
used a matrix-based representation to represent a transportation tree. Since then, there have been 
several studies on transportation problems (Bielli, Caramia, & Carotenuto, 2002; Gen, 
Altiparmak, & Lin, 2006; Altiparmak, F; Gen, M; Lin, L; Karaoglan, I, 2009). For example, 
Altiparmak et al. presented a solution procedure based on a steady-state genetic algorithm with a 
new encoding structure for the design of a single-source, multi-product, multi-stage SCN 
(Altiparmak, F; Gen, M; Lin, L; Karaoglan, I, 2009). They extended the priority-based encoding 
of the transportation tree to a multi-product case. Firoozi et al. solve a three level hierarchical 
supply chain, which is modeled with non-linear MIP, using a genetic algorithm (Firoozi, Ismail, 
Ariafar, Tang, & Ariffin, 2013). Izadi and Kimiagrari solve the location-allocation problem with 
an unknown demand function using a genetic algorithm and a Monte Carlo simulation approach 
(Izadi & Kimiagari, 2014).  
5.3 MIP FORMULATION 
To formulate the problem we define the following notation: 
Index sets 
𝐶𝐶: Central distribution center ={0} 
𝐻𝐻: Hub distribution centers ={1,2,…,|H|} 
𝐼𝐼: Local clinics = {|H|+1,…,N} 
𝐸𝐸: Edges:(𝑖𝑖, 𝑗𝑗)|𝑖𝑖 ∈ 𝐶𝐶 ∪ 𝐻𝐻, 𝑗𝑗 ∈ 𝐻𝐻 ∪ 𝐼𝐼; 𝑖𝑖 ≠ 𝑗𝑗 
𝑉𝑉: Vertices: 𝐶𝐶 ∪ 𝐻𝐻 ∪ 𝐼𝐼 
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𝐿𝐿: Levels: {central (=0), hub (=1), local clinic (=2)} 
𝑇𝑇: Transportation vehicles: {cold truck (=0), 4×4 truck (=1), motorbike (=2)} 
𝑅𝑅: Storage devices: {cold room (=0), regional device (=1), district device (=2), local clinic 
device (=3)} 
𝐹𝐹: Replenishment frequency: {Quarterly (=0), Monthly (=1)}  
 
Parameters 
𝐶𝐶𝑖𝑖𝑖𝑖𝑡𝑡
𝑇𝑇 : Transportation cost per km of vehicle type 𝑡𝑡 from location 𝑖𝑖 to location 𝑗𝑗 ; (𝑖𝑖, 𝑗𝑗) ∈ 𝐸𝐸; 𝑡𝑡 ∈ 𝑇𝑇 
𝐶𝐶𝑟𝑟
𝑆𝑆: Annual storage cost per storage device 𝑓𝑓; 𝑓𝑓 ∈ 𝑅𝑅 
𝐶𝐶𝑖𝑖
𝐹𝐹: Annual facility cost when the facility is level 𝑙𝑙; 𝑙𝑙 ∈ 𝐿𝐿 
𝑃𝑃𝑡𝑡
𝑇𝑇: Transportation capacity per trip of vehicle 𝑡𝑡; 𝑡𝑡 ∈ 𝑇𝑇 
𝑃𝑃𝑟𝑟
𝑆𝑆: Storage capacity of device 𝑓𝑓; 𝑓𝑓 ∈ 𝑅𝑅 
𝐺𝐺𝑓𝑓: Annual number of replenishments  𝑓𝑓 ∈ 𝐹𝐹 (=4 if k=0; =12 if k=1) 
𝑆𝑆: Buffer stock factor for vaccines stored at a location 
𝐷𝐷𝑖𝑖𝑖𝑖: Distance (km) between location 𝑖𝑖 and location 𝑗𝑗 ; (𝑖𝑖, 𝑗𝑗) ∈ 𝐸𝐸 
𝐵𝐵𝑖𝑖: Annual demand (𝐵𝐵𝑖𝑖<0,  𝑗𝑗 ∈ 𝐼𝐼) or supply (𝐵𝐵𝑖𝑖>0, 𝑗𝑗 ∈ 𝐶𝐶) volume at location 𝑗𝑗; 𝐵𝐵𝑖𝑖 = 0 for 𝑗𝑗 ∈
𝐻𝐻  
 
Variables 
𝑋𝑋𝑖𝑖𝑖𝑖: Annual flow (volume) of vaccines from location 𝑖𝑖 to location 𝑗𝑗 ; (𝑖𝑖, 𝑗𝑗) ∈ 𝐸𝐸 
𝑊𝑊𝑖𝑖 ∈ {0,1}: 1 if a location 𝑗𝑗 is open, 0 otherwise; 𝑗𝑗 ∈ 𝑉𝑉 
𝑌𝑌𝑖𝑖𝑟𝑟𝑓𝑓: Number of storage devices of type 𝑓𝑓 at location 𝑗𝑗 with replenishment frequency 𝑓𝑓; 
𝑗𝑗 ∈ 𝑉𝑉, 𝑓𝑓 ∈ 𝑅𝑅, 𝑓𝑓 ∈ 𝐹𝐹 
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𝑍𝑍𝑖𝑖𝑖𝑖𝑡𝑡𝑓𝑓: Number of vehicle trips per replenishment from location 𝑖𝑖 to location 𝑗𝑗 using vehicle type 
𝑡𝑡 with replenishment frequency 𝑓𝑓; (𝑖𝑖, 𝑗𝑗) ∈ 𝐸𝐸, 𝑡𝑡 ∈ 𝑇𝑇,𝑓𝑓 ∈ 𝐹𝐹 
𝑉𝑉𝑖𝑖 ∈ {0,1}: 1 if a location 𝑗𝑗 has monthly replenishment frequency, 0 otherwise; 𝑗𝑗 ∈ 𝐻𝐻 ∪ 𝐼𝐼 
𝑈𝑈𝑖𝑖𝑖𝑖 ∈ {0,1}: 1 if vaccines flow from location 𝑖𝑖 to location 𝑗𝑗, 0 otherwise; (𝑖𝑖, 𝑗𝑗) ∈ 𝐸𝐸 
 
Our formulation is: 
𝑀𝑀𝑖𝑖𝑛𝑛 � �� 2𝐶𝐶𝑖𝑖𝑖𝑖𝑡𝑡𝑇𝑇 𝐺𝐺𝑓𝑓𝐷𝐷𝑖𝑖𝑖𝑖𝑍𝑍𝑖𝑖𝑖𝑖𝑡𝑡𝑓𝑓 + ���𝐶𝐶𝑟𝑟𝑆𝑆𝑌𝑌𝑖𝑖𝑟𝑟𝑓𝑓 +
𝑟𝑟∈𝑅𝑅𝑓𝑓∈𝐹𝐹𝑖𝑖∈𝑉𝑉
 
𝑓𝑓∈𝐹𝐹𝑡𝑡∈𝑇𝑇(𝑖𝑖,𝑖𝑖)∈𝐸𝐸 𝐶𝐶0𝑊𝑊0 + �𝐶𝐶1𝐹𝐹𝑊𝑊𝑖𝑖𝑖𝑖∈𝐻𝐻 + �𝐶𝐶2𝐹𝐹𝑊𝑊𝑖𝑖𝑖𝑖∈𝐼𝐼   (57)  
𝑠𝑠𝑠𝑠𝑏𝑏𝑗𝑗𝑀𝑀𝑐𝑐𝑡𝑡 𝑡𝑡𝑓𝑓   
� 𝑋𝑋𝑖𝑖𝑖𝑖
𝑖𝑖∈𝑉𝑉:(𝑖𝑖,𝑖𝑖)∈𝐸𝐸 − � 𝑋𝑋𝑖𝑖𝑖𝑖𝑖𝑖∈𝑉𝑉:(𝑖𝑖,𝑖𝑖)∈𝐸𝐸 = 𝐵𝐵𝑖𝑖 𝑓𝑓𝑓𝑓𝑓𝑓 ∀𝑖𝑖 ∈ 𝑉𝑉 (58)  
��𝑃𝑃𝑡𝑡
𝑇𝑇𝐺𝐺𝑓𝑓𝑍𝑍𝑖𝑖𝑖𝑖𝑡𝑡𝑓𝑓 ≥ 𝑋𝑋𝑖𝑖𝑖𝑖
𝑓𝑓∈𝐹𝐹𝑡𝑡∈𝑇𝑇
 𝑓𝑓𝑓𝑓𝑓𝑓 ∀ (𝑖𝑖, 𝑗𝑗) ∈ 𝐸𝐸 (59)  
��𝑃𝑃𝑟𝑟
𝑆𝑆𝐺𝐺𝑓𝑓𝑌𝑌𝑖𝑖𝑟𝑟𝑓𝑓 ≥ (1 + 𝑆𝑆) � 𝑋𝑋𝑖𝑖𝑖𝑖
𝑖𝑖∈𝐶𝐶∪𝐻𝐻:(𝑖𝑖,𝑖𝑖)∈𝐸𝐸𝑓𝑓∈𝐹𝐹𝑟𝑟∈𝑅𝑅  𝑓𝑓𝑓𝑓𝑓𝑓 ∀𝑗𝑗 ∈ 𝑉𝑉 (60)  
𝑀𝑀𝑊𝑊𝑖𝑖 ≥ � 𝑋𝑋𝑖𝑖𝑖𝑖
𝑖𝑖∈𝐶𝐶∪𝐻𝐻:(𝑖𝑖,𝑖𝑖)∈𝐸𝐸 + � 𝑋𝑋𝑖𝑖𝑖𝑖𝑖𝑖∈𝐻𝐻∪𝐼𝐼:(𝑖𝑖,𝑖𝑖)∈𝐸𝐸   𝑓𝑓𝑓𝑓𝑓𝑓 ∀𝑗𝑗 ∈ 𝐻𝐻 (61)  
𝑋𝑋𝑖𝑖𝑖𝑖 ≤ 𝑀𝑀𝑈𝑈𝑖𝑖𝑖𝑖 𝑓𝑓𝑓𝑓𝑓𝑓 ∀ (𝑖𝑖, 𝑗𝑗) ∈ 𝐸𝐸 (62)  
� 𝑈𝑈𝑖𝑖𝑖𝑖
𝑖𝑖∈𝐶𝐶∪𝐻𝐻:(𝑖𝑖,𝑖𝑖)∈𝐸𝐸 ≤ 1 𝑓𝑓𝑓𝑓𝑓𝑓 ∀𝑗𝑗 ∈ 𝐻𝐻 ∪ 𝐼𝐼  (63)  
��𝑌𝑌𝑖𝑖𝑟𝑟𝑓𝑓 ≤ 𝑀𝑀𝑊𝑊𝑖𝑖
𝑓𝑓∈𝐹𝐹𝑟𝑟∈𝑅𝑅
 𝑓𝑓𝑓𝑓𝑓𝑓 ∀𝑗𝑗 ∈ 𝐻𝐻 (64)  
�𝑌𝑌𝑖𝑖𝑟𝑟1 ≤ 𝑀𝑀𝑉𝑉𝑖𝑖
𝑟𝑟∈𝑅𝑅
 𝑓𝑓𝑓𝑓𝑓𝑓 ∀𝑗𝑗 ∈ 𝐻𝐻 (65)  
�𝑌𝑌𝑖𝑖𝑟𝑟0 ≤ 𝑀𝑀(1 − 𝑉𝑉𝑖𝑖)
𝑟𝑟∈𝑅𝑅
 𝑓𝑓𝑓𝑓𝑓𝑓 ∀𝑗𝑗 ∈ 𝐻𝐻 (66)  
𝑋𝑋𝑖𝑖𝑖𝑖 ≤ 𝑀𝑀𝑉𝑉𝑖𝑖 𝑓𝑓𝑓𝑓𝑓𝑓 ∀𝑖𝑖, 𝑗𝑗 ∈ 𝐻𝐻 (67)  
𝑉𝑉𝑖𝑖 ≤ 2 − 𝑈𝑈0𝑖𝑖 − ∑ 𝑈𝑈𝑖𝑖𝑖𝑖𝑖𝑖∈𝐻𝐻 |𝐻𝐻|  𝑓𝑓𝑓𝑓𝑓𝑓 ∀𝑖𝑖 ∈ 𝐻𝐻 (68)  
𝑊𝑊𝑖𝑖 = 1 𝑓𝑓𝑓𝑓𝑓𝑓 ∀𝑖𝑖 ∈ 𝐶𝐶 ∪ 𝐼𝐼 (69)   𝑉𝑉𝑖𝑖 = 1 𝑓𝑓𝑓𝑓𝑓𝑓 ∀𝑖𝑖 ∈ 𝐼𝐼 (70)  
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𝑌𝑌000 = 1  (71)  
𝑋𝑋𝑖𝑖𝑖𝑖 ≥ 0 𝑓𝑓𝑓𝑓𝑓𝑓 ∀(𝑖𝑖, 𝑗𝑗) ∈ 𝐸𝐸 (72)  
𝑊𝑊𝑖𝑖 ∈ {0, 1} 𝑓𝑓𝑓𝑓𝑓𝑓 ∀𝑗𝑗 ∈ 𝑉𝑉 (73)  
𝑌𝑌𝑖𝑖𝑟𝑟𝑓𝑓 ∈ {0, 1, 2, … } 𝑓𝑓𝑓𝑓𝑓𝑓 ∀𝑗𝑗 ∈ 𝑉𝑉,∀𝑓𝑓 ∈ 𝑅𝑅,∀𝑓𝑓 ∈ 𝐹𝐹 (74)  
𝑍𝑍𝑖𝑖𝑖𝑖𝑡𝑡𝑓𝑓 ∈ {0, 1, 2, … } 𝑓𝑓𝑓𝑓𝑓𝑓 ∀(𝑖𝑖, 𝑗𝑗) ∈ 𝐸𝐸,∀𝑡𝑡 ∈ 𝑇𝑇,∀𝑓𝑓 ∈ 𝐹𝐹 (75)  
𝑉𝑉𝑖𝑖 ∈ {0, 1} 𝑓𝑓𝑓𝑓𝑓𝑓 ∀𝑗𝑗 ∈ 𝐻𝐻 ∪ 𝐼𝐼 (76)  
𝑈𝑈𝑖𝑖𝑖𝑖 ∈ {0, 1} 𝑓𝑓𝑓𝑓𝑓𝑓 ∀(𝑖𝑖, 𝑗𝑗) ∈ 𝐸𝐸 (77)  
   where M is a large number.   
The objective function (57) consists of three terms: Annual round-trip transportation cost, 
annual storage cost and annual facility cost. Constraint (58) is a conservation of flow equation, 
where the inbound flow to a hub facility is equal to its outbound flow and the inbound flow to a 
clinic is equal to its total demand. Constraint (59) ensures that if an edge representing 
transportation between two locations is used, there are sufficient trips during each replenishment 
using the selected vehicle to transport the total volume of vaccines required to be transported 
along the edge. Constraint (60) ensures that a facility is able to have enough capacity (number of 
storage devices) to store the total amount of vaccines before the next replenishment (including 
any buffer stock). Constraint (61) states that if a facility is closed, the inbound flow to the facility 
and outbound flow from the facility is 0. Constraint (62) states that if an edge is not used, there is 
no flow on the edge. Constraint (63) ensures that each hub and clinic has at most one inflow. 
Constraint (64) allows a facility to have storage devices only when a facility is open. Constraints 
(65) and (66) stipulate that the 𝑌𝑌𝑖𝑖𝑟𝑟𝑓𝑓 variable has the appropriate value corresponding to the 
selected replenishment frequency at facility 𝑗𝑗. Constraint (67) states that the trip or replenishment 
frequency at a hub that is supplied by another hub is once a month. Constraint (68) guarantees 
that a hub that is supplied by the center gets replenished once every quarter. Note that the 
quantity 
∑ 𝑈𝑈𝑖𝑖𝑖𝑖𝑖𝑖∈𝐻𝐻 |𝐻𝐻|  is a positive fraction between 0 and 1 so that if there is shipment from the 
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central store to hub 𝑖𝑖, then 𝑉𝑉𝑖𝑖 must be equal to zero (quarterly replenishments); otherwise it could 
be 0 or 1. Constraint (69) ensures that the central distribution center and all local clinics are 
open, while Constraint (70) ensures that all local clinics have monthly replenishments. Finally, 
Constraint (71) states that the central distribution center must have a cold room. 
The above formulation can be used to solve the network problem optimally, but as the 
problem size becomes bigger, the computational time increases exponentially. For example, 
suppose there are three kinds of storage devices and three kinds of transportation vehicles, along 
with five candidate hubs and 125 clinic locations.  For this problem, the MIP formulation leads 
to approximately 102,500 integer variables. If we increase the number of candidate hubs and 
clinics by a factor of four (which would be quite representative of the structure in many 
countries), the number of integer variables increases by a factor of 16 to approximately 
1,627,000. Even if the computational effort is not directly proportional to the number of integer 
variables, the additional computational time required to solve the model can be prohibitive. For 
example, the largest problem we can solve with the MIP formulation has 210 locations including 
13 candidate hubs. It takes 196 hours using IMB ILOG CPLEX 12.6 on a computer with an Intel 
Xeon CPU E5450 3.00 GHz with 20.0 GB memory (also note that different combinations of 
CPLEX parameters were evaluated before choosing the one that minimized computational time). 
This problem represents only two of the eight regions in Niger. Many network problems have a 
similar issue with dramatic increases in computational effort as the size of the problem gets 
larger. Often, this issue is addressed by developing heuristics based on Lagrangian relaxation, 
linear programming, or constructive methods, or by using so-called metaheuristics (Melo, 
Nickel, & Saldanha-Da-Gama, 2009). 
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In the next section, we propose a metaheuristic that uses an evolutionary strategy (ES) to 
obtain a good solution to the network problem in a reasonable amount of time. 
5.4 EVOLUTIONARY STRATEGY ALGORITHM 
5.4.1 Introduction 
An Evolutionary Strategy (ES) is a population based algorithm that is related to genetic 
algorithms, which were developed independently (Whitley, 1994) and have been used to solve 
large network problems (Altiparmaka, F; Genb, M; Linb, L; Paksoy, T, 2006; H. Aytug , M. 
Khouja & F. E. Vergara, 2003; Altiparmak, F; Gen, M; Lin, L; Karaoglan, I, 2009). ES is based 
on the work of Rechenberg and Schwefel (Schwefel, 1975).  
An ES can be a good candidate for solving the vaccine distribution network design 
problem based on the problem’s characteristics and its likely optimal network structure: (a) most 
clinics will tend to be supplied from the nearest open hub, (b) the number of candidate hubs is 
relatively small; e.g., Niger has 40 candidate hubs even though there are 644 clinic locations, and 
(c) the optimal network has a tree structure which is not very deep and its branches can be 
clustered. Fact (a) implies that the ES does not need to have all connection information for the 
entire network and that the network structure from the central distribution center to the hubs is 
more critical (this is discussed in more detail later).  Facts (a) and (b) permit the design of a 
simple ES representation that facilitates ES operations such as crossover and mutation, and can 
decrease the evaluation time of a candidate solution. Fact (c) is a good feature to have for a 
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population based method such as ES because the ES operations can be effective at finding 
improved solutions in successive iterations of the algorithm.  
There are two types of ES: (𝜇𝜇 + 𝜆𝜆)-ES and (𝜇𝜇, 𝜆𝜆)-ES. The (𝜇𝜇, 𝜆𝜆)-ES is closer to the 
canonical genetic algorithm, where 𝜇𝜇 parents produce 𝜆𝜆 offspring and only the best 𝜇𝜇 of the 
𝜆𝜆 offspring replace the 𝜇𝜇 parents (𝜇𝜇 < 𝜆𝜆).  On the other hand, in the (𝜇𝜇 + 𝜆𝜆)-ES, 𝜇𝜇 parents 
produce 𝜆𝜆 offspring, and the population is then reduced again to 𝜇𝜇 parents by selecting the best 
solutions from among both the parents and offspring (Whitley, 1994). In this chapter, a (𝜇𝜇 +
𝜆𝜆)-ES is used to apply high selective pressure. Goldberg and Deb have shown that replacing the 
worst member of the population tends to produce higher selective pressure (Goldberg & Deb, 
1991).  
One of the reasons for long computation times for the MIP model is that the vaccine 
volumes handled at the hubs cannot be fixed before the network structure is set. In the ES, a 
chromosome decides the network structure from the central storage location to the hubs and the 
local clinics are automatically assigned to the nearest open hub to then complete the entire 
network. Throughout the network, the amount of vaccine that must be handled at each hub 
location is decided and then appropriate transportation and storage devices are selected. Note that 
the best possible result found using the ES representation is not guaranteed to be an optimal 
solution since the local clinics do not necessarily have to be connected to the nearest open hubs. 
This is because clinic to hub assignments that result in more travel distance may result in lower 
overall cost of storage device costs. For example, if Hub A can eliminate one storage device by 
not servicing one of its clinics and there is another hub, say Hub B, which has sufficient storage 
space to supply the clinic which was supplied by Hub A.  If the cost of doing this from Hub B is 
lower than the cost of using one more storage device at Hub A, then the local clinic (which was 
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supplied by Hub A) can now be supplied by Hub B. However, it is reasonable that in an optimal 
solution one could expect many of the local clinics to be connected to the nearest open hubs. 
Therefore, even though the ES does not guarantee that it can solve the network problem 
optimally, it can hopefully produce a very good solution. In addition, if we fix the portion of the 
network structure that does not include the clinics, solving the problem is much easier and 
computation times decrease dramatically because the number of clinics greatly exceeds the 
number of candidate hub locations.  
In this section, an evolutionary strategy is introduced in order to address the 
computational problems associated with the MIP formulation of the vaccine network problems, 
and numerical examples are presented to illustrate the approach and demonstrate its 
effectiveness.  
5.4.2 An ES for vaccine supply chain network design  
5.4.2.1  The ES procedure 
Figure 14 shows the flow of the ES. The upper part shows the ES procedures and the lower part 
presents the post processing that occurs after terminating the ES. The ES basically follows a 
Genitor (𝜇𝜇 + 𝜆𝜆) strategy. However, here we initially generate a population of size 2𝜇𝜇 and then 
choose the best 𝜇𝜇 of these for higher selective pressure. Moreover, we continue to maintain a 
population of size 𝜇𝜇 until termination, where the members are ranked at the beginning of each 
iteration in descending order of their fitness/performance. In the crossover step we select one 
parent at random from the population and another from the top α1% of the population. As we 
will explain, because of how the crossover is performed the number of offspring chromosomes 
produced (λ1) is not the same at each iteration. Similar to crossover, in the mutation step we elect 
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one chromosome at random from the population and another from the top α2% of the population, 
these generate λ2=2 new chromosomes. The 𝜆𝜆 = 𝜆𝜆1 + 𝜆𝜆2 new offspring generated at the iteration 
are then added to the existing µ members and the entire population is then re-ranked and reduced 
to a new set of µ members by eliminating the ones at the bottom.  This completes one iteration 
and we repeat the process with the new population.  The process is terminated either when there 
is no change in the population’s best α3% of chromosomes over T successive iterations or after 
Tmax iterations. In the post-processing step we then solve the MIP with the central-to-hub 
structure fixed according to the best chromosome in order to obtain the assignment of clinics to 
hubs. 
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Figure 14. Evolution strategy for the network problem 
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   The solution representation and initialization are now described in more detail. A 
matrix-based representation, which falls into the category of edge-based representations, is used 
to represent the solutions. A chromosome is represented by an (𝑛𝑛 + 1) × 𝑛𝑛 matrix, where 𝑛𝑛 is 
the number of hubs.  Rows in the matrix correspond to the outbound flow from hubs and 
columns to the inbound flow into hubs. That is, 𝑀𝑀𝑖𝑖𝑖𝑖 = 1 implies that hub 𝑖𝑖 supplies hub 𝑗𝑗, and 
𝑀𝑀𝑖𝑖𝑖𝑖 = 0 implies that hub 𝑖𝑖 and hub 𝑗𝑗 are not connected, where 𝑀𝑀𝑖𝑖𝑖𝑖 is an element of the matrix in 
row 𝑖𝑖 and column 𝑗𝑗. The first row represents the central distribution center. Figure 15 shows 
examples of two chromosomes for 𝑛𝑛 = 6. 
 
 
Figure 15. Chromosome examples 
 
Note that since each location can be supplied by exactly one location, each column sum is 
less than or equal to one.   
For initializing a new chromosome, we use the following steps: 
Step 1. The values of the elements in the first row are decided randomly, with each 
column having a probability 𝑝𝑝1 of being selected and assigned a value of 1. This fixes which 
hubs are supplied from the central distribution center. If hub 𝑖𝑖 is supplied from the central store, 
it is an open hub and 𝑖𝑖 is inserted into the open hub set (= 𝑂𝑂). Other hubs that are not in 𝑂𝑂 are 
assigned to the complementary set 𝐿𝐿.  
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Step 2. Next, wechoose an open hub, say 𝑗𝑗 ∈ 𝑂𝑂, update 𝑂𝑂 = 𝑂𝑂\{𝑗𝑗}, and randomly decide 
whether 𝑗𝑗 supplies other hubs or not, where  𝑝𝑝2 is the probability that hub 𝑗𝑗 supplies other hubs 
and (1-𝑝𝑝2) the probability that it does not. If 𝑗𝑗 is selected to supply other hubs, then a hub 𝑘𝑘 ∈ 𝐿𝐿 
is selected to be supplied from 𝑗𝑗 with probability 𝑝𝑝3 and we update 𝑂𝑂 = 𝑂𝑂 ∪ {𝑘𝑘} and 𝐿𝐿 = 𝐿𝐿\{𝑘𝑘} 
with each selection k.  
Step 3. Repeat step 2 until 𝑂𝑂 = ∅. 
5.4.2.2  Evaluation  
A chromosome c has network information from the central store to the hubs, but does not have 
information from hubs to clinics. Therefore, for evaluation of a chromosome, each clinic is 
temporarily assigned to the nearest open hub and the flows into each hub are determined. Based 
on the flows into each location, the transportation volume along each connected arc and the 
storage volume at each open facility are decided across the entire network. This is because once 
the flows are fixed, the demand (or volume of vaccine to be stored) at each location is also 
known. Based on this volume, we know the storage and transportation volumes required at each 
node and along each arc that is used, respectively. Once these volumes are fixed, the 
performance of the chromosome(= 𝐸𝐸(𝑐𝑐)) is evaluated as follows: 
𝐸𝐸(𝑐𝑐) = � 2𝐷𝐷𝑖𝑖𝑖𝑖 min𝑡𝑡∈𝑇𝑇,𝑓𝑓∈𝐹𝐹 {𝐶𝐶𝑖𝑖𝑡𝑡𝑓𝑓𝑇𝑇 𝐺𝐺𝑓𝑓 � 𝑋𝑋𝑖𝑖𝑖𝑖𝑃𝑃𝑡𝑡𝑇𝑇𝐺𝐺𝑓𝑓�}(𝑖𝑖,𝑖𝑖)∈𝐸𝐸 + � min𝑟𝑟∈𝑅𝑅,𝑓𝑓∈𝐹𝐹 {𝐶𝐶𝑟𝑟𝑆𝑆 �(1 + 𝑆𝑆)∑ 𝑋𝑋𝑖𝑖𝑖𝑖𝑖𝑖∈𝐶𝐶∪𝐻𝐻:(𝑖𝑖,𝑖𝑖)∈ 𝐸𝐸𝑃𝑃𝑟𝑟𝑆𝑆𝐺𝐺𝑓𝑓 �}𝑖𝑖∈𝑉𝑉 + 𝐶𝐶0𝑊𝑊0+ �𝐶𝐶1𝐹𝐹𝑊𝑊𝑖𝑖
𝑖𝑖∈𝐻𝐻
+ �𝐶𝐶2𝐹𝐹𝑊𝑊𝑖𝑖
𝑖𝑖∈𝐼𝐼
 
(78)  
The first term, where the lowest cost transportation vehicle and the shipping frequency 
are decided, determines the annual transportation cost. The second, where the lowest cost storage 
device and replenishment frequency are decided, determines the total annual storage cost, and 
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the last term determines the annual facility cost.  Note that the network structure determines the 
values of Wj and Uij. 
5.4.2.3  Selection 
After a chromosome is evaluated, a fitness value is assigned based on the chromosome’s rank in 
the population. In the selection step for crossover, two parents are selected: one is chosen 
randomly from the whole population and the other is chosen randomly from the top 𝛼𝛼1% of the 
population, based on the fitness rank. The reason why we choose one parent from the top 𝛼𝛼1% is 
to apply higher selective pressure. Similarly, two chromosomes are also selected for mutation: 
one is randomly chosen from the top 𝛼𝛼2% of the population and the other is randomly chosen 
from the entire population. 
5.4.2.4  Crossover 
A 1-point crossover is performed between the two parents, where the crossover point is 
randomly selected. Swapping the fragments occurs only in the first row within the column and 
the other 𝑛𝑛 rows follow the crossover from the first rows. That is, the crossover point divides the 
network tree into two sub-trees and then sub-trees are swapped between the two parents. For 
example, in Figure 16, if chromosomes 1 and 2 at the top are swapped between column 3 and 4, 
the crossover results are shown. In this example there is no duplication of hubs and both 
offspring are feasible, but in general, this need not be the case. If redundant hubs exist across the 
two sub-trees, we might have a hub that is supplied from two upper level facilities (or a cycle 
may occur). For instance, in Figure 17, if node 2 in chromosome 1 supplies nodes 1 and 4 instead 
of nodes 1 and 3, then one of the offspring, chromosome 1′, has a cycle, where node 4 is 
supplied by both the central node and node 2. Node 4 can select only one supply node: either the 
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central node or node 2 as shown in the right hand side of the figure. Thus, chromosome 1′ and 
chromosome 2 produce three offspring. Note that there might be several redundant hubs when 
crossover is performed and because every redundant hub increases the number of offspring by a 
factor of 2. This is why 𝜆𝜆1is not fixed. If there are no redundant hubs, the two parents produce 
two offspring (𝜆𝜆1 = 2), but if there are in general, 𝑛𝑛(≥ 1) redundant hubs in a child chromosome 
after the crossover, it is replaced by 2 × 𝑛𝑛 new child chormosomes. 
 
 
Figure 16. Crossover example 
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 Figure 17. Example of handling a redundant hub in crossover 
5.4.2.5  Mutation 
Mutation occurs with probability 𝑝𝑝𝑚𝑚 at every iteration. Two chromosomes are selected for 
mutation: one from the top 𝛼𝛼2% of the population and the other randomly selected from the 
entire population. There are three options for mutation: (1) eliminating a hub, (2) adding a hub, 
and (3) exchanging hubs. Each type of mutation has the same probability of occurring. Figure 18 
illustrates these mutations. If option (1) is selected, a hub selected randomly from the open hubs 
is removed from the network. If a hub (say, Hub A) is removed, then any hubs supplied by Hub 
A are now supplied directly from the location that supplied Hub A. If option (2) is chosen, a hub 
(say, Hub B) among the closed hubs and a hub (say, Hub C) among the open hubs (including the 
central distribution center) are selected, and Hub C and Hub B are connected. In option (3), two 
hubs among the open hubs are selected and their positions are exchanged. 
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 Figure 18. Mutation 
5.4.2.6  Termination and optimization 
After evaluation, if no change is observed in the top 𝛼𝛼3% of the population over 𝑇𝑇 successive 
iterations, or we have reached our iteration limit of Tmax, the algorithm is terminated. Although 
the best chromosome has the minimum cost only the network structure from the central location 
to the hubs is considered for optimization, and the network from the hubs and the local clinics is 
not optimized. However, if the network from the central location to the hubs is fixed, assigning 
the local clinics to the hubs optimally is relatively easy. This is done by solving an MIP problem 
with the upper level of the network structure being fixed to the one that the ES produces. 
Consider an open location i∈C∪H and link i-j, j∈H along which vaccines flow, as determined by 
the ES and define:  
𝑊𝑊𝑖𝑖
𝐸𝐸 ∈ {0,1}: 1 if location 𝑗𝑗 is open, 0 otherwise; 𝑗𝑗 ∈ 𝐻𝐻 
𝑈𝑈𝑖𝑖𝑖𝑖
𝐸𝐸  ∈ {0,1}: 1 if vaccines flow from location 𝑖𝑖 to location 𝑗𝑗, 0 otherwise; 𝑖𝑖 ∈ 𝐶𝐶 ∪ 𝐻𝐻 𝑀𝑀𝑛𝑛𝑑𝑑 𝑗𝑗 ∈ 𝐻𝐻 
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The following additional constraints are added to the MIP Model in section 3.    
 𝑈𝑈𝑖𝑖𝑖𝑖 = 𝑈𝑈𝑖𝑖𝑖𝑖𝐸𝐸  𝑓𝑓𝑓𝑓𝑓𝑓 ∀ 𝑖𝑖 ∈ 𝐶𝐶 ∪ 𝐻𝐻 and ∀𝑗𝑗 ∈ 𝐻𝐻 (79)  
 𝑊𝑊𝑖𝑖 = 𝑊𝑊𝑖𝑖𝐸𝐸  𝑓𝑓𝑓𝑓𝑓𝑓 ∀𝑗𝑗 ∈ 𝐻𝐻 (80)  
5.4.3 Numerical example 
5.4.3.1  Niger 
The proposed approach is applied to a subset (2 regions) of the Niger distribution network. Table 
29 provides summary data for this subset of the Niger distribution network. Information on 
vaccines, transportation, storage and facilities is shown in Tables 30 through 33.   
 
Table 29. Summary data for Niger 
 Number 
Region and District distribution centers 13 
Clinics 196 
Vaccines 8 
Transportation device types 3 
Storage device types 4 
 
 
Table 30. Vaccine information for Niger 
Name 
Vaccine 
presentation 
Doses/vial 
Packed vol./ 
vial(cc) 
Doses 
/person 
Tuberculosis Lyophilized 20 24 1 
Tetanus Toxoid Liquid 10 30 3 
Measles Lyophilized 10 21.3 1 
Oral Polio Liquid 20 20 4 
Yellow Fever Lyophilized 10 25 1 
DTC-HepB-Hib 
liquid 
Liquid 1 16.8 3 
PCV13 Liquid 1 12 3 
Rotavirus Liquid 1 45.9 3 
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Table 31. Transportation information for Niger 
Vehicle Type Capacity (L) Cost ($/km) 
Cold truck 9,293 0.97 
4x4 Truck 172 0.54 
Motorbike 5 0.23 
    
Table 32. Storage information for Niger 
Device Type Capacity (L) Cost ($/year) 
Cold room 18,000 8,116 
Regional level device 1,843 1,582 
District level device 76 600 
Clinic level device 35 596 
 
Table 33. Facility information for Niger 
Facility type Cost ($/year) 
Central 40,000 
Region 13,000 
District/Hub 4,500 
Clinic 800 
 
Note that capacity and cost of transportation vehicles and storage devices at a particular 
level are weighted average values based on the equipment currently used at that level. For 
example, if there are 1,000 units of a 40-liter storage device and 600 units of a 20-liter storage 
device across the clinic level, the storage device assigned to the clinic level is assigned a capacity 
of 32.5 (=(1000×40+600×20)/1600) liters. This procedure is in order to simplify the problem. If 
we were to include every currently used vehicle and device type in the model as an option this 
would dramatically increase the computational effort.  Facility cost is estimated based on labor 
and building operation costs. 
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This subnetwork has one central distribution center, along with 13 regional and district 
distribution centers, which are potential hubs. Table 6 provides three different network design 
results for the network. The first is the cost of the original network with the currently assigned 
vehicles and storage devices for the routes and locations, respectively. The second still uses the 
original network structure, that is, all the facilities are open and vaccines are distributed using the 
current routes, but vehicles and storage devices are optimally assigned to each route and each 
facility. The last is the network that is optimized for structure as well as devices using the 
original MIP in Section 5.3. Figure 19 shows the resulting graphs for each network. Black lines 
imply the use of cold trucks, orange lines correspond to 4×4 trucks, and blue lines to motorbikes. 
 
Table 34. Network cost for Niger 
Network Total cost Transportation cost 
Storage 
cost 
Facility 
cost 
Computation 
time 
Original Network 961,014 394,852 293,862 272,300  
Original Network with 
optimized devices 660,330 140,064 247,966 272,300 ≤ 1 sec 
Optimized Network 605,193 135,107 237,286 232,800 196 hours 
 
 
 
   
Original Network Original Network  
with optimized devices 
Optimized Network 
Figure 19. Network graphs for Niger 
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The annual cost of the original network is $961,014. Maintaining the original network 
structure but optimizing the transportation vehicles and storage devices used reduces the costs to 
$660,330. Thus, if we assign the transportation vehicles and storage devices to the facilities more 
appropriately, a cost savings of about 30% is possible for this subset of the Niger network. These 
savings come mostly from reduced transportation costs. If we solve this network problem 
optimally using the MIP described in Section 5.3, the total cost is $605,193, which is almost 
another 10% in additional savings and around 37% in savings from the original network. 
However, the computation time required to solve the problem optimally was 196 hours. The 
computational experiments were done using a computer with an Intel Xeon CPU E5450 3.00 
GHz processor and 20.0 GB of RAM. Since the whole Niger network has 40 candidate hubs and 
644 clinics, solving the entire network with this computer in a reasonable amount of time is not 
possible.  
This same problem was also solved using the ES to fix the central-to-hub network 
combined with the MIP post processing to get the clinic to hub assignment. Table 35 shows the 
results of the ES + post processing for six different values of µ (the population size), where each 
of the six runs has 30 replications, each with different random number seeds.  The ES input 
parameters are shown in Table 36. Note that extensive pilot tests were run for a range of 
parameter values and these values were chosen because the pilot testing indicated that this set 
performed best.  The mean, standard deviation and minimum values across these 30 replicates 
along with the run times are reported.  We also report the number of replicates in which the best 
solution found by the ES is also the optimal solution of the MIP (=Frequency of optimum). 
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Table 35. ES results 
Population 10 25 50 100 300 600 
Min 605,193 605,193 605,193 605,193 605,193 605,193 
Avg 606,910 606,595 606,347 606,030 605,901 605,946 
SD 1,807 972 760 424 433 311 
Frequency of 
optimum 2 1 1 3 6 2 
Run time for 30 
replications (sec) 
1,114 1,122 1,383 1,744 1,957 2,354 
  
 
 
Table 36. ES parameter settings 
Parameter Value 
𝜇𝜇 (10, 25, 50, 100, 300, 600) 
𝑝𝑝𝑚𝑚 100% 
𝛼𝛼1 10 
𝛼𝛼2 20 
𝛼𝛼3 50 
𝜆𝜆2 2 
𝑝𝑝1 20% 
𝑝𝑝2 40% 
𝑝𝑝3 20% 
𝑇𝑇 100 
𝑇𝑇𝑚𝑚𝑚𝑚𝑚𝑚   1000 
 
 
 
 
Figure 20. ES results for Niger 
 
With 𝜇𝜇 ≥ 100, the ES provides stable results (Figure 20) in terms of the average quality 
of the best solution in the population. An analysis of variance indicates that there is no 
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significant difference between the solutions found by population sizes over 100 and the t-tests 
between different populations indicate that the poulation sizes that are over 100 have a 
significantly different average than those with population sizes less than 100. Thus, a population 
size of 100 or more is preferable although there is no advantage to making it larger than 100. For 
𝜇𝜇 ≥ 100, the value of the solution found is on average about $606,000, which is 0.14% higher 
than the cost found by the MIP. Recall that the ES does not assign clinics to hubs optimally, and 
therefore the best solution found by the ES is not guaranteed to be the optimal one found by 
solving the MIP. In this example, each experimental run has 30 replications and in all cases the 
minimum cost found by at least one of the replicates was equal to the optimal value of $605,193 
from the MIP. Each run takes 15 to 30 minutes to run 30 replications, which is a huge decrease 
in computation time compared to directly solving the original MIP. 
Since the clinics are assigned to the nearest hub in the ES evaluation step, the best ES 
solution is not necessarily the same as the optimal solution of the MIP. Before deciding the final 
network, replications are required to get the best solution. From the example of this section, 
regardless of the size of the population, the minimum solution across 30 replications was the 
same in all cases. So instead of increasing the size of the population, increasing the number of 
replication is a better strategy. 
5.4.3.2  Additional examples 
In order to further evaluate the performance of the ES, similar experiments, using a 
population size of 100 for the ES, are performed for a subset of the networks found in three 
countries: Benin, Country A, and Country B. (Note that we use Country A and B instead of the 
actual country names because the Ministries of Health in those countries did not give us 
permission to use their country names – while the Ministries of Health in Benin and Niger did 
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give permission to use their names.) The parameter settings for the ES are the same as with 
Niger. Table 37 provides summary data for the network subsets of these three countries. The 
results are shown in table 38. In the Benin and Country A cases, the ES consistently found the 
optimal solutions. The average ES cost for Country B is 213,692, which is 0.1% more than the 
optimal solution.  
 
Table 37. Summary data for Benin, Country A, and Country B 
 Benin Country A Country B 
Region and District distribution centers 13 10 11 
Clinics 114 106 130 
Vaccines 8 7 7 
Transportation device types 3 3 3 
Storage device types 4 4 4 
 
Table 38. Results for Benin, Country A, and Country B 
 Benin Country A Country B 
Original Network 158,330 771,290 294,739 
Original Network with optimized devices 157,052 771,290 291,103 
Optimized Network 142,543 593,326 213,422 
ES result (average of 30 replications) 142,5431) 593,3261) 213,6921) 
ES Run time for 30 replications (sec) 460 319 630 
1) These instances are relatively small, so the ES yields the same result for all 30 replications. 
 
These smaller test problems have been used to demonstrate the effectiveness of the ES 
since the optimal solution can be determined for these smaller problems. However, the ES was 
created to find solutions to larger problems which the MIP model cannot solve in a reasonable 
amount of time. Thus, we now examine country-level problems for four countries, which the 
MIP model cannot solve in real time: Niger, Benin, Country A, and Country B. Table 39 
provides summary data for these four countries. The parameter settings are the same as with the 
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previous Niger example except that the iteration limit is now set to 5000 (as opposed to 1000). 
The results are shown in Table 40.  
 
Table 39. Number of locations for Niger, Benin, Country A, and Country B 
 Niger Benin Country A Country B 
Region and District distribution centers 41 87 141 81 
Clinics 644 658 2733 851 
 
 
Table 40. Country level results for Niger Benin, Country A, and Country B 
 Niger Benin Country A Country B 
Original Network (A) 2,989,490 791,164 11,182,800 6,987,500 
Original Network with optimized devices 2,054,260 788,913 11,150,900 6,647,460 
Best ES result (B) 1,903,500 718,898 8,710,000 5,414,090 
Average 1,907,716 721,146 8,730,283 5,425,201 
Standard deviation 4,057 1,294 11,870 17,900 
Savings ((A-B)/A×100%) 36% 9% 22% 23% 
ES Run time for 30 replications 3.7 hours 5.9 hours 30.1 hours 21.5 hours 
 
5.4.4 Discussion 
The ES can obtain excellent solutions to the network problem in a very reasonable amount of 
computational time. Given that we cannot solve these large problems optimally in a reasonable 
amount of time, it is not possible to objectively evaluate the quality of the ES solution to these 
problems. However, since the ES did well on smaller examples where we could indeed verify 
optimality, it is reasonable to conclude that that these solutions are likely to be very good. This 
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performance may be explained in terms of the following structural features of the vaccine 
distribution network. 
1. A vaccine network does not have many candidate hubs relative to the total number of 
nodes in the network because the vast majority of nodes correspond to clinic locations. 
2. Clinics are often assigned to the nearest open hub in an optimal solution. 
3. The optimal network is not very deep. 
4. An optimal network has a tree structure.  
In addition, the following design features of the ES help it to find a good solution in a 
reasonable amount of time. 
1. The ES constructs the network structure only from a central distribution center to hubs. 
2. Clinics are heuristically assigned to the nearest open hub in the ES (although we allow 
ourselves the option of changing this in the post-processing step).  
3. The crossover occurs between hubs supplied by a central distribution center. 
5.5 SENSITIVITY ANALYSIS 
The vaccine distribution network has three associated cost parameters - storage, transportation 
and facility costs - that are calculated based on storage device cost per year, transportation cost 
per trip and facility cost per year, respectively. They are fixed values in the model but in practice 
it might not be possible to ascertain exact values for these. In order to investigate the effects of 
cost variation on the network structure, we perform a sensitivity analysis around these cost 
estimates. One cost element at a time is perturbed, while the other two other are fixed. Each cost 
element is altered from 10% to 1,000% of the baseline value (with the other two maintained at 
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their baseline values). Subsets of the Niger, Benin, Country A and Country B vaccine 
distribution networks are used with the MIP. For Niger a larger problem with 2 regions, which is 
used in section 5.4.3.1,is also considered, but with the ES (which will likely provide at least a 
near-optimal solution), since running the MIP for this several times would take an inordinate 
amount of time. Since the MIP can provide the optimal network, we can readily observe the 
impact of the changes. Table 41 shows the number of candidate hubs and clinics in the four 
countries.   
 
Table 41. Country information for sensitivity analysis 
Country Niger Benin Country B Country A 
Number of candidate hubs 5 13 11 10 
Number. of clinics 86 114 130 106 
 
Our interest is to study how the network changes according to how the costs vary. 
Therefore, we focus on the number of open hubs, the number of hubs supplied by a central 
distribution center and the number of levels. 
5.5.1 Results  
Table 42 shows the results of the sensitivity analysis for Niger (one district) which are obtained 
via the MIP. It indicates that changes in storage device costs have no effect on the network 
design but changes in transportation and facility cost can alter the network structure. As the 
transportation cost per trip increases from 10% to 1000% of its nominal value, the number of 
hubs increases. In the situation where the transportation cost is low, frequent trips are preferred 
and fewer hubs are open. When transportation costs are high, opening more hubs can reduce 
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costs by decreasing the number of trips required.  The effect of changes in facility cost per year 
has an opposite effect to transportation cost changes. Higher facility costs decrease the number 
of open hubs (with higher transportation costs) and lower facility costs increase the number of 
open hubs (with lower transportation costs). Tables 43-45 show the sensitivity analysis results 
for subsets of the Benin, Country B and Country A networks that were considered. These results 
show trends similar to those obtained for Niger.  
 
Table 42. Sensitivity analysis results for Niger (Dosso Province) 
Cost 
Setting Storage 10% 20% 50% 67% 100% 150% 200% 500% 1000% 
Results Number of hubs 3 3 3 3 3 3 3 3 3 Number of levels 3 3 3 3 3 3 3 3 3 
           Cost 
setting Transportation 10% 20% 50% 67% 100% 150% 200% 500% 1000% 
Results Number of hubs 1 1 3 3 3 4 4 5 5 Number of levels 3 3 3 3 3 3 3 3 3 
           Cost 
setting Facility 10% 20% 50% 67% 100% 150% 200% 500% 1000% 
Results Number of hubs 5 5 4 3 3 3 3 1 1 Number of levels 3 3 3 3 3 3 3 3 3 
 
 
Table 43. Sensitivity analysis results for Benin 
Cost 
settings Storage 10% 20% 50% 67% 100% 150% 200% 500% 1000% 
Results 
Number of hubs 5 5 5 5 4 4 3 3 3 
Number of levels 3 3 3 3 3 3 3 3 3 
           Cost 
settings Transportation 10% 20% 50% 67% 100% 150% 200% 500% 1000% 
Results 
Number of hubs 1 2 3 3 4 5 5 5 7 
Number of levels 3 3 3 3 3 3 3 3 3 
           
Cost 
settings Facility 10% 20% 50% 67% 100% 150% 200% 500% 1000% 
Results 
Number of hubs 5 5 5 4 4 4 3 2 1 
Number of levels 3 3 3 3 3 3 3 3 3 
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Table 44. Sensitivity analysis results for Country B 
Cost 
settings Storage 10% 20% 50% 67% 100% 150% 200% 500% 1000% 
Results 
Number of hubs 6 6 6 6 6 6 6 6 5 
Number of levels 3 3 3 3 3 3 3 3 3 
           
Cost 
settings Transportation 10% 20% 50% 67% 100% 150% 200% 500% 1000% 
Results 
Number of hubs 2 2 4 5 6 6 6 8 9 
Number of levels 3 3 3 3 3 3 3 3 3 
           Cost 
settings Facility 10% 20% 50% 67% 100% 150% 200% 500% 1000% 
Results Number of hubs 9 8 6 6 6 5 4 2 2 Number of levels 3 3 3 3 3 3 3 3 3 
 
 
 
Table 45. Sensitivity analysis results for Country A 
Cost 
settings 
Storage 10% 20% 50% 67% 100% 150% 200% 500% 1000% 
Results 
  
Number of hubs 2 2 2 2 2 2 2 2 2 
Number of levels 3 3 3 3 3 3 3 3 3 
           Cost 
settings 
Transportation 10% 20% 50% 67% 100% 150% 200% 500% 1000% 
Results 
  
Number of hubs 1 1 2 2 2 2 2 2 2 
Number of levels 3 3 3 3 3 3 3 3 3 
           Cost 
settings 
Facility 10% 20% 50% 67% 100% 150% 200% 500% 1000% 
Results 
  
Number of hubs 2 2 2 2 2 2 2 1 1 
Number of levels 3 3 3 3 3 3 3 3 3 
 
The Niger network instance includes only one of its eight districts, so the three level 
network is optimal even though the cost factors are altered. This makes it impossible to see any 
changes in the network’s depth. In order to examine this further, we also study a problem 
instance with two districts of Niger, which has 13 candidate hubs and 196 clinics. This instance 
can be solved by the MIP but it takes around 8 hours to get the optimal solution, so the ES is 
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used to obtain the best solution. The results are shown in Table 46. As the storage device cost 
increases, the number of levels decreases and the number of hubs decreases. This is because 
higher storage costs restrict the sizes of the open hubs and reduce the number of levels desired. 
As the transportation cost per trip increases, the number of hubs increases and the number of 
levels increases. This is because higher transportation costs call for shorter trips and the number 
of levels and hubs increase in order to reduce the trip distance. As the facility costs increase, the 
number of hubs and the number of levels decrease. In this case, in order to save costs, the 
network is forced to not open hubs and this leads to fewer levels. These increases and decreases 
exhibit monotonic behavior.  
 
Table 46. Sensitivity analysis results for Niger (two provinces) 
Cost 
settings 
Storage 10% 20% 50% 67% 100% 150% 200% 500% 1000% 
Results 
Number of hubs 9 9 8 8 8 7 7 6 4 
Number of levels 5 5 5 5 5 5 5 3 3 
           Cost 
settings 
Transportation 10% 20% 50% 67% 100% 150% 200% 500% 1000% 
Results 
Number of hubs 2 2 6 6 8 10 10 13 13 
Number of levels 3 3 3 4 5 5 5 6 7 
           Cost 
settings Facility 10% 20% 50% 67% 100% 150% 200% 500% 1000% 
Results 
Number of hubs 11 10 10 10 8 7 5 2 2 
Number of levels 5 5 5 5 5 5 4 3 3 
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5.6 APPLYING A LOOPING FACTOR 
5.6.1 Introduction  
The current model assumes that a vaccine transportation vehicle visits only one place and returns 
to the original point of departure. In practice, the vehicle may visit several locations during one 
trip as long as it has enough capacity to carry all required vaccines. In order to add travel routes 
between the central warehouse and hubs, vehicle routing constraints are required to be added to 
the MIP model. However, the vehicle routing problem (VRP) is known to be an NP-Hard 
problem. If we add VRP constraints into the current MIP model, it is not possible to solve it in 
reasonable time for even small networks. So a two-step procedure is proposed for adding vehicle 
routing. First, the network problem is solved using the MIP formulation or the ES procedure.  
Once the network is fixed and the locations supplied by each of the hubs are decided, a vehicle 
routing problem from each hub to its delivery locations is solved in order to optimize the travel 
routes for that hub. Since there may be several hubs, the number of VRPs solved would be equal 
to the number of hubs (plus one for the central warehouse). 
The introduction of vehicle routing to the network problem leads to a decrease in the 
transportation cost of the network because vehicles travel less than in a network where we 
assume that all trips are point-to-point. Thus the network structure obtained from solving our 
MIP (or by using the ES procedure) may be improved with the decreased transportation costs.  
However, we do not actually know these costs until the network is fully solved. We therefore use 
an estimate of the transportation cost for the optimization by applying a multiplicative looping 
factor, which is computed as the ratio of the transportation cost with vehicle routing to the 
transportation cost with all point-to-point travel. The transportation costs from the hub to each of 
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its delivery locations are then multiplied by this looping factor. The network design problem is 
then solved again using these lower transportation costs. Figure 21 shows an example of the 
looping factor calculation. Location D supplies locations 1-5. If a vehicle visits one place per 
trip, the total distance is 132 (left side of Figure 21). When the vehicle has two big loops (right 
side of Figure 21), the total distance is 93. Thus, the looping factor is calculated to be 0.705 
(=93/132). 
 
 
Figure 21. Looping factor example 
 
Two issues arise when we solve the network design problem again. First, the central 
distribution center and each of the hubs has its own looping factor, and the transportation costs 
between a hub and its delivery locations are each multiplied by the hub’s looping factor. The 
second issue is that the network structure obtained from the MIP or the ES procedure does not 
use all routes, so only a few vehicle routing paths are available after solving the VRPs. Therefore 
we assume that the network has representative looping factors depending on where the VRP 
origin and destinations are. We group the VRP deliveries in the network into three categories – 
central-to-hubs, hub-to-hubs and hub-to-clinics, and assume that there is a representative looping 
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factor corresponding to each of these categories.. Each representative looping factor is computed 
as the average of all looping factors computed by the different VRPs within each category. For 
example, consider the third category. Suppose there are five hubs with each one only supplying 
clinics, and suppose their looping factors are found to be 0.35, 0.4, 0.38, 0.42 and 0.45. Then the 
representative looping factor for hub-clinic deliveries is 0.4 (the average of these five values), 
and the transportation cost for deliveries from any hub to any clinic is multiplied by 0.4. 
5.6.2 Procedure 
After finding an initial network structure using the MIP or the ES, looping factors are calculated. 
However, once the network problem with the lower transportation costs is solved, the network 
structure originally obtained might change. If this happens, a fresh set of looping factors are 
computed for the new network and the procedure is repeated until there is no change in the 
network. That is, it is an iterative procedure, as shown in Figure 22.  
• STEP 0: Use the MIP or the ES to obtain the network structure {N}.  Looping factors are 
then obtained by solving VRPs resulting from {N} and the “true” cost of the network 
(assuming we use these routes) is estimated as Z; this is done by multiplying each point-
to-point transportation cost in the network by its looping factor.  
• STEP 1: The network problem is re-solved with these looping factors using the MIP or 
the ES. If the structure of the new network {Nnew} is identical to {N} , we stop and the 
current network structure is the best we can find. If the network structure has changed, 
the VRPs resulting from this new structure {Nnew} are solved and new looping factors 
obtained. The “true” cost of the network {Nnew} is estimated as Znew by multiplying the 
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original point-to-point transportation costs in the network by the appropriate looping 
factors 
• STEP 2: If Znew ≥ Z then the new network {Nnew} is not better and we stop with {N} as the 
best structure we can find. If Znew < Z  we have a better network, so we redefine 
{N}≡{Nnew},  Z = Znew  and return to Step 1.  
 
 
Figure 22. Apply looping factors 
 
5.6.3 Vehicle routing problem 
There are many algorithms that have been developed for the VRP. Because the VRP is known to 
be NP-Hard, many of these are heuristics. For this network problem, both an MIP formulation 
and a heuristic method are used in this research. Since we need to solve many VRPs while 
applying a looping factor, the MIP formulation is used for smaller problems where the VRPs can 
be solved efficiently, while the heuristic is used when the VRPs take too much time to solve 
optimally.  
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5.6.3.1 MIP Formulation 
In this section, we describe a mathematical formulation corresponding to the VRPs that we solve. 
This formulation considers the vehicle type to use for each loop and its capacity. It uses a binary 
variable as a vehicle flow variable to show if there is travel between two locations using a 
specific vehicle.  
 
Notation 
 𝐶𝐶𝑖𝑖𝑖𝑖𝑡𝑡𝑇𝑇 ,𝑑𝑑𝑖𝑖,𝐵𝐵𝑖𝑖,𝑃𝑃𝑡𝑡𝑇𝑇 ,𝐶𝐶,𝐻𝐻, and 𝑇𝑇 follow the same notation as the network MIP. Define  
𝑥𝑥𝑖𝑖𝑖𝑖𝑡𝑡 ∈ {0,1}: 1 if 𝑖𝑖 and 𝑗𝑗 are connected using vehicle type 𝑡𝑡;  0 otherwise. 
𝑦𝑦𝑖𝑖𝑖𝑖𝑡𝑡 ∶ amount of vaccine transported from 𝑖𝑖 to 𝑗𝑗 using vehicle type 𝑡𝑡.    
The following MIP is used to solve the VRP:  Min � � 𝐶𝐶𝑖𝑖𝑖𝑖𝑡𝑡𝑇𝑇 𝑥𝑥𝑖𝑖𝑖𝑖𝑡𝑡
𝑖𝑖,𝑖𝑖∈𝐶𝐶∪𝐻𝐻𝑡𝑡∈𝑇𝑇   (81)  
𝑠𝑠𝑠𝑠𝑏𝑏𝑗𝑗𝑀𝑀𝑐𝑐𝑡𝑡 𝑡𝑡𝑓𝑓   
� � 𝑥𝑥𝑖𝑖𝑖𝑖𝑡𝑡
𝑖𝑖∈𝐶𝐶∪𝐻𝐻𝑡𝑡∈𝑇𝑇
= 1 for   ∀𝑗𝑗 ∈ 𝐻𝐻 (82)  
� 𝑥𝑥𝑖𝑖𝑖𝑖𝑘𝑘
𝑖𝑖∈𝐶𝐶∪𝐻𝐻
− � 𝑥𝑥𝑖𝑖𝑖𝑖𝑡𝑡
𝑖𝑖∈𝐶𝐶∪𝐻𝐻
= 0 for   ∀𝑝𝑝 ∈ 𝐻𝐻,∀𝑡𝑡 ∈ 𝑇𝑇 (83)  
� � 𝑦𝑦𝑖𝑖𝑖𝑖𝑡𝑡
𝑖𝑖∈𝐶𝐶∪𝐻𝐻𝑡𝑡∈𝑇𝑇
−� � 𝑦𝑦𝑖𝑖𝑖𝑖𝑡𝑡
𝑖𝑖∈𝐶𝐶∪𝐻𝐻𝑡𝑡∈𝑇𝑇
= 𝑑𝑑𝑖𝑖 for   ∀𝑗𝑗 ∈ 𝐻𝐻 (84)  
𝐵𝐵𝑖𝑖𝑥𝑥𝑖𝑖𝑖𝑖𝑡𝑡 ≤ 𝑦𝑦𝑖𝑖𝑖𝑖𝑡𝑡 ≤ 𝑃𝑃𝑡𝑡
𝑇𝑇𝑥𝑥𝑖𝑖𝑖𝑖𝑘𝑘 for   ∀𝑖𝑖, 𝑗𝑗 ∈ 𝐶𝐶 ∪ 𝐻𝐻, 𝑖𝑖 ≠ 𝑗𝑗,∀𝑡𝑡 ∈ 𝑇𝑇 (85)  
𝑦𝑦𝑖𝑖𝑖𝑖𝑡𝑡 ≥ 0 for   ∀𝑖𝑖, 𝑗𝑗 ∈ 𝐶𝐶 ∪ 𝐻𝐻, 𝑖𝑖 ≠ 𝑗𝑗,∀𝑡𝑡 ∈ 𝑇𝑇 (86)  
𝑥𝑥𝑖𝑖𝑖𝑖𝑡𝑡 ∈ {0, 1} for   ∀𝑖𝑖, 𝑗𝑗 ∈ 𝐶𝐶 ∪ 𝐻𝐻, 𝑖𝑖 ≠ 𝑗𝑗,∀𝑡𝑡 ∈ 𝑇𝑇 (87)  
 
Constraints (82) and (83) ensure that a facility is visited exactly once and that if a vehicle 
visits a location, it must also depart from it. Constraint (84) specifies that the difference between 
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the quantity of vaccines a vehicle carries before and after visiting a facility is equal to the 
demand of that facility. Constraint (85) ensures that the vehicle capacity is never exceeded. 
5.6.3.2  Heuristic method 
Our heuristic uses a constructive method based on the algorithm of Clark and Wright (1964). In 
this algorithm, point-to-point routes are combined to form a loop by choosing the routing path 
that gives the largest transportation cost savings at each iteration until every location is linked. 
For our network problem, vehicle type is considered when the savings on the route are 
calculated. For checking if a route is feasible, both vehicle capacity and trip distance are 
considered.  
 
Modified Clark and Wright algorithm  
Label the delivery locations as 1, 2, ..., n and label the origin  as 0. 
Determine the costs 𝐶𝐶𝑖𝑖𝑖𝑖𝑡𝑡𝑇𝑇  to travel between all pairs of delivery locations  and between each 
delivery location and the origin and for each vehicle type, i.e., for i=0, 1, .., n; j=0, ..., n and j≠i , 
t∈T 
1. Calculate the savings 𝑆𝑆𝑖𝑖𝑖𝑖𝑘𝑘=𝐶𝐶𝑖𝑖0𝑡𝑡𝑇𝑇 + 𝐶𝐶0𝑖𝑖𝑡𝑡𝑇𝑇 − 𝐶𝐶𝑖𝑖𝑖𝑖𝑡𝑡𝑇𝑇    for all pairs of delivery -locations i, 
j and vehicle types t (i=1, 2...n; j=1, 2...n; i=/ j, t∈T). 
2. Order the savings, 𝑆𝑆𝑖𝑖𝑖𝑖𝑡𝑡, from largest to smallest. 
3. Starting with the largest savings, do the following: 
    (a)      If linking  delivery locations i and j results in a feasible route, then add this link to 
the route; if not, reject the link. 
    (b)      Try the next savings in the list and repeat (a). 
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Checking for route feasibility 
If the sum of vaccine volumes required at the delivery locations on the route is less than or equal 
to the capacity of the vehicle and the total travel distance of the vehicle is less than or equal to 
the maximum travel distance of the vehicle, the route is feasible; otherwise, the route is 
infeasible. 
5.6.4 Numerical example 
Table 47 shows results from the Cotonou province of Benin when vehicle routing is considered. 
This example is small enough that we can use the MIP to solve the network and also use an MIP 
formulation to solve the VRPs. The original optimal value for the network {N} obtained after 
solving the problem is 142,543. The corresponding VRPs are then solved and the looping factor 
for the central distribution center to the hubs is computed as 0.4333 (i.e., 43.33%) while the 
looping factor for the hub to the clinics is 0.4585 (i.e., 45.85%). There is no hub to hub 
connection in this original network. The network cost with vehicle routing is estimated as 
Z=138,810; this is obtained by multiplying the transportation costs at each route (edge) by its 
looping factor. In particular, the transportation costs per km (𝐶𝐶𝑖𝑖𝑖𝑖𝑡𝑡𝑇𝑇 ) from the central distribution 
center to each hub and from each hub to a clinic are multiplied by 0.4333 and 0.4585, 
respectively.  
Next, the MIP is solved again with transportation costs based on the above looping 
factors and we obtain a new network {Nnew} with a cost of 138,393. After solving the associated 
VRPs this new network yields values of 1.00 and 0.391 respectively for the looping factors for 
central to hubs and hub to clinics each, and the true cost for this network {Nnew} with routing is 
estimated as Znew =138,333. Since the network is changed and the cost has decreased 
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(138,333<138,810 (Table 47)), we perform a second iteration after resetting Z=138,333 and 
{N}≡{Nnew}.  
After the second iteration, the new network {Nnew} is different from {N} and the VRPs 
yield new looping factors of 1.00 and 0.316. Since there is improvement in the network cost 
(Znew= 137,494<138,333=Z  (Table 47)), a third iteration is performed after resetting Z=137,494. 
After the third iteration, the solution to the network design problem is the same as the one from 
the previous iteration. Therefore, we stop here and accept this network structure with vehicle 
routing as the final one. Table 48 also shows the results for the same problem using the heuristic 
method for the VRPs instead of the MIP formulation. The iterations proceed in a similar fashion 
but the final network is different with looping factors of 1.00 and 0.3533 and a final cost of 
Z=137,831. The final network with the MIP VRP solver is little bit better than with the heuristic 
VRP solver (137,474 <137,831), because the MIP VRP solver provided optimal VRP solutions. 
 
Table 47.  Results of applying a looping factor for Benin (MIP-MIP) 
  Initial Network Iteration 1 Iteration 2 Iteration 3 
MIP  Cost 142,543 138,393 138,171 137,494 
Looping 
Factor  
(MIP) 
C-H 43.33% 100.0% 100.0% 100.0% 
H-H - - - - 
H-I 45.85% 39.10% 31.60% 31.60% 
Cost (Z) 138,810 138,333 137,494 137,494 
 
 
Table 48. Results of applying a looping factor for Benin (MIP-Heuristic) 
   Initial Network Iteration 1 Iteration 2 Iteration 3 
MIP Cost 142,543 138,753 138,419 137,831 
Looping 
factor 
(Heuristic) 
C-H 43.33% 100% 100% 100% 
H-H - - - - 
H-I 50.64% 41.85% 35.33% 35.33% 
Cost (Z) 139,106 138,539 137,831 137,831 
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Figure 23 shows the network structures at each iteration. As the iterations proceed, the 
number of hubs decreases. This is because allowing vehicle routing reduces the transportation 
cost substantially and this result is similar to the one obtained while conducting sensitivity 
analysis on transportation costs.  
 
 
Figure 23. Network structure at each iteration (MIP-MIP) 
 
5.6.5 Discussion 
If a vehicle has enough capacity, visiting several locations during a trip is reasonable. Actually, 
this is common in practice. So solving a network assuming point-to-point trips can result in an 
undesirable solution. In this section, we described how vehicle routing can be incorporated into 
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the network problem using looping factors. Here, three looping factors – central distribution 
center to hubs, hub to hub, and hub to clinic - are used. This makes the simplifying assumption 
that the transportation costs between all points at one level and all destinations at the next lower 
level can be reduced by a similar percentage using delivery loops.  
We cannot guarantee that the final network is optimal with vehicle routing because the 
network and the vehicle routing problems are not solved together. However, since vehicle 
routing has the effect of reducing transportation costs, if that reduced transportation cost can be 
incorporated when the network problem is solved, we can expect to find high quality solutions 
by applying looping factors.  
5.7 IMPROVING THE EVOLUTIONARY STRATEGY 
5.7.1 Introduction 
The ES solves the network design problem from a central distribution center to hubs and a sub-
network from hubs and clinics is automatically constructed by assigning the clinics to the nearest 
open hub. After the ES process, an MIP is used to optimize the sub-network. Since the sub-
network is not optimized when the ES decides the best solution, the best ES solution before 
optimizing the sub-network might not be the best solution after optimizing the sub-network. For 
example, the 10th ES solution can lead to the best solution of the network after optimizing the 
sub-network. In this section, we improve the ES for this problem by storing some of the solutions 
that are obtained during the intermediate ES iterations. 
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5.7.2 Improved ES 
Since the ES is a stochastic optimization method, it is run for a predetermined number of 
replications in order to obtain the best solution. For example, if there are n replications of the ES, 
we have 𝑛𝑛 ES runs and 𝑛𝑛 MIP runs during post-processing. Without increasing the run time, we 
could possibly improve the ES results. Instead of solving an MIP corresponding to the best ES 
solution after each ES run and repeating this process 𝑛𝑛 times, we start by storing the best 𝑛𝑛 ES 
solutions from the first run. After each of the subsequent runs we update the list of the 𝑛𝑛 best ES 
solutions found thus far by replacing existing solutions on the list with any better ES solutions 
found in the current run. After 𝑛𝑛 replications of the ES, we solve 𝑛𝑛 MIPs using the final list of 
the 𝑛𝑛 best ES solutions. This method could possibly provide a network solution that might not 
have been possible to obtain using our original ES approach.  
 
 
Figure 24. Original ES vs Improved ES 
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5.7.3 Numerical example  
Table 49 shows the result of the original ES (left) and the improved ES (right) for 3 regions of 
Niger; 20 ES runs are performed for this network problem. The left half of the table (with the 
original ES) shows the best original ES value from each run and the value after applying the MIP 
to these. After 20 runs, the final best solution of the original problem yields a cost of 1,032,590. 
The right half of the table (with the improved ES) shows the final best 20 ES values (arranged in 
order) after 20 runs/replications. After using the MIP to further improve each, the best solution is 
1,032,550 which is slightly better than the final solution of the original ES and could not be 
obtained by the original ES.  
 
Table 49. Original ES vs improved ES for 3 regions of Niger 
Run Original ES Original ES + MIP  Order Improved ES Improved ES + MIP 
Rank 
(Improved ES + MIP) 
1 1,038,580 1,035,840  1 1,035,330 1,032,590 2 
2 1,040,200 1,036,690  2 1,035,860 1,033,120 5 
3 1,035,330 1,032,590  3 1,035,870 1,033,130 6 
4 1,036,130 1,033,390  4 1,035,940 1,034,710 15 
5 1,036,440 1,033,700  5 1,035,950 1,034,710 15 
6 1,036,290 1,032,720  6 1,036,070 1,032,550 1 
7 1,036,670 1,033,930  7 1,036,290 1,032,720 3 
8 1,035,330 1,032,590  8 1,036,330 1,033,590 9 
9 1,036,330 1,033,590  9 1,036,350 1,035,120 18 
10 1,035,330 1,032,590  10 1,036,360 1,033,200 8 
11 1,037,110 1,033,540  11 1,036,400 1,033,690 10 
12 1,037,840 1,034,270  12 1,036,440 1,033,700 11 
13 1,036,440 1,033,700  13 1,036,470 1,035,230 19 
14 1,035,330 1,032,590  14 1,036,470 1,035,230 19 
15 1,036,670 1,033,930  15 1,036,590 1,033,050 4 
16 1,038,580 1,035,840  16 1,036,670 1,033,930 12 
17 1,036,660 1,033,920  17 1,036,810 1,033,160 7 
18 1,037,470 1,033,900  18 1,036,850 1,034,110 13 
19 1,036,330 1,033,590  19 1,036,870 1,034,130 14 
20 1,036,290 1,032,720  20 1,036,900 1,034,830 17 
Min 1,035,330 1,032,590  Min 1,035,330 1,032,550  
Original ES   Improved ES 
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Similarly, table 50 shows a comparison of the original ES and improved ES results for 4, 
5, 6, and 7 (all) regions of Niger. The figures in the table are the final solution of each ES after 
processing via the MIP. In all cases, the improved ES results are slightly better than the original 
ES. 
 
Table 50. Original ES vs. Improved ES results for Niger 
 4 Regions 5 Regions 6 Regions 7 Regions 
Original ES + MIP 1,304,170 1,647,660 1,761,630 1,904,160 
Improved ES + MIP 1,302,930 1,647,570 1,759,320 1,902,850 
  
 
5.7.4 Discussion 
Here, the number of ES iterations and the number of solutions in the final set of the best ES 
solutions are the same, but this need not have to be the case depending on the problem size and 
time available to solve it. As the size of the problem increases, the list can be longer and cover 
more different network structures as long as the computational time does not increase too much. 
Also, the ES runs can be stopped earlier if we cannot update the ES best solution set for some 
predetermined number of experimental runs (replication).  For example, we might start with a 
plan of n=50 runs, but if there is no improvement in the best ES solution set for 10 successive 
runs after the 17th one, the ES process might then be halted after the 27th iteration.  
While the improved ES can generally provide a better solution, this is not necessarily 
guaranteed because the best solution obtained by the original ES method might not be included 
in the best 𝑛𝑛 ES solutions after 𝑛𝑛 ES runs. This issue can be readily resolved by also storing the 
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best solution from each ES run across the entire set of runs and also solving the MIPs 
corresponding to these after the completion of all runs. This requires at most 𝑛𝑛 more MIP runs. 
However, since many of the best solutions from each ES run will be included in the ES best 
solution set, it is likely to be much smaller in practice. This additional step ensures that the 
improved ES is never worse than the original ES. 
5.8 USING THE ES RESULTS AS MIP CONSTRAINTS 
5.8.1 Introduction 
For a large network problem, the rapid increase in computational effort makes the MIP an 
impractical approach. Because the network is fully connected, the MIP searches all possible 
solutions, and pruning the undesirable solutions is time consuming. If we can restrict the network 
structure by adding constraints that help decrease the solution space, the processing time can 
decrease. Since the improved ES generally provides very good solutions, one approach might be 
to make use of information about common characteristics of good solutions from the ES. In this 
section, we study what information from the best ES solutions we can use, and how. 
5.8.2 Available network structure information from the ES solutions 
The ES solutions provide the network structures from the central distribution warehouse to the 
hubs. The network structure from each of the solutions has the following information associated 
with it: 
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1. The number of open hubs  
2. The number of hubs supplied by the central distribution center  
3. The number of hubs supplying only clinics  
4. Hubs that are open in all ES solutions in the solution set 
5. Hubs that are closed in all ES solutions in the solution set 
6. Hubs that are supplied by the central distribution center in all ES solutions in the 
solution set 
7. Hubs that are not supplied by the central distribution center in all ES solutions in the 
solution set 
8. Hubs that supply only clinics in all ES solutions in the solution set 
 
Predetermining the number of hubs (based on 1, 2, and 3) can directly decrease the 
solution space in the MIP model. For example, if the number of open hubs is prespecified to be 
between four and six in a problem which has 11 potential hub locations, the MIP does not need 
to search among solutions that have more than six or fewer than four hubs. The information on 
hubs that are open or  closed in all good solutions (based on 4 and 5) also can directly set the 𝑊𝑊 
variables in the MIP which represent whether a hub is open or not. Information on whether open 
hubs are supplied by the central distribution center or not (based on 6 and 7) can decide the value 
of the 𝑈𝑈 variables from central distribution to hubs. Finally, the information on whether open 
hubs supply only clinics (from 8) sets the U variables. If a hub supplies only clinics, the values of 
U from the hub to other hubs becomes 0. 
These can be categorized into three groups depending on where the information comes 
from. The first group (1, 4, and 5) is related to open hubs for each ES solution. The second group 
(2, 6, and 7) is connected to open hubs supplied by the central warehouse. The third group (3 and 
8) relate to open hubs supplying only clinics. 
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Table 51 shows how to use the ES solutions for the first group. The example network has 
10 candidate hubs and 10 ES solutions after the improved ES. The 0 or 1 in for each solution in 
the table represents whether the corresponding hub is open or not for that solutions. The last 
column is the total number of open hubs. The minimum number of open hubs is four (ES 
solution 1 and 3) and the maximum is six (ES solution 9). This implies that the optimal solution 
probably has four to six open hubs. So we can add following constraints into the MIP model.   
�𝑊𝑊𝑖𝑖 ≤ 6|𝐻𝐻|
𝑖𝑖=1
  (88)  
�𝑊𝑊𝑖𝑖 ≥ 4|𝐻𝐻|
𝑖𝑖=1
 
 (89)  
 
The sum for each column is the number of times that the hub 𝑖𝑖 corresponding to that 
column is chosen in our solutions. For example, the value of 10 for the second column indicates 
that the second hub is always selected as an open hub. The sum for the eighth column is 7 this 
indicates that the eighth hub is not always selected for opening. The first hub is never selected.  
If the sum for column 𝑖𝑖 is 10, the 𝑖𝑖𝑡𝑡ℎ hub is always open hub and if the sum is 0, the hub is 
always closed. So we can add following constraints into the MIP model. 
𝑊𝑊2 = 𝑊𝑊3 = 𝑊𝑊4 = 1  (90)  
𝑊𝑊1 = 𝑊𝑊6 = 𝑊𝑊7 = 0  (91)  
If we look at the eighth and ninth column, we can see that exactly one of these is selected 
in each of the 10 runs. So we could add the following constraint. 
𝑊𝑊8 + 𝑊𝑊9 = 1  (92)  
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 Table 51. First group example (whether a hub is open or not) 
Solutions 
Hub No. of open 
hubs 1 2 3 4 5 6 7 8 9 10 
1 0 1 1 1 0 0 0 0 1 0 4 
2 0 1 1 1 0 0 0 1 0 1 5 
3 0 1 1 1 0 0 0 1 0 0 4 
4 0 1 1 1 1 0 0 1 0 0 5 
5 0 1 1 1 1 0 0 0 1 0 5 
6 0 1 1 1 0 0 0 1 0 1 5 
7 0 1 1 1 0 0 0 0 1 1 5 
8 0 1 1 1 1 0 0 1 0 0 5 
9 0 1 1 1 1 0 0 1 0 1 6 
10 0 1 1 1 0 0 0 1 0 1 5 
Total 0 10 10 10 4 0 0 7 3 5   
 
Table 52 shows how to use the ES solutions for the second group. The example network 
is the same as with the first group. In this table, the figures represent whether a hub is supplied 
by the central distribution center (=1) or not (=0) for each ES solution. The last columns displays 
the number of hubs supplied by the central warehouse in each ES solution. The minimum 
number is two and the maximum is three. This indicates that the central warehouse probably 
supplies two to three hubs in the optimal network. So we can add following constraints into the 
MIP model.   
�𝑈𝑈0𝑖𝑖 ≤ 3|𝐻𝐻|
𝑖𝑖=1
  (93)  
�𝑈𝑈0𝑖𝑖 ≥ 2|𝐻𝐻|
𝑖𝑖=1
 
 (94)  
The sum for each column is the number of times in our solution set that hub 𝑖𝑖 is chosen to 
be supplied by the central warehouse. For example, the value of 10 for the second column 
indicates that the second hub is always supplied by the central warehouse. The sum for the third 
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column is 8, but the sum for the third column in Table 52 was 10. This implies that the third hub 
is not always supplied directly by the central warehouse when it is open. The fourth hub is never 
supplied by the central warehouse. If the sum for column 𝑖𝑖 is 10, the 𝑖𝑖𝑡𝑡ℎ hub is always considered 
to be supplied by the central distribution center and if the sum is 0 even though the hub is open, 
it is supplied by some other hub. So we can add following constraints into the MIP model. 
𝑈𝑈02 = 1  (95)  
𝑈𝑈04 = 𝑈𝑈05 = 𝑈𝑈0,10 = 0  (96)  
 
Table 52. Second group example (whether a hub is supplied by the central location) 
ES 
Solutions 
Hub 
Total 
1 2 3 4 5 6 7 8 9 10 
1 0 1 1 0 0 0 0 0 1 0 3 
2 0 1 1 0 0 0 0 1 0 0 3 
3 0 1 1 0 0 0 0 0 0 0 2 
4 0 1 1 0 0 0 0 0 0 0 2 
5 0 1 0 0 0 0 0 0 1 0 2 
6 0 1 1 0 0 0 0 1 0 0 3 
7 0 1 1 0 0 0 0 0 1 0 3 
8 0 1 1 0 0 0 0 1 0 0 3 
9 0 1 1 0 0 0 0 1 0 0 3 
10 0 1 0 0 0 0 0 1 0 0 2 
Total 0 10 8 0 0 0 0 5 3 0   
 
Finally, Table 53 shows how to use the ES solutions for the third group. Once again, we 
use the same example as before. In this table, the figures represent whether a hub supplies other 
hubs or not for each ES solution (i.e., serves as a transshipment node for other hubs). We denote 
any hub that does not supply other hubs as a leaf hub. If the hub is a leaf hub, the value in the 
table is 1. If the hub supplies other hub(s) or is not open, the value is 0. The last column indicates 
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the number of leaf hubs for each ES solution. The minimum number is one and the maximum is 
three. This indicates that the number of leaf hubs is probably between one and three in the 
optimal network. Using just the current notation in the MIP model, it is impossible to express 
these additional restrictions. The sum for a column is the number of times across all the ES 
solutions that the corresponding hub 𝑖𝑖 is chosen as a leaf hub. For example, the value of 10 for 
the fourth column indicates that the fourth hub is always a leaf hub. It can be seen that the entries 
for the fourth, fifth and tenth columns are identical to those in Table 53 for the same columns. 
This indicates that these two hubs serve as leaf hubs whenever they are chosen to be open. So we 
can add the following constraints into the MIP model. 
�𝑈𝑈4𝑖𝑖 =|𝐻𝐻|
𝑖𝑖=1
�𝑈𝑈5𝑖𝑖 =|𝐻𝐻|
𝑖𝑖=1
�𝑈𝑈10𝑖𝑖 = 0|𝐻𝐻|
𝑖𝑖=1
  (97)  
 
Table 53. Third group example (whether a hub supplies other hubs) 
ES 
Solutions 
Hub 
Total 
1 2 3 4 5 6 7 8 9 10 
1 0 0 0 1 0 0 0 0 0 0 1 
2 0 0 0 1 0 0 0 0 0 1 2 
3 0 0 0 1 0 0 0 1 0 0 2 
4 0 0 0 1 1 0 0 1 0 0 3 
5 0 0 1 1 1 0 0 0 0 0 3 
6 0 0 0 1 0 0 0 0 0 1 2 
7 0 0 0 1 0 0 0 0 0 1 2 
8 0 0 0 1 1 0 0 0 0 0 2 
9 0 0 0 1 1 0 0 0 0 1 3 
10 0 0 1 1 0 0 0 0 0 1 3 
Total 0 0 2 10 4 0 0 2 0 5   
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5.8.3 Numerical example 
Since the additional constraints from the ES results can reduce the search space for the MIP, we 
can expect a reduction in its run time. Table 54 shows results for subsets of Benin (Benin 1 and 
2), with 20 runs of the ES. Benin 1 and 2 are smaller problems, so they can be solved by the MIP 
in reasonable time. In the table, “MIP” implies that the problem is solved by the MIP without 
any additional constraints. MIP + ES 1 means that the constraints from the first group are added 
into the problem. MIP + ES 1/2 means that the constraints from the first and second groups are 
added into the problem. When the Benin 1 problem is solved without any additional constraint, it 
takes 67 seconds. If we add the first group of constraints, the run time decreases to 30 seconds. 
When the first and second group constraints are added, the run time is only 8 sec. . For Benin 2, 
the results shows a similar performance improvement. 
 
Table 54. Run time for Benin 1 and 2 
Region No. of Locations MIP MIP + ES 1 MIP + ES 1/2 
Benin 1 128 67 sec. 30 sec. 8 sec. 
Benin 2 162 153 sec. 88 sec. 13 sec. 
 
Table 53 shows another example of a larger subset of Benin (Benin 3). This example is 
with two regions of Benin (Cotonou and Porto Novo) with 271 locations. The original MIP 
cannot be solved for this problem. After 30 runs of the improved ES, the cost of the best solution 
is 264,949 with a 2,940 second run time. When we use only the first group information, the MIP 
still cannot be solved even after running for 24 hours. When the second group information is also 
used, we can solve the problem in 318 seconds with a value of 264,802, which is slightly better 
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than the ES solution. This example shows that adding constraints mined from the ES result can 
lead to better solutions from the MIP formulation.  
 
Table 55. Results for Benin 3 
Benin 3 Improved ES (30 runs) MIP + ES 1 MIP + ES 1/2 
Best Solution 264,949 264,802 264,802 
Run time 2,940 sec. Stopped after 24hours 318 sec. 
 
The next example is for two and three regions of Niger and the results are shown in Table 
56. The Niger two-region instance is the largest problem for which we were able to obtain an 
optimal solution with the original MIP formulation albeit in 196 hours of run time. This example 
shows how much of a reduction in run time of the MIP can be obtained by using the ES results. 
Note that MIP+ ES 1/2/3 means that constraints from all the groups are added into MIP. Without 
additional constraints, it takes 196 hours to get the optimal solution. However, as we add more 
constraints, the run time decreases to 61.8 hours, then to 11.5 hours and finally, to 0.5 hours with 
all three constraint groups. Thus we are able to solve the same problem using only 0.3% of the 
original MIP run time when all information from the ES solutions is used. The Niger 3 region 
instance could not be solved at all by the original MIP. Even when the constraints from the first 
and second group are added, we are still unable to obtain a solution. But, when constraints 
derived from all three groups are inserted, the MIP could be solved in 16.4 hours. 
 
Table 56. Results for two and three regions of Niger 
Niger  MIP MIP + ES 1 MIP + ES 1/2 MIP + ES 1/2/3 
2 Regions Best Solution 605,190 605,190 605,190 605,190 Run time 196 hours 62 hours 11.5hours 0.5 hours 
3 Regions 
Best Solution 1,032,593 1,032,593 1,032,593 1,032,551 
Run time Stopped after 48 hours 
Stopped after 24 
hours 
Stopped after 24 
hours 16.4 hours 
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5.8.4 Discussion 
Clearly, adding constraints derived from the ES solutions into the MIP model can significantly 
reduce the run time because it decreases the search space; note that this search space still 
includes the best solution from the ES results. There are two issues when we use the ES 
solutions. First, the number of ES solutions to use should be decided carefully. If we have too 
many, the search space might not be reduced sufficiently to save run time because the ES 
solution set might include some relatively poor solutions that lead to relatively weak constraints. 
For example, as we have more ES solutions, the range of the number of open hubs will increase 
or the open hubs that are always selected might not be found. Conversely, if we do not have 
enough ES solutions, the solution space might be too tight for the MIP with the additional 
constraints in order to be able to find a better solution. There could also be correlations that are 
coincidental. For example, in Table 21, the eighth and ninth hubs are mutually exclusive in the 
10 ES solutions, so the constraint 𝑊𝑊8  +  𝑊𝑊9  = 1 might be added. But this might be a 
coincidence, and it might not be easy to say whether these hubs are truly mutually exclusive; we 
should probably look at the geographical relationship between two locations before using this 
constraint. Even if hub A and hub B are chosen to be mutually exclusive, if they are located far 
apart, it is probably better not to use this constraint.  
Finally, we also experimented briefly with constraining the number of levels in the 
network.  In the examples of Benin in section 5.8.3, we can observe that the depth of the optimal 
network might be two since all the open hubs are supplied by the central distribution center in all 
ES solutions. Therefore, we could also try limiting the depth of the network. The constraint 
restricting the network depth to two is obtained by not allowing a flow between candidate hubs: 
𝑈𝑈𝑖𝑖𝑖𝑖 = 0 for all 𝑖𝑖, 𝑗𝑗 ∈  𝐻𝐻. If we add this constraint for Benin 1, 2, and 3 examples, the run times 
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are 28, 58 and 1,528 seconds. These run times are shorter than MIP + ES 1 but longer than MIP 
+ ES 2/3. This is likely because ES 2/3 constraints already involve depth restriction constraints 
and appear to be more efficient than adding the depth constraint.  
5.9 DISCUSSION AND CONCLUSIONS 
Cordeau et al. argue that solving a real-life problem to optimality is rarely justified due to errors 
contained in the data estimates. Since the margin of error for data tends to be larger than 1%, 
they suggest that it is adequate to run the mathematical solver until a feasible solution within 1% 
of optimality has been identified (Cordeau, Pasin, & Solomon, 2006). In the vaccine network, the 
demands at local clinics, transportation costs, and storage costs are fluid and we use 
estimated/averaged values here for these here. The solutions produced by the ES are reasonably 
close to the optimal MIP solutions (less than 1% difference). In addition, the computation time is 
vastly smaller. Therefore, solving the vaccine distribution network design problem using an ES 
approach can be a good way to address the problem. 
This chapter focuses on designing a vaccine distribution network in terms of cost 
minimization. Obviously, the resulting network is more cost effective than the original one. 
However, there are other considerations that are not able captured by this model. First, we may 
have to consider the cost of closing a hub. This is not considered in our model since usually the 
candidate hub is a local health facility with other functions that it will continue with, even 
without the vaccine distribution role. But if a hub is not open, the devices used in the hub, such 
as refrigerators, might be moved to another facility that needs them. So, if the cost associated 
with this is included in the model, we can have more precise results. Second, the new network 
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usually has fewer intermediate hubs. This might increase the risk of losing more vaccines due to 
unexpected circumstances such as unstable power supply. The countries supported by the WHO-
EPI program still have problems such as unannounced electricity blackouts and poorly trained 
workers, and a significant number of vaccine vials might be wasted because of undesirable 
handling of vaccine or events such as electricity loss. The fewer the number of facilities where 
vaccines are stored, the more the amount of vaccines at any single facility and the higher the 
consequences of such losses. Third, vehicles with limited capacity are used in the model. But in 
practice, they can transport more vaccines, especially at the clinic level. As an extreme example, 
when a vehicle has a capacity of 5 liters and 5.1 liters of vaccine should be delivered, a vehicle 
may be able to carry 5.1 liter of vaccine in a trip, but we assume in our model that two vehicle 
trips are needed. 
This chapter also does not consider the introduction of new vaccines in the future. If a 
new vaccine is introduced, it will require more space in storage and transportation and may 
change the optimal network structure. In order to address this, some kind of robustness analysis 
with respect to the vaccine schedule should be performed. This can be done as follows. First, set 
the demands at clinics based on different vaccine schedules. Second, obtain the vaccine networks 
for each scenario. Third, compare the cost of each network for the different demands. The 
network which has the lowest total cost for all demands could then be the final network 
For NP-hard problems like the one in this chapter, the MIP computation time increases 
dramatically as the problem size gets larger. Since most real world vaccine distribution networks 
have many candidate hubs and demand nodes, finding the optimal solution using an MIP 
formulation of the problem cannot be done in a reasonable amount of time. Therefore, in this 
chapter, an ES algorithm is proposed to solve this problem, and it is shown that the ES 
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consistently produces a near-optimal solution in reasonable times. In addition, visiting several 
locations during a trip is common practice. In order to model this, the two step procedure using 
looping factors was introduced. Since the effect of vehicle routing is a reduction in transportation 
costs, solving the network problem after modifying the transportation cost using a looping factor 
presents a comparable result with solving the network problem using vehicle routing. Therefore, 
this study can help decision makers who plan to redesign their distribution chain which has 
features similar to those described here. 
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6.0  SUMMARY AND CONCLUSIONS 
In this dissertation, we have proposed models and methodologies that can help increase the 
efficiency of the WHO-EPI vaccine supply chain in meeting the demand for life-saving vaccines 
in low and middle income countries.  Despite many technological advances that have been made 
over the last four decades, these distribution chains and their operations still pose many problems 
in many places around the world.  The problems relate both to how the distribution chain is 
designed as well as to how it is operated, and in this dissertation we address both of these 
aspects. The overall goal is to improve coverage and to be able to inoculate the millions of 
children who still do not receive life-saving vaccines against preventable diseases because of 
inadequacies in the distribution system.    
This research had focused on three major areas. First, we have introduced four 
optimization models for the vaccine outreach supply chain in developing countries.  Since the 
level of coverage that one gets from outreach in practice is not clearly understood, we develop 
three different models, each of which is based on a different plausible coverage assumption, and 
we have presented robust approaches to cope with the uncertainty associated with our coverage 
assumptions, as well as the uncertainty associated with demand for outreach. To our knowledge 
the work reported here is the first to provide a formal modeling framework for decision making 
with respect to outreach. Currently, there are no standard guidelines for outreach, and these 
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models can aid decision makers to improve coverage when they are establishing outreach 
policies.   
In next two chapters, we have addressed operational issues and focused on simplifying 
vaccine ordering logistics. This is important because in many low and middle income countries 
these operations are performed in the field by personnel who are not necessarily trained for 
logistics activities. Thus it is critical to develop operational procedures that are efficient but also 
simple enough to be implemented in a resource constrained environment.   First, we have 
suggested a modular packaging system for vaccines. The modular packaging can be obtained by 
standardizing the dimensions of vaccine vials and packaging units as far as possible. This could 
offer significant advantages over a conventional vaccine packaging system with respect to space 
efficiency as well as convenience of handling vaccine orders by allowing for more vaccines to be 
stored within the same volume in the storage devices. Second, we have proposed vaccine 
ordering policies using inner packs for the clinic level in order to simplify how inventories are 
managed in the field.  The proposed policies can reduce errors in counting and ordering, as well 
as order fulfillment effort, and are based on lean concepts that are already used widely in 
manufacturing. Because these policies might need a larger packaging unit that increases the 
required storage volume, we have performed the required analyses with respect to cold storage 
during transportation as well as at clinics in order to evaluate their impact.  The proposed 
simplified ordering policies are shown to work better when the vaccine inner packs are 
standardized because the modular packaging can use space more efficiently.  
Lastly, we address the fundamental issue of designing the vaccine distribution network 
based on the specific characteristics and operating environment of the country where it will be 
implemented. This is similar to how any other supply chain network is designed and in contrast 
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to the somewhat rigid structure that exiting WHO-EPI networks have.  We have presented 
methodologies which can improve the design of vaccine distribution networks at a country level 
while considering constraints on capacity for storage and transportation, by formulating the 
problem as a mixed integer program and developing an evolutionary strategy that can be used in 
conjunction with the MIP. Computational examples based on real data are used to illustrate that 
this is an appropriate approach. In order to reflect how deliveries might be made in practice, we 
have developed the notion of looping factors and presented how these can be applied in the 
network problem. In addition, we have suggested ways to improve the efficiency of the ES 
algorithm without any significant additional computational effort. 
Although we have addressed a diverse set of issues in this research there are still open 
questions including the design and optimization of alternative outreach policies that can be 
standardized in the field, the development of easy-to-use policies and procedures that can reduce 
operational inefficiencies (especially at the clinic level), and the development of better and more 
detailed models for designing/redesigning the WHO-EPI network that can also be solved 
efficiently.   
There is also the potential to evaluate different modeling frameworks because the current 
MIP is a flow based formulation and its computational time grows quickly as the size of the 
problem gets larger. Alternative formulations may be able to reduce the computational time. All 
of these present areas for future research. 
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